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Chapter 1
Outline and introduction
Chapter 1
During their lifespan, erythrocytes become smaller and lose haemoglobin in 
an age-dependent manner. In Chapter 1, Introduction, several aspects of the 
study of erythrocyte aging related to this thesis are summarized. In Chapter 2, 
Quantification of loss of haemoglobin components from the circulating 
red blood cell in vivo, the contribution of the various major and minor 
haemoglobin components to the net loss of haemoglobin molecules is 
described. The various haemoglobin components are measured in erythrocyte 
fractions obtained by separation according to volume and, subsequently, to 
density. These fractions differ in mean cell age. This technique enables us to 
track cellular loss and posttranslational modification of haemoglobin 
components during the life span of the erythrocyte.
Vesicles, defined as subcellular microparticles, are present in the circulation. 
Those vesicles originate from various cell types, including erythrocytes. In 
chapter 3, Haemoglobin loss from erythrocytes in vivo results from 
spleen-facilitated vesiculation, the haemoglobin composition of 
erythrocyte-derived vesicles is explored. It proved to be possible to compare 
the relative concentrations of the major and minor haemoglobin components 
in both young and old erythrocytes with those in vesicles. This comparison 
allows to discover clues on the mechanisms involved in the loss of 
haemoglobin. In order to elucidate the role of the spleen in this process, the 
loss of haemoglobin in patients who underwent splenectomy, was 
investigated. In the absence of a spleen, erythrocytes are macrocytic and 
contain more and larger intracellular vesicles than control erythrocytes. 
Furthermore, the erythrocytes of asplenic individuals contain an increased 
percentage HbAlc.
In chapter 4, Liver Kupffer cells rapidly remove red blood cell-derived 
vesicles from the circulation by scavenger receptors, the fate of 
erythrocyte-derived vesicles and the role of Kupffer cells and scavenger 
receptors are explored. Firstly, in rats an age-dependent haemoglobin loss 
occurs that is similar to the human situation. In this rat model 51Cr-labelled, 
erythrocyte-derived vesicles are cleared from the blood very rapidly, mainly
Outline of this thesis
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by Kupffer cells in the liver. This uptake is inhibited by blockade of 
scavenger receptors.
Current theories about the removal of old erythrocytes are centred around 
naturally occurring autoantibodies against senescent cell antigens. Some 
argue that complement has an additional role in this process, whereas others 
state that the exposure of phosphatidylserine on old erythrocytes may suffice. 
Both mechanisms facilitate phagocytosis. In chapter 5, Erythrocyte 
vesiculation: a self-protective mechanism?, human erythrocyte-derived 
vesicles were investigated for the presence of removal signals, such as band 
3-associated senescent cell antigens, cell-bound IgG, and phosphatidylserine.
Programmed cell death, apoptosis, constitutes an important regulatory 
mechanism in the function and life of nucleated cells. In chapter 6, 
Erythrocyte aging: a more than superficial resemblance to apoptosis?,
the experimental data from our and others studies on erythrocyte aging to the 
mechanism that leads to apoptosis are compared. The discussion is focussed 
on membrane-associated processes and ligands for phagocytosis. 
Enumeration of erythrocyte-derived vesicles in combination with clearance 
and loss of volume allows quantitative estimations of the kinetics of the 
vesiculation process.
In chapter 7, The red cell revisited: matters of life and death, our studies 
are summarized and the consequences of our findings for erythrocyte 
lifespan, metabolism of glycated haemoglobins, the M-indices of 
erythrocytes and transfusion medicine, especially regarding transfusion 
efficiency and transfusion-related side effects are discussed.
In chapter 8, General discussion and summary, our recent results are 
summarized and discussed. A new model is proposed, which integrates 
erythrocyte vesiculation as an essential process in erythrocyte aging. This 
model could inspire further studies to improve our understanding of the aging 
process and hopefully leads to improvements of erythrocyte units for 
transfusion.
11
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The erythrocyte loses volume, surface area and haemoglobin when it 
becomes older. In this thesis the mechanism involved in the decrease of these 
parameters is studied, particularly with respect to the role of vesiculation. 
Characterization, function, and removal of erythrocyte-derived vesicles are 
explored and the findings are correlated with the age-related changes of 
erythrocytes and the elimination of old erythrocytes.
The lifespan of the erythrocyte
Death is not only inherent to life in general, but also to the life of the 
erythrocyte. When blood of a compatible but discordant blood group is given 
to a patient, the donor erythrocytes will disappear during the following weeks 
(Ashby, 1919) as assessed by differential agglutination (Todd & White, 
1911). The measured survival curve is linear and shows that the lifespan of 
transfused erythrocytes amounts to approximately 120 days (Callender et al, 
1945; Dornhorst, 1951). This observation suggested that erythrocytes have a 
limited lifespan. Consequently, it had to be assumed that the erythrocyte 
population is constantly renewed. This hypothesis was subsequently 
confirmed by means of cohort labelling of erythrocytes through 
administration of a labelled precursor of erythrocyte constituents during a 
short period of time. Haemoglobin was marked with the stable isotope 15N by 
oral administration of 15N-glycine during a few days. In these experiments it 
was established that, after leaving the bone marrow, mature erythrocytes 
remain in the circulation for 120 +/- 15 days (Shemin & Rittenberg, 1946).
In a similar fashion, administered 59Fe, bound to transferrin, is rapidly taken 
up by erythroblasts and reticulocytes, which results in a rapid increase in 
erythrocytic 59Fe (Finch et al, 1949; Berlin & Berk, 1975). Although efficient 
reutilisation of iron prohibits a reliable measurement of the lifespan of the 
erythrocyte (Berlin et al, 1959), the 59Fe labelling technique proved to be 
very useful for the study of iron metabolism (Ricketts et al, 1975; Ricketts et 
al, 1977; Marx, 1979; Marx & van den Beld, 1981), as well as for the 
validation of methods used to fractionate old and young erythrocytes (Borun 
et al, 1957; Prankerd, 1958; Hoffman, 1958; Van der Vegt et al, 1985).
Introduction
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Similarly, the survival of erythrocytes can be measured by monitoring the 
disappearance of erythrocytes that are randomly labelled with Na251CrO4, 
which binds preferentially to haemoglobin (Berlin et al, 1959; Mollison et 
al, 1987). In contrast to the Fe-label, the 51Cr-label is not reutilized. 51Cr-label 
was originally used for the measurement of total erythrocyte mass, but later 
it was predominantly applied for measurement of the survival of 
heterologous as well as homologous erythrocytes (Mollison et al, 1987). 
Elution of the 51Cr-label from the erythrocyte at a variable rate with a mean 
of 1% per day is a serious drawback of this technique. It results in 
curvilinear disappearance curves and necessitates the use of correction factors 
(Berlin et al, 1959; Mollison et al, 1987). Although in this way clinically 
significant reductions in erythrocyte survival can be measured, it does not 
permit a direct determination of the erythrocyte life span (Cavill, 2002).
DF32P (di-isopropyl phosphofluoridate) is another random label (Cohen & 
Warringa, 1954), which in an irreversible manner binds to cholinesterase at 
the outside of the erythrocyte (Mollison et al, 1987). After reinjection of the 
marked erythrocytes about 5 - 10% of the label is lost during the first 24 
hour, whereafter the disappearance curve remains linear (Bratteby & 
Wadman, 1968). Life span measured with this label ranged from 99 to 130 
days (Mollison et al, 1987).
More recently, random biotinylation of erythrocytes in vivo or ex vivo has 
been described in studies of erythrocyte aging. Fluorochrome-labelled 
streptavidin allows enumeration of biotinylated erythrocytes with 
flowcytometry (Hoffmann-Fezer et al, 1991; Hoffmann-Fezer et al, 1993; de 
Jong et al, 2001; Suzuki & Dale, 1987; Mock et al, 1999b; Mock et al, 
1999a). The results obtained with biotinylation were virtually identical to the 
results achieved with 51Cr. Development of anti-biotin-antibodies may 
interfere with an accurate interpretation of the eventual data (Cordle et al, 
1999). Also, changes in the expression of erythrocyte antigens have been 
described after biotin labelling (King & Hemming, 1994; Cowley et al, 
1999). In addition, it has to be taken into account that a steep decrease in the 
number of biotinylated erythrocytes may occur after the consumption of eggs,
14
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that contain high concentrations of avidin (Cavill et al, 1988). In a recent 
study the lifespan of the erythrocyte was shown to range from 100 to 140 
days in healthy subjects. This may explain the variation in percentage HbAic 
(Cohen et al, 2008).
The results of a rather restricted number of measurements of erythrocyte life 
span, as summarized by Mollison, do not allow a clear consensus, but lead to 
the conclusion that the erythrocyte life span must be somewhere between 105 
and 135 days in a healthy individual (Mollison et al, 1987).
The fate of haemoglobin
The use of labelled glycine in the first cohort studies (Shemin Rittenberg, 
1946) was more than appropriate for the combined study of formation and 
breakdown of erythrocytes as well as haemoglobin. Indeed, glycine is not 
only used for the synthesis of the globin moiety of haemoglobin, it is also an 
essential precursor of protoporphyrin that forms the haem moiety after the 
addition of iron. This allows measurement of the lifespan of the erythrocyte 
by the rate of disappearance of labelled erythrocytes and by the rate of 
appearance of the 15N-label in stercobilin, one of the breakdown products of 
haem.
After administration of 15N-labelled glycine, two peaks in the levels of 
excreted 15N-labelled bile pigment were found (London et al, 1950). The 
early increase appeared to originate from intramedullarly destructed 
haemoglobin molecules, indicating that a subset of the erythroblasts is 
removed early during erythropoiesis. A marked second peak, observed after 
120 days, represents the removal of old erythrocytes. During the episode 
between both peaks a low, stable amount of labelled stercobilin was 
measured. It took quite some time before a reasonable explanation for this 
phenomenon was found. Eventually, it was postulated that this steady 
presence of traces of degraded haemoglobin was due to continuously ongoing 
erythrocyte destruction (Berlin et al, 1959). This observation served as a 
trigger to explore the dynamics of the mechanisms that control the 
homeostasis of the erythrocyte population without unnecessary loss of
15
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precious resources. Various studies that address this issue are the subject of 
this thesis.
Methods to obtain erythrocytes of various ages
In order to enable the study of the mechanisms that govern the lifespan of the 
erythrocyte, methods had to be developed to obtain pure populations of 
erythrocytes of defined ages. Around 1950, it became apparent that after 
centrifugation, the fraction of the most dense cells at the bottom of the tube, 
is enriched for old erythrocytes (Allison & Burn, 1955; Borun et al, 1957; 
Prankerd, 1958; Hoffman, 1958; Bernstein, 1959). However, when attempts 
were made to validate density fractionation by means of cohort labelling of 
erythrocytes with 59Fe, the dense fractions were shown to be more 
heterogeneous with respect to erythrocyte age than the lighter fractions. The 
latter were strongly enriched for reticulocytes and young erythrocytes 
(Bernstein, 1959; Berlin et al, 1959; Garby & Hjelm, 1963; Van Gastel, 
1965). Higher centrifugal forces did not improve the quality of the separation. 
Slighty better results were achieved by means of continuous or discontinuous 
density gradients (Corash et al, 1974), but it became clear that age-related 
purification on the basis of density alone has inherent restrictions (van der 
Vegt et al, 1985; Bosch et al, 1992). Notwithstanding these limitations, the 
results appeared solid enough for some investigators to formulate several 
hypotheses about aging and death of erythrocytes (Glader, 2004).
In the meantime it had been recognized that the shape of cells in combination 
with their volume allowed for a physical separation of the individual 
populations by means of counterflow centrifugation (Lindbergh, 1932; 
Lindahl, 1948). In this technique a flow of buffer is established from the 
outer end to the inner end of the centrifugation chamber, counteracting the 
centrifugal force (Sanderson et al, 1976; Sanderson & Bird, 1977). Using 
59Fe labelling, it was shown that this technique yields fractions enriched for 
old and young cells, (van der Vegt et al, 1985). Subsequently, it was 
reported that the erythrocyte populations obtained by combining counterflow 
with subsequent density centrifugation, were much more homogeneous with
16
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respect to cell age than when either of the techniques was used separately 
(Bosch et al, 1992).
Percentage of HbA1c as a marker of erythrocyte age
The non-enzymatic glycation of haemoglobin (HbA0) leading to the 
intracellular accumulation of the minor hemoglobins, HbAia, HbAib, and 
HbAic has been shown to constitute a solid basis for the use of HbAic in 
particular as a marker of cell aging (Bunn et al, 1976). The percentage of 
HbAic is dependent on the mean glucose concentration in plasma over a 
period of time of several weeks (Koenig et al, 1976). In a healthy individual 
with a well-controlled glucose concentration and erythrocyte life span, a 
linear and reproducible increase in the percentage of HbAic can be expected. 
The validity of HbAic as a cell age marker was corroborated by measuring 
the specific 59Fe radioactivity of HbA1c and of HbA0 after administration of 
59Fe-labelled transferrin. The specific activity of HbA0 displayed a rapid 
increase, whereas the specific activity of HbAic showed a slow, linear 
increase, which flattened after approximately 80 days (Bunn et al, 1976). 
Since the percentage of HbAic can be accurately determined in very small 
numbers of erythrocytes, it is evident that HbAic is a very useful marker of 
cell age (van der Vegt et al, 1985; Bosch et al, 1992)
Age-dependent changes in erythrocyte MCV, MCH, MCHC, and surface 
area
In most studies on the separation of erythrocytes on the basis of density, an 
inverse relationship was found between density and size (Hoffman, 1958; 
Borun, 1963; Westerman et al, 1963; Prentice & Bishop, 1965; Van Gastel, 
1965; Piomelli et al, 1967; Murphy, 1973; De Regt, 1973; Cohen et al, 1976; 
Seaman et al, 1977; Kirkpatrick et al, 1979; Shiga et al, 1979; Nash & 
Wyard, 1980; Linderkamp & Meiselman, 1982). The higher density of 
smaller cells is a rather consistent, although not unchallenged, observation 
(van der Vegt, 1984). However, after a density separation the cell volume 
distribution curve is rather broad (Van Gastel, 1965). Moreover, 
measurements of distribution curves of both erythrocyte volume and
17
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erythrocyte haemoglobin concentration by means of haemocytometry 
confirmed that density fractionation alone yields fractions that are very 
heterogeneous in cell volume (Mohandas et al, 1986; Bosch et al, 1992). The 
MCV of fractions obtained with counterflow centrifugation differ 
substantially (van der Vegt et al, 1985; Bosch et al, 1992). When 
counterflow centrifugation was followed by density centrifugation, the MCV 
decreased from 101 fl in the lightest and largest erythrocyte fraction to 72 fl 
in the fraction with the most dense and smallest erythrocytes. The fractions 
showed a considerably less broad cell volume-based distribution curve in 
comparison with fractions separated with density alone (Bosch et al, 1992).
Erythrocyte fractionation on the basis of density showed inconsistent results 
with regard to the amount of haemoglobin per cell, the MCH (Bernstein, 
1959; Borun, 1963; Prentice & Bishop, 1965; Van Gastel, 1965; Piomelli et 
al, 1967; Murphy, 1973; De Regt, 1973; Cohen et al, 1976; Seaman et al, 
1977). On the other hand, a separation procedure according to volume 
displayed a consistent, significant decrease in MCH in the erythrocyte 
fractions with a lower MCV (van der Vegt et al, 1985; Bosch et al, 1992). 
When density separation was applied after an initial counterflow separation 
no further decrease in MCH was observed in the final erythrocyte fractions 
(Bosch et al 1992).
Density separation demonstrated, as expected, an increase in MCHC in the 
most dense fractions, whereas fractions separated according to volume did 
not expose any differences in MCHC at all (van der Vegt et al, 1985; Bosch 
et al, 1992). The smallest cells revealed the highest MCHC when both 
fractionation techniques were combined (Bosch et al, 1992).
Fractions obtained by the combination of separation techniques showed a 
decrease in surface area of approximately 20%. Because the decrease of 
MCV is larger, the surface to volume ratio increases, which may increase 
deformability. However, this favourable effect is abolished by an increase of 
the MCHC and probably by a decreased elasticity of the erythrocyte 
membrane (Bosch et al, 1994; Bosch, 1994).
18
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When haemocytometry, which allows for the simultaneous measurement of 
MCV and MCHC of individual erythrocytes, was applied to erythrocyte 
fractions obtained with density or volume separation alone or with the 
combination of both separation techniques, the cell population of the lighter- 
larger fraction and the denser-smaller fraction from the combination of 
separation techniques did not show any overlap in the erythrocytograms. This 
contrasts with the fractions obtained by the single separations. Likewise, a 
larger difference in the percentage of HbAic was found for the erythrocyte 
fractions acquired by combination of the separation methods. This 
observation indicates that combining separation techniques yields erythrocyte 
fractions with a greater difference in mean cell age than does separation on 
the basis of density or volume alone (Bosch et al, 1992).
The importance of volume in the changes of the erythrocyte during its 
lifespan is underscored by the linear correlation between MCV and the 
percentage of HbAic (van der Vegt et al, 1985; Bosch et al, 1992). This 
finding was confirmed by others (Lasch et al, 2000; Gifford et al, 2006). In 
contrast, both MCH and MCHC correlate poorly with age (Bosch et al, 
1992).
In summary, it can be firmly stated that, during its life, the erythrocyte loses 
30% of its volume and 20% of its haemoglobin, whereas its haemoglobin 
concentration increases by 14%. This also implies that erythrocytes lose 
proportionally more water than haemoglobin when they become older (Bosch 
et al, 1992).
The function of the spleen in the maturation of erythrocytes and its 
influence on erythrocyte life span
Analysis of the events that occur after splenectomy provides compelling 
evidence for a regulatory function of the spleen in the homeostasis of the 
erythrocyte (Crosby, 1952; Crosby, 1977; Clark & Shohet, 1985; De Haan, 
1988). After splenectomy, the erythrocytes display, at a steady state, a 
moderate increase in volume together with a larger increase in surface area, 
resulting in a higher area to volume ratio than observed in non-
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splenectomized controls. These processes account for a higher osmotic 
resistance as well as for the emergence of extremely thin red blood cells, the 
so-called leptocytes (Crosby, 1952; Cooper & Jandl, 1969; Eggink, 1973; De 
Haan et al, 1988c). Leptocytosis also has been found in iron deficiency, 
thalassaemia and in diseases of liver and bile duct (Werre, 1968). Normally, 
reticulocytes are significantly larger than mature erythrocytes. Maturation of 
the reticulocyte is accompanied by a decrease in both its cell volume and cell 
surface area, in association with an increase in its haemoglobin concentration 
(Winterbourn & Batt, 1970; Shattil & Cooper, 1972; Snyder et al, 1985; 
Houwen, 1992). Membrane remodelling in reticulocyte maturation is 
associated with the release of exosomes, which are preformed in 
multi vesicular bodies and contain for instance the transferrin receptor 
(Johnstone, 2005). In various animal models splenectomy is followed by a 
delayed and incomplete reticulocyte maturation with less outspoken changes 
in volume and surface area as compared with reticulocytes of animals with a 
functional spleen (Winterbourn & Batt, 1970; Shattil & Cooper, 1972; 
Snyder et al, 1985).
A study on the time course of the changes in reticulocytes and erythrocytes 
after splenectomy in humans, did not show splenectomy-associated 
differences in the cellular volume of reticulocytes. However, one week after 
splenectomy, a threefold increase in reticulocytes was observed. After two 
months, a stable phase was established with a slightly higher number of 
reticulocytes. Furthermore, no evidence was found that splenectomy 
stimulates erythropoiesis. Therefore, these results suggest a delayed 
maturation of reticulocytes after splenectomy (De Haan et al, 1988a). The 
effects of splenectomy on changes in the mature erythrocyte were studied as 
well. As discussed in the previous section, both volume and surface area of 
mature erythrocytes decline continuously during their life time. After 
splenectomy, old cells display a higher surface area to volume ratio than 
younger cells, mainly due to a lesser decrease of the surface area. Therefore, 
in a splenectomized individual older erythrocytes contribute to the higher 
osmotic resistance of the erythrocyte population (De Haan et al, 1988c). 
These observations indicate that the effects of splenectomy are not restricted
20
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to the reticulocytes and young cells. The delayed reticulocyte maturation and 
impaired decrease in surface area after splenectomy implies a specialized 
function of the spleen that is only partially taken over by other organs 
(Crosby, 1977). Under normal circumstances this specialized task is 
presumably exerted by the mononuclear phagocyte system of the spleen.
The proportional contribution of the phagocytes in the various organs such as 
bone marrow, spleen, liver and lungs to the actual elimination process of old 
erythrocytes remains a matter of discussion. Since the life span of 
erythrocytes before and after splenectomy is similar (Gevirtz et al, 1962; 
Berlin & Berk, 1975), it can be concluded that the presence of a spleen is not 
essential for the removal of old erythrocytes in humans.
Intra-erythrocytic vacuoles and the spleen
Electronmicrographs revealed that cytoplasmic vacuoles are found in the 
cytoplasma of erythrocytes from both normal, healthy subjects and 
splenectomized patients (Koyama et al, 1962). The erythrocytes of 
splenectomized patients contain more small vacuoles as well as larger 
vacuoles than erythrocytes from subjects with a spleen (Reinhart & Chien, 
1988). The larger vacuoles are seen as pits in phase contrast microscopy 
(Holroyde et al, 1969). After splenectomy the percentage of ‘pitted’ 
erythrocytes can be as high as 30%, whereas in healthy subjects only a small 
number of such pitted cells are found (Koyama et al, 1962; Holroyde & 
Gardner, 1970; De Haan et al, 1988a). It should be noted that 4% - 10% 
pitted erythrocytes can be found in elderly people, due to an impaired splenic 
function in 25% of the elderly population (Markus & Toghill, 1991). Usually 
the vacuoles are empty, but some studies have indicated that they may 
contain amorphous material as well as membrane patches and, more 
frequently, haemoglobin or haemoglobin degradation products (Koyama et 
al, 1962; Kent et al, 1966; Holroyde & Gardner, 1970; Schnitzer et al, 1971). 
It has been suggested that the pits in erythrocytes are related to the 
autophagic vacuoles in erythroblasts and reticulocytes (Kent et al, 1966). 
When erythrocytes from healthy donors with an intact spleen are given to an 
asplenic recipient, pits that are identical to those seen in the recipient’s
21
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erythrocytes will emerge in the donor erythrocytes. Conversely, when 
erythrocytes from a splenectomised individual are transfused to control 
recipients, the pits disappear rapidly (Holroyde & Gardner, 1970). Hence, it 
can be concluded that normal erythrocytes may carry pits that are removed or 
dissolved under the influence of the spleen. It has been argued that 
haemoglobin or haemoglobin-derived products play a key role in the 
complex process of pit formation and elimination (Koyama et al, 1962; Kent 
et al, 1966; Holroyde & Gardner, 1970; Schnitzer et al, 1971). This process 
shows analogy to the process of pitting of other inclusion bodies as Heinz 
bodies, Howell-Jolly bodies, and siderotic granules, a specialized function of 
the spleen (Crosby, 1959). The increase in intracellular HbAi, found after 
splenectomy, may be related to the retention of vacuoles within the 
erythrocytes, suggesting a role of the spleen in the removal of haemoglobin 
and haemoglobin derivatives (De Haan et al, 1988b). It has been suggested 
that under normal condition haemoglobin is eliminated by the release of 
haemoglobin containing vesicles (Crosby, 1977; Lux & John, 1977; 
Dumaswala & Greenwalt, 1984). Exploration of the possible influence of the 
spleen on the loss of haemoglobin from the erythrocytes during their lifespan 
is one of the subjects of this thesis.
Band 3, erythrocyte aging and removal signals
The anion exchanger and major integral membrane protein band 3 has been a 
crucial subject in the research of erythrocyte lifespan and phagocytosis of old 
erythrocytes. Band 3 is a member of the SLC4 anion exchanger family, and 
plays as the chloride/bicarbonate exchanger a major role in carbon dioxide 
transport (Alper, 2006). Band 3 also has a key role in regulation of 
erythrocyte metabolism. The cytoplasmic N-terminus of band 3 provides high 
affinity sites for enzymes of glycolysis. Binding of glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH), a key enzyme in glycolysis, inhibits its 
activity and is under control of protein tyrosine phosphorylation (Alper, 
2006; Campanella et al, 2005). Furthermore, band 3, at the centre of a 
multiprotein complex (Bosman & Kay, 1990; Bruce et al, 2003), has an 
essential role in the maintenance of the membrane structure. The cytoplasmic
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N-terminus provides through the intermediate action of ankyrin the 
interaction site by which the lipid bilayer is anchored to the spectrin/actin 
cytoskeleton (Reid & Mohandas, 2004).
It has been shown that older erythrocytes bind autoantibodies. Peptide 
inhibition studies reveal that these antibodies are directed against epitopes on 
band 3 (Kay, 2005). Autoantibodies that bind to old erythrocytes (100 -  500 
copies per cell may be sufficient) lead to recognition and subsequently 
phagocytosis of old erythrocytes by macrophages (Kay, 2005). This 
senescent cell antigen (SCA) is thought to be formed by a conformational 
change of band 3, that occurs somewhere during the lifespan of the 
erythrocyte. This conformational change is probably the result of a 
breakdown of band 3 (Kay, 2005). High molecular-weight forms of band 3 or 
band 3-containing that are reactive with autoantibodies have been described 
as specific for old erythrocytes (Belo et al, 2002; Ciccoli et al, 2004; Rossi et 
al, 2006). Thus there is no consensus on whether the crucial changes leading 
to senescent cell antigen activity are caused by band 3 degradation or cross­
linking (Arese et al, 2005; Kay, 2005). Others have noticed that the binding 
of deoxyhaemoglobin and denatured haemoglobin at the cytoplasmic tail of 
band 3 induces band 3 aggregation (Low et al, 1985), although this has been 
disputed (Lelkes 1988). They postulate that this aggregation is the trigger for 
the formation of the senescent cell antigen.
Others hypothesize that old erythrocytes are recognized through the exposure 
of phosphatidylserine on the outer leaflet of the plasma membrane (Shukla & 
Hanahan, 1982; Connor et al, 1994; Boas et al, 1998; Rettig et al, 1999; 
Kuypers & de Jong, 2004). Indeed, it is known that membrane regions with a 
high exposure of phosphatidylserine serve as strong ligands for scavenger 
receptors (Terpstra et al, 2000) and PS specific receptors (Fadok et al, 2000; 
Fadok et al, 2001) on macrophages. However, this mechanism has only been 
proven to be active in the removal of pathologic erythrocytes (Kuypers & de 
Jong, 2004).
In this thesis, changes in band 3, the role of the senescent cell antigens 
leading to binding of IgG, and phosphatidylserine exposure are studied with
23
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respect to their role in the elimination of erythrocytes and erythrocyte-derived 
vesicles.
Plasma vesicles
In early days, it was recognised that plasma contains a subcellular factor 
that is capable of stimulating coagulation (Chargaff & West, 1946; 
O'Brien, 1955). Later, this factor was identified as platelet-derived 
microparticles, termed ‘platelet dust’ (Wolf, 1967). The clinical 
importance of these microparticles was revealed in patients suffering from 
a rare hereditary disease with a bleeding tendency, the Scott syndrome. 
The platelets of these patients show a markedly deficient 
prothrombinase activity accompanied by a decreased formation of 
vesicles (Weiss et al, 1979; Zwaal & Schroit, 1997). The calcium- 
induced vesiculation of erythrocytes of these patients was found to be 
decreased as well (Zwaal & Schroit, 1997). Vesicles obtained from 
plasma contain haemoglobin, which indicates that, similar to 
platelets, erythrocytes generate vesicles in vivo (Dumaswala & 
Greenwalt, 1984). The erythrocyte origin of these vesicles could be 
confirmed by demonstration of the presence of the erythrocyte-specific 
marker protein glycophorin A (Simak & Gelderman, 2006). Moreover, 
plasma was also found to contain vesicles derived from endothelial cells, 
from monocytes, granulocytes and lymphocytes (Nieuwland et al, 
1997; Berckmans et al, 2001; VanWijk et al, 2003; Simak & 
Gelderman, 2006) These vesicles, especially those derived from 
platelets and endothelial cells, are the subject of increasing attention 
from experts in the field of haemostasis and thrombosis (VanWijk et al, 
2003; Freyssinet, 2003; Hugel et al, 2005; Morel et al, 2006; Lynch 
& Ludlam, 2007; Ardoin et al, 2007). Finally, vesicles may also play 
a role in the thrombotic sequela of cancer (Rauch & Antoniak, 2007).
Vesiculation occurs upon activation or apoptosis of cells. The 
mechanism of vesiculation was studied in detail during platelet 
activation (Zwaal & Schroit, 1997). From these studies the view 
emerged that an increase in the cytosolic calcium concentration is one
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of the many effects of platelet activation. This increase has 
consequences for the activity of the enzymes involved in the 
maintenance of the phospholipid asymmetry of the plasma membrane. 
Phosphatidylcholine and sphingomyeline are mainly present in the outer 
leaflet of the plasma membrane and phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) are mainly present in the inner leaflet. 
The enzyme flippase, a Mg+ ATP-dependent aminophospholipid 
translocase, facilitates the rapid transport of the phospholipids PS and 
PE from the outer to the inner leaflet. The transport of all phospholipids 
from the inner to the outer leaflet is facilitated by the multidrug 
resistance protein 1, MRP I , a ATP-dependent enzyme, at a much slower 
rate than flippase. The phospholipid asymmetry of the plasma membrane is 
maintained by the concerted action of these enzymes. An increased 
cytosolic calcium concentration inhibits flippase and activates Ca2+ 
dependent scramblase, which facilitates rapid movement of the phospholipids 
from the inner leaflet to the outer leaflet of the plasma membrane and vice 
versa. It has been speculated that a further increase in cytosolic Ca2+- 
concentration may cause activation of the protease calpain. This protease is 
supposed to disrupt the interactions between plasma membrane and the 
cytoskeleton which leads to microvesiculation.
Due to the aforementioned activation of scramblase the vesicles expose 
phosphatidylserine at their surface (Zwaal & Schroit, 1997). This 
negatively charged area provides a suitable binding place for 
coagulation factors, suggesting a role of plasma vesicles in coagulation 
and thrombosis. Furthermore, the phosphatidylserine at the surface can 
be recognized by scavenger receptors (Terpstra et al, 2000) and the PS 
specific receptors (Fadok et al, 2001) of various types of phagocytes.
Microvesiculation accompanies apoptosis. Externalization of PS is an early 
sign of proapoptotic stimulation (Zwaal & Schroit, 1997) and has been 
associated with microvesiculation (Simak & Gelderman, 2006). In this 
process an increased Ca2+-concentration in the cytoplasma and activation of 
calpain (Zwaal & Schroit, 1997; Boulanger et al, 2006) and caspases-1 like
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activity (Simak & Gelderman, 2006) are suggested to be active. The 
apoptotic execution protease caspase-3 is not involved in apoptotic 
microvesiculation in contrast to its essential role in the formation of apoptotic 
bodies (Simak & Gelderman, 2006).
Erythrocyte vesiculation in vitro: models and experiments
Erythrocyte vesiculation is studied almost exclusively in experimental 
conditions. In a typical experiment, erythrocytes were stored for 3 -  7 days in 
autologous plasma. Vesiculation was made visible by electron microscopy 
(EM) (Bessis & Mandon, 1972). The erythrocyte morphology changed from 
the normal discoid cells to echinocytes. The scanning EM pictures clearly 
show protrusions, on top of which vesicles seem to be pinched off, and 
chains of vesicles protrude from the cell. In some cells intracellular vesicles 
are observed (Bessis & Mandon, 1972).
Erythrocyte vesiculation has been used as a model for calculations on the 
interaction between membrane and cytoskeleton (Sens & Gov, 2007). In one 
model, the membrane stretches the cytoskeleton. Without this stretching 
force, the area of the cytoskeleton would be reduced 3- to 5-fold. Vice versa, 
the cytoskeleton exerts a compressing force on the membrane. When the 
stretching action diminishes, e.g. by a disruption of the linkage between lipid 
bilayer and cytoskeleton, or when the bending tendency of the membrane 
increases, the compressive force of the cytoskeleton induces a membrane 
buckle, that easily is pinched off by fusion of the opposite membrane patches 
(Sens & Gov, 2007).
Several experimental approaches has been developed for the study of 
erythrocyte vesiculation. The most important models will shortly be 
discussed.
Ca2+-induced vesiculation
Vesiculation has been studied in detail by increasing the intracellular Ca2+- 
concentration through incubation with the ionophore A23187. This treatment 
induces a complete transition of all erythrocytes to echinocytes within one 
hour (Allan & Michell, 1975). In these circumstances the erythrocytes form
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haemoglobin-containing vesicles. Two populations arise that differ in size: 
microvesicles ranging from 100 to 250 nm and nanovesicles with a diameter 
of less than 100 nm (Allan et al, 1980; Salzer et al, 2002). Further studies 
revealed that vesiculation is dependent on two effects of increasing the 
intracellular Ca2+-concentration: both K+-efflux leading to cell shrinkage and 
breakdown of phosphatidylinositolphosphate (PtdInsP) and 
phosphatidylinositol-biphosphate (PtdInsP2) (Allan & Thomas, 1981). 
Calcium-induced crosslinking and proteolytic breakdown of proteins may not 
be essential for vesiculation (Allan & Thomas, 1981). Another consequence 
of increased cytoplasmic Ca2+-concentration is the loss of the phospholipid 
asymmetry of the membrane (Comfurius et al, 1990; Schroit & Zwaal, 1991; 
Zwaal & Schroit, 1997). As a consequence, both remnant cells and vesicles 
expose phosphatidylserine (PS) at the outside of the erythrocyte and stimulate 
prothrombinase activity (Comfurius et al, 1990; Kuypers et al, 1996). 
Although Ca2+-induced vesiculation and phospholipid scrambling are closely 
related, it is not known whether the loss of lipid asymmetry is essential for 
vesiculation. Increased calcium concentration may induce phospholipid 
redistribution and microvesicle release in erythrocytes by independent 
pathways (Bucki et al, 1998). PtdInsP2, which promotes the Ca2+-induced 
phospholipid scrambling, may do so by formation of lateral membrane 
domains of PtdInsP2 (Bucki et al, 2000). During Ca2+-induced vesiculation, 
phosphorylation of band 3 occurs, but inhibition of this phosphorylation, did 
not prevent vesiculation to occur (Minetti et al, 1996).
Amphiphilic compounds and vesiculation
Vesiculation also can be induced by exposing erythrocytes to amphiphilic 
compounds such as glycocholate (Billington & Coleman, 1978), 
dimyristoylphosphatidylcholine (DMPC) (Ott et al, 1981), and merocyanine 
540 (MC540) (Allan et al, 1989). According to the bilayer membrane model 
(Sheetz & Singer, 1974), negatively charged amphiphilic compounds 
preferentially intercalate in the outer leaflet resulting in its expansion. In 
erythrocytes, this would lead to an echinocytic phenotype. In contrast, 
positively charged amphiphilic compounds preferentially are inserted in
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inner leaflet. This results in an expansion of the inner leaflet. In erythrocytes 
this expansion causes a cupped morphological phenotype. A relatively small 
expansion of the outer or inner leaflet may be sufficient for a shape change 
(Allan et al, 1978; Ferrell, Jr. et al, 1985). In this context, the selective 
distribution in the outer leaflet of DMPC, glycocholate, and MC540 is 
thought to increase the membrane curvature, eventually leading to 
vesiculation (Allan et al, 1978; Hagelberg & Allan, 1990). In experimental 
vesiculation induced by amphiphilic compounds no breakdown of PtdInsP or 
PtdInsP2 is observed (Hagelberg & Allan, 1990). In contrast, shape change 
and vesiculation are prevented by chlorpromazine, which by its insertion in 
the inner leaflet counteracts the expansion of the outer leaflet by for instance 
DMPC (Butikofer et al, 1987).
Vesiculation and ATP depletion
Vesiculation as a consequence of ATP depletion (Lutz et al, 1977) also has 
been associated with the transition of the discoid to the echinocytic shape and 
the breakdown of PtdInsPs (Muller et al, 1981). It has been suggested that the 
vesiculation induced by ATP-depletion is caused by the entry of Ca2+ (Allan 
& Michell, 1979). However, in the ATP-depletion model scrambling of 
phospholipids of the vesicles does not occur, in contrast to the vesicles 
derived from Ca2+-induced vesiculation (Salzer et al, 2002). In another 
hypothesis, vesiculation was explained by the shrinkage of the inner leaflet 
of the membrane caused by the breakdown of the PtdInsPs (Ferrell, Jr. & 
Huestis, 1984; Butikofer et al, 1989). Indeed, propranolol and 
chlorpromazine were shown to inhibit vesiculation without preventing the 
ATP-depletion and chlorpromazine prevented the breakdown of PtdInsPs 
(Snyder et al, 1978; Butikofer et al, 1989). However, PtdInsPs are involved 
in the interaction between membrane and cytoskeleton (Anderson & 
Marchesi, 1985). Their breakdown probably is contributing to vesiculation by 
diminshing this interaction. The remnant erythrocytes of ATP-depletion bind 
autologous IgG. It has been suggested that autoantibodies recognize 
cryptantigens, that become exposed through the depletion of energy (Muller 
& Lutz, 1983).
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Vesiculation and lysophosphatidic acid
Treatment of erythrocytes with lysophosphatidic acid (LPA) induces 
vesiculation (Chung et al, 2007). Although LPA is known to open a Ca2+- 
channel (Yang et al, 2000), activation of a Ca2+-independent protein kinase C 
(PKC) isoform, PKCZ was shown to be responsible for the respons on LPA. 
LPA-induced phospholipid scrambling and vesiculation could have clinical 
consequences, since the LPA-induced effects were observed using LPA 
concentrations comparable to LPA concentrations observed in patients 
(Chung et al, 2007).
Vesiculation in bloodbank storage conditions
Although a wealth of data on the formation of vesicles during storage is 
available (Greenwalt, 2006), there is still no comprehensive theory on the 
mechanism by which they are generated and their contribution to the adverse 
side effects of transfusion. Several alterations observed in stored erythrocytes 
merit consideration as a possibly contributing factors (Bosman et al, 2008b).
-  Erythrocyte metabolism. Stored erythrocytes show a typical decline of 
erythrocyte ATP content, which shows a strong and significant 
correlation with the number of vesicles in transfusion units (Salzer et al, 
2008) and which is probably caused by a reduction in the rate of 
glycolysis. Storage-related changes in band 3 are associated with loss of 
metabolic modulation (Messana et al, 2000).
-  Membrane structure. Already during the first week of storage, not only 
band 3 but also protein 4.1, 4.2, and spectrin are oxidatively modified and 
degraded (Wolfe et al, 1986; Wolfe, 1989; Wagner et al, 1987; Bosman 
& Kay, 1988a; Bosman et al, 2005; Bosman et al, 2008a; D'Amici et al, 
2007; Kriebardis et al, 2007b; Kriebardis et al, 2007a). Storage-related 
changes in binding of ankyrin are associated with an increase in 
aggregation and degradation of band 3 (Bosman & Kay, 1988b; Messana 
et al, 2000). Haemoglobin becomes denatured and aggregated and 
associated to the membrane (Wolfe, 1989; Kriebardis et al, 2007a). It has 
been suggested that the binding of denatured haemoglobin to band 3
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could induce an aggregation of band 3 (Low et al, 1985). These structural 
changes will all contribute to a diminished interaction between plasma 
membrane and cytoskeleton.
-  Neoantigen and IgG binding. The formation of senescent cell antigen 
activity during storage is indicated by the storage-related increase of 
binding of autologous IgG (Bosman & Kay, 1988a; Ando et al, 1993; 
Luten et al, 2004; Kriebardis et al, 2007b). This binding is associated 
with changes in band 3 structure. Binding of IgG to oligomers or 
oligomerisation induced by binding of IgG can lead to vesiculation, as 
has also been observed in experiments with antibody-induced ligation of 
glycophorin A, acetylcholinesterase (Groenen-Döpp & Bosman, 
unpublished results) and glycophorin C (Head et al, 2005).
-  A shape transition to irreversibly spheroechinocytes of part of the 
erythrocytes occurs during the final stages of blood bank storage 
(Rumsby et al, 1977; Laczko et al, 1979; Laczko et al, 1985). This 
transition could be related to the considerable portion of up to 30% of the 
transfused erythrocytes which disappear within 24 hour after transfusion 
(Hogman & Meryman, 1999; Luten et al, 2008). It has been suggested 
that this fraction of removal-prone erythrocytes may be mainly 
responsible for the observed storage related changes and may contribute 
to the adverse effects of transfusion (Bosman et al, 2008b). It is not 
known whether these removal-prone erythrocytes have exhausted their 
capacity to shed vesicles, but younger erythrocytes shed more vesicles in 
experimental conditions than older erythrocytes (Snyder et al, 1985; 
Greenwalt & Dumaswala, 1988)
Characteristics of experimental derived vesicles and mechanistic 
considerations
Under all these experimental conditions, vesicles are generated that share 
several important features. In all cases the vesicles contain hardly any 
spectrin and ankyrin (Allan et al, 1976; Lutz et al, 1977; Ott et al, 1981; 
Rumsby et al, 1977). However, in storage vesicles actin has been
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demonstrated (Bosman et al, 2008a). This indicates that detachment of 
plasma membrane and cytoskeleton is a key event in vesiculation, but the 
mechanism is not simply a general disruption of the anchorage sites of the 
plasma membrane to the cytoskeleton.
Vesicles are enriched in the glycosyl phosphatidyl inositol (GPI)-anchored 
proteins acetylcholinesterase AChE and CD55. GPI-anchored proteins are 
associated with microdomains of the plasma membrane which are rich in 
cholesterol and sphingolipids, the lipid rafts (Simons & Toomre, 2000). 
These rafts, that are also enriched in the integral proteins stomatin and 
flotillin and cytoplasmic proteins synexin, sorcin, have also been shown in 
the erythrocyte membrane (Salzer & Prohaska, 2001). Ca2+-induced 
microvesicles and nanovesicle are enriched in lipid rafts (Salzer et al, 2002). 
Stomatin is the major raft-associated protein in microvesicles and synexin 
and sorcin are the major raftproteins in nanovesicles. In both types of vesicles 
flotillin-1 and flotillin-2 were not found (Salzer et al, 2002). In storage 
vesicles the different behaviour of stomatin and flotillins was even more 
pronounced (Salzer et al, 2008). These data indicate that raft formation and 
vesiculation are associated processes. As yet, the molecular events underlying 
this association remain enigmatic.
Band 3 and glycophorins have been found in all types of microvesicles, but 
not in Ca2+-induced nanovesicles (Salzer et al, 2002). The relative amount is 
lower compared with the erythrocyte membrane (Hagelberg & Allan, 1990; 
Salzer et al, 2002). Although storage vesicles show no signs of aggregation 
and breakdown of band 3 in PAGE with conventional protein detection 
(Salzer et al, 2008), proteomic and immunochemical analysis revealed both 
increased aggregated and broken down band 3 in vesicles compared to the 
erythrocytes (Bosman et al, 2008a). Thus changes in band 3 conformation 
may be associated not only with IgG binding but also with vesiculation in 
storage conditions.
Binding of autologous IgG has been demonstrated by vesicles that were 
produced by ATP-depletion (Muller & Lutz, 1983) and in storage vesicles 
(Bosman et al, 2008a; Kriebardis et al, 2008). Vesicles that were induced by
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ATP-depletion, were rapidly cleared from the circulation (Bocci et al, 1980). 
In this situation IgG acts presumably as the only signalling molecule for 
removal, because ATP-depletion induced vesicles do not show PS-exposure 
(Salzer et al, 2008).
The phospholipid distribution of the vesicle membrane resembles to a large 
extent the distribution of the parent erythrocytes with one notable exception. 
The minor phospholipids PtdInsP and PtdInsP2 are present in a considerably 
lesser amount in vesicles that were induced by increased Ca2+-concentration, 
ATP-depletion or DMPC (Hagelberg & Allan, 1990). To our knowledge such 
data are not available for storage vesicles. In the Ca2+-induced and ATP 
depletion-induced vesicles, this deficit in PtdInsPs reflects the observed 
breakdown of both PtdInsPs, which may disturb the stretching force of the 
membrane on the cytoskeleton.
A portion of the Ca2+- induced and storage vesicles exposes PS (Salzer et al, 
2008). In contrast, ATP-induced vesicles (Salzer et al, 2008) and DMPC- 
induced vesicles (de Jong & Ott, 1993) did not show any signs of 
phospholipid redistribution. This indicates that phospholipid scrambling is 
not always associated with vesiculation.
In conclusion, various mechanisms may cause detachment of the membrane 
from the cytoskeleton as a key event in experimental vesiculation. On the 
other hand, the vesicles obtained under various experimental conditions differ 
in several characteristics, although they share some important features. In this 
thesis several characteristics of vesicles formed in vivo are determined in 
order to study the underlying mechanisms and physiological consequences.
Erythrocyte aging, vesiculation, and apoptosis
The definite lifespan of erythocytes, not only in humans, but in all animal 
species investigated so far (Vacha, 1983), implies that erythrocyte lifespan is 
well regulated. The process leading to the removal of old erythrocytes may 
be regarded as a specialized form of apoptosis (Lang et al, 2005), enabling 
the body to remove billions of erythrocytes per day without causing 
inflammation (Kuypers & de Jong, 2004). In the most important view on
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recognition of aged erythrocytes, autologous IgG binds to epitopes, which 
develop in the final stages of the lifespan of the erythrocyte (Kay, 1975), 
most probably through oxidation-triggered changes in band 3 (Kay, 2005). 
This represents one of the first demonstrations of a physiological function of 
autoimmune reactivity (Kay, 1978; Lutz, 2004). Various aspects of the 
changes in band 3, the specificity of the autologous IgG, the involvement of 
PS, the disappearance of CD47 and the role of complement are a matter of 
debate (Arese et al, 2005; Ando et al, 1996; Bratosin et al, 1998; Oldenborg 
et al, 2000; Kuypers & de Jong, 2004).
In this thesis this debate is addressed and expanded with the integration of 
vesicle formation as an integral part of the physiological erythrocyte aging 
process in vivo.
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Abstract:
Previous studies have shown that a considerable amount of haemoglobin is 
lost from the intact red cell during its lifespan. The aim of this study was to 
determine the relative contribution of all the haemoglobin components to this 
process. Therefore, the relative amount of haemoglobins A0, A2, F and the 
glycated haemoglobins were determined in 24 fractions of different cell age. 
These fractions were obtained by the combination of counterflow and density 
centrifugation. When the absolute amounts of all haemoglobin components 
were calculated using the MCH-values of each fraction, it appeared that the 
mean red cell loss of haemoglobins A0, A2, F, an unknown X and "rest" 
comprised, respectively, 440, 23, 1, 4 and 1 amol per cell, while the mean 
gain of the glycated haemoglobins was 84 amol per cell. This resulted in a net 
loss of 385 amol of haemoglobin per cell. One of the glycated haemoglobins 
(HbA1e2) turned out to be the product of further carbamylation. It was 
concluded that in the first half of the red cell lifespan HbA0 and HbA2 
decreased by glycation and carbamylation and that in the second half some of 
the HbA0 and HbA2 but also some of the glycated and carbamylated 
haemoglobin components leave the red cell. The total loss amounts to about 
20%.
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Introduction
A previous study has shown that by using a combination of counterflow 
centrifugation and subsequent Percoll-centrifugation red cell fractions could 
be obtained that differed in MCV, MCH and MCHC. It turned out that the 
fractions with the highest MCV showed the highest MCH and the lowest 
MCHC; the fractions with the lowest MCV showed the lowest MCH and the 
highest MCHC (1). When iron-59 labelled transferrin was transfused in a 
normal individual it was shown that the fraction with the highest MCV was 
enriched with young cells, whereas the fraction with the lowest MCV 
contained only cells more than 30 d of age, indicating that volume changes 
were age-dependent (2). Van der Vegt et al. (3), also using iron-59 as cohort 
label, showed in 2 normal individuals that within 60 d after transfusion of 
labelled transferrin most of the specific activity was found in the fractions 
with the highest MCV.
Besides using a cohort label such as iron-59 the age dependency of red cell 
changes can also be investigated by making use of changes in post- 
translational processes, e.g. the glycation of haemoglobin. Bunn et al. (4) 
showed that after iron-59 labelled transferrin was transfused in a patient 
recovering from pure erythrocyte aplasia and in a normal individual specific 
activity slowly rose with time in a nearly linear fashion in the HbA1a, HbA1b 
and HbA1c fractions. In the normal individual the specific activity leveled off 
after 80 d indicating that, among others, HbA1c is a useful marker of cell age 
in red cell fractions. Other post-translational processes such as carbamylation 
also give rise to haemoglobin components (5). However, the relation to a 
normally strictly controlled blood component such as glucose for HbA1c is 
less well established. When HbA1c was measured in red cell fractions 
obtained by counterflow centrifugation and subsequent Percoll gradient 
centrifugation it was shown that there was an excellent negative correlation 
between MCV and HbA1c-percentage. Also a negative correlation was 
obtained between MCH and HbAlc percentage and a positive one for MCHC 
and HbAlc. Therefore it was concluded that, while they age, red cells lose 
volume by the loss of haemoglobin and (relatively more) water, thereby 
explaining the changes in the red cell indices MCV, MCH and MCHC. In the
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study by Bosch et al. (1) the MCV and MCH decreased by 30% and 18%, 
respectively, while the MCHC increased by 15%.
The concept of haemoglobin loss from intact red cells in the circulation has 
bearing on some clinical problems:
1) The concept offers a better understanding of the heterogeneous 
nature of red cell indices.
2) When considering the efficacy of red cell transfusions one should 
take into account that haemoglobin loss from the donor red cells is 
another reason why the recovery is less than one would expect.
The aim of this study was to determine in which way the different 
haemoglobin components take part in the decrease of the MCH during the red 
cell lifespan using HbAlc as marker of red cell age.
Methods
Venous blood samples of 20 ml from 5 healthy volunteers were collected in 
heparinized tubes (50 U/ml blood).
RBC fractionation according to cell volume
RBC fractionation according to cell volume was performed using 
counterflow centrifugation in a Dijkstra Curame 3000 elutriation system 
(Dijkstra Vereenigde BV, Lelystad, The Netherlands). In the elutriation 
chamber cells are subjected to the centrifugal force of centrifugation and to 
centripetal force, due to the buffer flow towards the centre of the rotor. At a 
given flow rate of the buffer, both forces are in balance at a higher speed of 
rotation for small cells then for large cells. Therefore, small cells are carried 
away with the buffer at a higher speed of rotation.
The separation was performed at a flow rate of 10 ml/min at 20°C. An 
isotonic buffer containing albumin and glucose (GASP) was used. The 
composition of the GASP-buffer was: 9 mmol/L Na2HP04, 1.3 mmol/L 
NaH2PO4, 140 mmol/L NaCl, 5.5 mmol/L glucose and 0.8 g/L bovine serum 
albumin (fraction V, Sigma Chemical Company, St Louis, MO, USA), pH
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7.4. Blood was diluted 1:10 with the GASP-buffer and 2 ml of this 
suspension was introduced into the buffer flow to the elutriation chamber. 
RBCs with increasing volume were eluted from the elutriation chamber at 6 
different speeds of rotation from 2300 to 1700 rpm yielding 6 fractions.
RBC fractionation according to density
RBC fractionation according to density was done by means of a 
discontinuous Percoll gradient essentially as described by Rennie et al. (6). 
The gradient was built up in 5 layers of 2 ml containing, respectively, 80% 
(1.096 g/ml), 73% (1.090 g/ml), 68% (1.085 g/ml), 65% (1.083 g/ml) and 
40% (1.060 g/ml) Percoll, buffered with a HEPES (N-(2-hydroxyethyl)- 
piperazine-N'-2-ethanesulphonic acid) buffer containing bovine serum 
albumin (SAH). The composition of the SAH-buffer was: 26.3 g/L bovine 
serum albumin, 132 mmol/L NaCl, 4.6 mmol/L KCl and 10 mmol/L HEPES, 
pH 7.1.
RBCs were washed with GASP-buffer and diluted with 1 vol of GASP- 
buffer; 0.5 ml of this suspension was layered on the Percoll gradient. 
Separation was achieved after 15 min centrifugation at 3000 rpm at room 
temperature. Four RBC fractions were collected by careful pipetting and then 
extensively rinsed with GASP-buffer in order to remove the residual Percoll.
RBC separation
RBC separation was performed by means of counterflow centrifugation 
followed by Percoll separation, yielding 24 fractions, as published earlier (1).
Parameters
The RBC parameters MCV and MCHC were determined on a Technicon H1 
(Bayer-Technicon, Tarrytown, NY; USA). The MCV was directly measured. 
The H1 is capable of determining the MCHC in 2 ways: a conventional 
method and a direct measurement using the sideways scatter of the 
flowcytometric signal (CHCM). We used this CHCM, converted to mmol/l. 
We found an excellent correlation between the CHCM and the manual
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determination of the MCHC (data not shown). The value of the MCH was 
calculated as MCV times CHCM.
Percentage of haemoglobin subfraction
The percentage of haemoglobin subfractions was measured by means of ion­
exchange HPLC. An ion-exchange column, especially selected for the 
separation of proteins, was supplied by Waters (Protein-Pak SP8HR, 
Millipore Corporation, Milford, MA, USA). The equipment for gradient 
HPLC was obtained from Waters (Division of Millipore, Milford, MA, 
USA). The elution buffers used were based on a buffer system as described 
by Jeppsson et al. (7). The composition of buffer A was: 20 mmol/L malonic 
acid and 1 mmol/L NaCN, pH 5.9 in HPLC-grade water. Buffer B had the 
same composition as buffer A with the addition of 380 mmol/L NaN03. 
Sodium cyanide was used as a stabilizer of haemoglobin. Before use the 
buffers were passed through a 0.22 mm filter and degassed. The column was 
kept at 30°C.
Haemoglobin components
The haemoglobin components were separated with the use of a buffer 
gradient. The eluting haemoglobin components were monitored with a 
photodiode array detector; in this way an absorption spectrum at the top of 
each peak could be measured. Those spectra indicated the absence of 
oxidation of all haemoglobin components. The elution profile was measured 
at 417 nm. The relative amount of each component was calculated from the 
peak area of that component at 417 nm divided by the total area of all 
components. With the use of this technique, 10 fractions were separated, as 
shown in Fig. 1.
However, fraction HbA1d was not always sufficiently separated from 
fraction HbA1c. In the further analysis these 2 fractions were combined.
After HbA2 unknown components were found. One component could 
chromatographically be discriminated from the others and was designated 
"X"; the other components as "Rest".
52
loss of haemoglobin components
-  100 
-  80 
-  60
-  40
-  20 
— L o
40 min.
Fig. 1. HPLC chromatogram of haemoglobin components Elution profile OD (— ); percentage buffer (— )
The absorption spectrum of "X" indicated the possibility of a haem- 
containing component. The absolute amount of all components was 
calculated from the relative amount x MCH. All data shown were the mean 
of the results of 5 healthy volunteers. Significance of the differences was 
assessed using the ranked sign test of Wilcoxon for paired data.
Results
In Fig. 2 the MCV values of the 24 red cell fractions were plotted against the 
HbA 1c-values as in the previous study. The same excellent negative 
correlation was found.
Figs 3 and 4 show that the increase in MCHC and decrease in MCH are 
related mainly to the lower and higher HbA1c-values, respectively. This 
indicates that these changes take place mainly in the first and second half of 
the red cell lifespan, respectively.
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Fig. 2. The percentage of HbA1c vs. MCV. The results of 24 fractions are 
shown. Each symbol represents the mean of 5 observations per fraction. The 
line represents the regression line.
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HbAlc (%)
Fig. 3. The percentage of HbAlc vs. MCHC. The results of 24 fractions are 
shown. Each symbol represents the mean of 5 observations per fraction. The 
line represents the second order curve fit
HbAlc (%)
Fig. 4. The percentage of HbAlc versus MCH. For details see legend to Fig. 3
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When the absolute amounts of the nonglycated haemoglobin components of 
each fraction were compared to the HbAlc-values, it was shown that HbA0 
and HbA2 were significantly lower only in the fractions with the higher 
HbA1c-values, indicating that the decrease in HbA0 and HbA2 occurs mainly 
in the second half of the red cell lifespan (Fig. 5).
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Fig. 5. The percentage of HbAlc vs. the absolute amount of HbA0, HbF, HbA2 and the unknown 
fractions HbX and "Rest". The results of 24 fractions are shown. Each symbol represents the mean 
of 5 observations per fraction. The lines represent the second order curve fits
When the values of the absolute amounts of the glycated haemoglobins were 
compared to the values of the HbA1c-percentage it was shown that all 
fractions except one (HbA1b) increased with leveling off in the fractions with 
the higher HbA1c values, indicating either decreased activity of the glycation 
process or loss of glycated haemoglobins from the cell in the second part of 
the red cell lifespan (Fig. 6).
The comparison of our chromatograms with published chromatograms (5) 
indicates that the HbA1e2 component is not only the result of glycation but 
also of carbamylation. The amount of this component also increased mainly 
during the first part of the red cell lifespan.
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Fig. 6. The percentage of HbAlc vs. the absolute amount of the glycated haemoglobins. For details see 
legend to Fig. 5
When the haemoglobin composition of the fractions with the lowest and the 
highest HbAlc-values were compared, it was shown that the glycated and 
carbamylated haemoglobins were relatively increased in the fraction with the 
highest HbAlc-value, except one, while HbA0 was relatively decreased 
(Table 1).
When the absolute amount of each component was calculated, a significant 
rise in glycated and carbamylated haemoglobins (a mean of 84 amol per cell) 
and a decrease in HbA0 and HbA2 (440 and 23 amol per cell, respectively) 
was found resulting in a net loss of 385 amol from the living red cell (Table
2).
Discussion
In this study the excellent negative correlation between MCV and HbA1c 
could be confirmed. Analysis of the relationships between MCH and MCHC 
on one hand, and HbAlc on the other hand, showed that the increase of 
MCHC and the decrease of MCH take place mainly in the first and second 
half of the red cell lifespan, respectively. It is remarkable that water loss as 
cause of the MCHC increase and the haemoglobin loss as cause of the MCH 
decrease are so neatly interrelated that the MCV decreases regularly during 
the whole of the red cell lifespan.
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Table 1 Relative changes from youngest to oldest fraction in normal individuals 
(n=5)
Percentage (%)
Component Young“ Oldb P
HbA1 9.51 ±2 .48 16.71±3.93 < 0.03
HbAla 0.85±0.34 1.61±0.75 < 0.03
HbAlb 1.29±0.63 2.03±1.33 NS
HbAlc 4.07±1.22 7.27±0.63 < 0.03
HbA1e1 1.00±0.78 1.99±1.82 < 0.03
HbA1e2 2.30±0.36 3.82±0.49 < 0.03
HbA0 82.15±3.34 74.76±4.77 < 0.03
HbF 0.40±0.18 0.43±0.13 NS
HbA2 3.94±0.73 3.44±0.69 NS
X 2.06±0.93 2.31±1.63 NS
"Rest" 1.96±1.34 2.35±2.04 NS
a Wilcoxon; NS: not significant.
b Fractions with lowest and highest HbA1 c-values, respectively.
Table 2. Absolute changes from youngest to oldest fraction in normal Individuals 
(n=5)
Component
Amount (amol/cell) 
Youngb Oldb Pa Differenceamol/cell
HbA1 194±47 278±64 <0.03 +84
HbA1a 17±6 26±11 <0.03 9
HbA1b 26±12 34±23 NS 8
HbA1c 83±23 121±9 <0.03 38
HbA1e1 21 ±17 33±31 <0.03 12
HbA1e2 47±6 64±7 <0.03 17
HbA0 1692±131 1252±138 <0.03 -440
HbF 8±4 7±2 NS -1
HbA2 81±16 58±12 <0.03 -23
X 42±1 7 38±27 NS -4
"Rest" 40±28 39±34 NS -1
Total 2057 1 672 Net loss -385
a Wilcoxon; NS: not significant.
b Fractions with lowest and highest HbAlc-values. respectively
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The decrease of HbA0 and HbA2 took place mainly in the second half of the 
red cell lifespan, running parallel with the decrease in MCH. The increase in 
the glycated haemoglobins took place mainly in the first half of the red cell 
lifespan, indicating that the influence of the glycation process on the total 
amount of HbA0 and HbA2 is less than that of loss from the cell. This also 
holds true for the carbamylated haemoglobin component. This product is 
handled in the same way as HbAlc.
Preliminary results show that the haemoglobin composition of in plasma 
circulating vesicles resembles that of old red cells. Therefore, vesiculation 
seems at least a partial explanation for the haemoglobin loss in the second 
half of the red cell lifespan. Moreover, it means that glycated and 
carbamylated haemoglobins also leave the intact red cell (8). In conclusion it 
can be said that in the first half of the red cell lifespan HbA0 and HbA2 
decrease by glycation and carbamylation and that in the second half some of 
the HbA0, HbA2, but also some of the glycated and carbamylated 
haemoglobin components leave the red cell. The total loss amounts to 20% of 
the total haemoglobin.
This is not only in accordance with the studies by Bunn et al. (4) but also 
with 15N-glycin cohort studies (9-11). These show a considerable 
haemoglobinmarker loss between d 80 and 120 and a rise in marker activity 
in haemoglobin degradation products in the same period. The mechanism by 
which in vivo at least a fifth of the total of haemoglobins leaves the intact red 
cell is not clear. At least a partial explanation is haemoglobin loss via 
shedding of haemoglobin containing vesicles.
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Abstract
Previous studies have shown that approximately 20% of hemoglobin is lost 
from circulating red blood cells (RBCs), mainly during the second half of the 
cells' life span. Because hemoglobin-containing vesicles are known to 
circulate in plasma, these vesicles were isolated. Flow cytometry studies 
showed that most RBC-derived vesicles contain hemoglobin with all 
hemoglobin components present. The hemoglobin composition of the 
vesicles resembled that of old RBCs. RBC cohort studies using isotope­
labeled glycine have been described, which showed a continuous presence of 
this label in hemoglobin degradation products. The label concentration of 
these products increased during the second half of the RBC life span, 
accompanied by a decrease within the RBC. It is concluded that the hemoglo­
bin loss from circulating RBCs of all ages can be explained by shedding 
hemoglobin-containing vesicles. This loss occurs predominantly in older 
RBCs. Apparently the spleen facilitates this process since asplenia vesicle 
retention within RBCs of all ages has been described, accompanied by an 
increase in the percentage of total HbA1 . The present study shows that in old 
RBCs of asplenic individuals, the decrease of hemoglobin content per cell 
such as seen in old RBCs of control individuals is absent due to an increase 
in the absolute amount of HbA1c and HbA1e2 . It is concluded that 
hemoglobin-containing vesicles within old RBCs are "pitted" by the spleen.
62
hemoglobin loss from RBC’s
In previous studies we showed that approximately 20% of hemoglobin is lost 
from the circulating red blood cell (RBC).1,2 Moreover, it was clear that this 
loss increases substantially during the second half of the RBC life span.2 In 
accordance, RBC cohort studies using isotope-labeled glycine demonstrated a 
continuous presence of the label in hemoglobin degradation products with an 
increase during the second half of the RBC life span. Concomitantly, the 
label concentration in the RBC decreased,3,4 which indicates that hemoglobin is 
lost from RBCs of all ages, predominantly from older cells. As hemoglobin- 
containing vesicles are known to circulate in plasma,5 it appeared worthwhile to 
investigate their possible role in the process of hemoglobin loss. Vesicles were 
isolated from plasma obtained by pheresis and were studied by electron 
microscopy and flow cytometry. In addition, their hemoglobin composition 
was determined and compared with that of RBC fractions of different 
ages.
In individuals without a functioning spleen, the RBCs have an increased 
number of normally present small vacuoles (diameter < 300 nm) in 
combination with abnormally big vacuoles (diameter > 300 nm) in about 
30% of the cells. Some of these vacuoles are known to contain hemoglobin.6 
A previous study indicated a positive relation between the number of RBCs 
with big vacuoles (‘pitted’ cells), and the HbAj percentage in RBC 
populations fractionated according to density.7 Likewise, the HbAi 
percentage in whole blood was higher in asplenic individuals.
In order to evaluate the role of the spleen in this respect, we determined the 
hemoglobin content and composition of RBC populations fractionated 
according to volume and density in splenectomized individuals.
Materials and methods
Erythrocytes
Venous blood samples of 20 mL from 5 healthy regular blood donors and 5
Introduction
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splenectomized individuals who were not diabetic were collected in heparinized 
tubes (50 U/mL blood). Splenectomy was performed in the course of a staging 
laparotomy for malignant lymphoma. Chemotherapy had been administered in 2 
individuals more than one year prior to blood sampling. In none of the patients has 
the lymphoma recurred.
Vesicles
Vesicles were isolated from plasma obtained by means of pheresis from the 5 
healthy regular blood donors. After centrifugation at 8000 x g at 4°C for 15 
minutes, plasma was passed through an 0.8-pm pore size nitrocellulose filter 
MILLEX-AA 0.8 (Millipore, Milford, MA). The filtrate was centrifuged at 
50 000 x g at 4°C for 90 minutes. Control plasma was obtained from regular 
blood donations from 2 of the 5 healthy individuals. The isolated (red) pellet 
containing vesicles was examined with freeze-fracture electron microscopy, 
hemoglobin chromatography, and flow cytometry.
Electron microscopy
Freeze-fracture electron microscopy was performed as follows: glycerol was 
added to the samples up to a concentration of 25%. The samples were then frozen 
in a mixture of liquid and solid nitrogen, fractured in a Balzers freeze fracture 
device 301 (Balzers, Liechtenstein) and subsequently replicated with 
platina/carbon according to standard procedures.
Flow cytometry
The expression of glycophorin A (GPA) on and the presence of hemoglobin in 
vesicles were examined by flow cytometry (Beckman Coulter, Fullerton, CA). The 
following monoclonal antibodies were used: anti-GPA labeled with R- 
phycoerythrin (clone JC159, IgG1: DAKO, Glostrup, Denmark) and anti-Hb labeled 
with fluorescein isothiocyanate (FITC; clone 4B8, IgG2b; Wallac, Akron, OH). For 
each analysis 1 x 104 events were collected using Beckman Coulter software EXPO32 
on the flow cytometer. In the forward scatter-side scatter dotplot a gate was set 
around the area with small particles. In order to identify the presence of 
hemoglobin, vesicles had to be blocked, fixed, permeabilized, and washed, 
respectively, by using a solution containing 0.1% sodium azide, a solution
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containing buffered formaldehyde, a solution containing sodium dodecyl sulfate, 
and phosphate-buffered saline containing heparin and Triton X-100 (IQ Products, 
Groningen, The Netherlands).
RBC fractionation according to cell volume
RBC fractionation according to cell volume was performed using counter-flow 
centrifugation in a Dijkstra Curame 3000 elutriation system (Dijkstra Vereenigde 
B.V., Lelystad, The Netherlands).
The separation was performed at a flow rate of 10 mL/min at 20°C. An isotonic 
buffer containing albumin and glucose (GASP) was used. The composition of the 
GASP buffer was 9 mM Na>HPO4, 1.3 mM Na^PO 4, 140 mM NaCl, 5.5 mM 
glucose, and 0.8 g/L bovine serum albumin (fraction V; Sigma Chemical, St 
Louis, MO), pH 7.4. Blood was diluted 1:3 with the GASP buffer, and 2 mL of this 
suspension was introduced into the buffer flow to the elutriation chamber. RBCs 
with increasing volume were eluted from the elutriation chamber at 6 different 
speeds of rotation from 2300 to 1700 rpm, yielding 6 fractions.
RBC fractionation according to cell density
RBC fractionation according to density was performed by means of a 
discontinuous Percoll gradient essentially as described by Rennie et al.8 The gradient 
was built up in 5 layers of 2 mL containing 80%, 73%, 68%, 65%, and 40% for 
healthy individuals and 80%, 67%, 64%, 61%, and 40% for splenectomized 
individuals (to achieve an even as possible distribution of RBCs in the fractions, 
in view of the lower mean cellular hemoglobin concentration [MCHC] of these 
individuals). In this way, fractions with the lowest HbAic percentage contained 
2.5% and 2.1% of the total number of RBCs in healthy and asplenic individuals, 
respectively, whereas fractions with the highest HbAic, contained 0.4% and 2.9%, 
respectively. The Percoll solutions were buffered with a HEPES (N-(2- 
hydroxyethyl)-piperazine-N'-2-ethanesulphonic acid) buffer containing 5% 
bovine serum albumin, 132 mM NaCl, 4.6 mM KCl and 10 mM HEPES, pH 7.1.
RBCs were washed with GASP buffer and diluted with 1 volume of GASP 
buffer; 0.5 mL of this suspension was layered on the Percoll gradient. Separation was 
achieved after 15 minutes centrifugation at 3000 rpm at room temperature. Four
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RBC fractions were collected by careful pipetting and then extensively rinsed 
with GASP buffer in order to remove the residual Percoll.
RBC fractionation
RBC fractionation was performed by means of counterflow centrifugation 
followed by Percoll gradient centrifugation, yielding 24 fractions of various ages, 
as published earlier.1
RBC parameters
The RBC parameters mean cellular volume (MCV) and MCHC were 
determined on a Technicon H1 (Bayer-Technicon, Tarrytown, NY). The MCV 
was directly measured. The MCHC was measured using the sideways scatter of the 
flow cytometry signal called CHCM. This CHCM was converted to mM. The 
value of the hemoglobin content per cell (MCH) was calculated as MCV x CHCM.
Hemoglobin fractionation
Hemoglobin fractionation was performed by means of ion exchange 
chromatography (Protein-Pak, SP8HR, Millipore). The elution buffers used were 
based on a buffer system as described by Jeppson et al.9 The composition of 
buffer A was 20 mM malonic acid and 1 mM NaCN, pH 5.9, in high-performance 
liquid chromatography (HPLC)-grade water. Buffer B had the same composition as 
buffer A with the addition of 380 mM NaNO3. Sodium cyanide was used as a 
stabilizer of hemoglobin. Before use, the buffers were passed through a 0.22-^m 
filter and degassed. The column was kept at 30°C. The hemoglobin components 
were separated with the use of a buffer gradient and monitored at 417 nm with a 
photodiode array detector; in this way an absorption spectrum at the top of each peak 
could be measured. Those spectra indicated the absence of oxidation of all 
hemoglobin components. The relative amount of each component was calculated 
from the peak area of that component at 417 nm divided by the total area of all 
components. With the use of this technique, 10 fractions were separated, as shown 
in Figure 1. However, fraction HbAid was not always sufficiently separated from 
fraction HbAic. In further analysis these 2 fractions were combined. Unknown 
components were found that eluted after HbA2. One component could 
chromatographically be discriminated from the others and was designated "X"; the
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other components as "Rest.” The absorption spectrum of ”X” indicated the 
possibility of a heme-containing component. The absolute amount of all 
components in the RBCs was calculated from the relative amount times MCH. 
All data shown are the mean of the results of 5 healthy and 5 asplenic volunteers.
:
0 10 20 30 40 min.
Figure 1. HPLC chromatogram of hemoglobin components; elution profile OD (— ); 
percentage buffer (— )
Statistical analysis
Significance was analyzed using the Student t test or Mann-Whitney U test. 
Regression analysis was done using second order linear regression, because 
goodness of fit was substantially better than using first order linear regression
Results
Normal condition
Freeze-fracture electron microscopy studies showed that the red-colored pellet 
obtained by centrifugation of pheresis plasma contained vesicles (Figure 2). 
As can be deduced from the density of the membranous particle distribution on the 
convex and concave fracture faces, there were relatively small vesicles (< 200 nm) 
with right-side-out- and inside-out-oriented membranes and vesicles with a 
wide variety in size (200-800 nm), with predominantly right-side-out
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membranes. This picture is not an artifact created by the plasmapheresis 
procedure, because vesicles from plasma isolated from regular blood donations 
without pheresis showed an identical picture.
Flow cytometry studies demonstrated that vesicles were derived mostly from 
RBCs (approximately 65% of the vesicles reacted with the RBC-specific 
antiserum against glycophorin A).
Figure 2. Freeze-fracture electron microscopy of vesicles.
Vesicles were isolated from plasma obtained by pheresis from a healthy blood bank donor. The sidedness of 
the vesicles can be deduced from the density of the intramembranous particles on the convex and 
concave fracture faces of the RBC membranes. This density is 3 times higher on the protoplasmic than on 
the exoplasmic fracture face.10
One third of the vesicles were platelet derived (35% anti-CD41-FITC 
positive). After fixation and permeabilization, the percentage GPA-positive 
vesicles was significantly reduced to approximately 30%, irrespective of the 
presence of anti-Hb (Table 1).
Table 1. Effect of fixation and permeabilization on GPA positivity of vesicles in plasma 
obtained by pheresis (n = 8 )
Vesicles Anti-GPA-PE positive (% ± SD)
Before fixation/permeabilization 65.4 ± 11.7*
After fixation/permeabilization
In the absence of anti-Hb-FITC 31.7 ± 5.9t
In the presence of anti-Hb-FITC 29.8 ± 4.6t
*Anti-GPA-PE negative vesicles were nearly all anti-CD41 positive. 
tSignificantly different (P < .0002) from control vesicles (Student paired t test).
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This can be explained by loss of GPA antigenicity during the procedure. Since 
all vesicles, GPA positive and/or Hb positive, are RBC derived (both GPA and 
Hb are specific markers), 74% (40.4 of 54.9) of all RBC-derived vesicles 
contain hemoglobin (Table 2). Under the assumption that the presence of 
hemoglobin is unaffected by the fixation/permeabilization procedure, 62% (40.4 
of 65.4) of all GPA-positive vesicles contain hemoglobin (Tables 1 and 2). 
From both percentages it can be concluded that most of the RBC-derived 
vesicles contain a detectable amount hemoglobin.
Table 2. Flow cytometry after fixation and permeabilization of vesicles in plasma obtained 
by pheresis using anti-GPA-PE and anti-Hb-FITC (n = 8 )
Vesicles Percentage ± SD
All GPA+ 29.8 ± 4.6
All Hb+ 40.4 ± 6.4
GPA+; Hb- 14.5 ± 1.4
GPA+; Hb+ 15.3 ± 4.4
GPA-; Hb+ 25.1 ± 3.4
GPA-; Hb- 45.2 ± 6.2
The composition of the hemoglobins found in the vesicles was determined and 
compared with results obtained from measurements in the RBC fractions with the 
lowest and highest HbA1c percentage, that is, the youngest and oldest RBC 
fractions, respectively (Table 3). From these comparisons it can be concluded that 
the hemoglobin composition of vesicles closely resembles that of old RBCs.
Asplenia
The MCH was determined in RBC fractions of different ages from control 
and asplenic individuals (Figure 3). From this figure it can be deduced that 
the MCH in controls decreased from 2.0 to 1.6 fmol per cell (20%) and in 
asplenic individuals from 2.05 to 1.75 fmol per cell (15%). This difference 
of decrease in MCH is caused by the absence in asplenic individuals of the 
additional decrease in MCH as seen in older cells of control individuals.
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Figure 3. The relationship between MCH and HbA1c% in control and asplenic individuals. The
results of 24 fractions of asplenic individuals are shown. Each symbol represents the mean of 5 
observations per fraction. The drawn line is the second order curve fit of the asplenic individuals; 
the broken line, that of the controls (individual values not given).
Table 3. Hemoglobin components in young and old RBCs and vesicles obtained by 
plasmapheresis from control individuals
Hb
component
Percentage of total hemoglobin ± SD
Young RBCs* 
(n = 5)
Old RBCst 
(n = 5)
Vesicles 
(n = 4)
HbA1 9.5i ± 2.48Í i6 .7 i ± 3.93 i6.40 ± 2.69
ia
<
b
X
0.85 ± 0.34 i.6 i ± 0.75 i.28 ± 0.37
HbAib i.29 ± 0.62 2.03 ± i.33 i.29 ± 0.i7
<
b
X
4.07 ± i.2 2 t 7.27 ± 0.63 6.83 ± 0.90
HbAiei i.00 ± 0.78 i.99 ± i.82 2.i8 ± i.38
HbAie2 2.30 ± 0.36Í 3.8i ± 0.49Í 4.90 ± 0.23
HbA0 82.i5 ± 3.34 74.76 ± 4.77 78.50 ± 3.24
HbA2 3.94 ± 0.73Í 3.44 ± 0.69Í 2.62 ± 0.i4
HbF 0.40 ± 0.i8 0.43 ± 0.i3 0.27 ± 0 .ii
HbX + rest 4.00 ± 2.i7 4.66 ± 3.63 2.i3 ± 0.59
*,t Fractions with lowest and highest HbAic values, respectively.
Í  Significantly different (P < .05) from vesicles (Mann-Whitney U test, one-tailed P value).
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A comparison of the hemoglobin composition of RBCs of asplenic individuals 
with that of RBCs of control individuals shows that in whole blood of asplenic 
individuals, the percentage of HbAi is increased, due mainly to an increase of 
HbAic and HbAie2 in combination with a lower percentage HbA0 (Table 4).
Table 4. Hemoglobin components in RBCs of control and asplenic individuals
Hb component
Percentage of total hemoglobin ± SD
Controls (n = 8 ) Asplenic individuals (n = 5)
HbAi 1 0 .6 6 ± 0.98 11.84 ± 1 .2 1 *
HbAia 0.55 ± 0 .1 0 0.69 ± 0.09*
HbAib 0.97 ± 0.30 0.90 ± 0.08
HbAic 5.33 ± 0.40 5.86 ± 0.48*
HbAiei 0.76 ± 0.27 0.78 ± 0.29
HbAie2 3.06 ± 0.23 3.61 ± 0.55*
HbA0 84.62 ± 1.28 82.27 ± 1.44*
HbA2 3.08 ± 0.39 3.38 ± 0.50
HbF 0.35 ± 0.17 0.23 ± 0.07
HbX + rest 1.38 ± 0.40 2.28 ± 0.67*
‘ Significantly different (P < .05) from controls (Mann-Whitney U test, one-tailed 
P value).
These relative differences appear to be RBC age-dependent. When the absolute 
amounts of hemoglobin components in RBC fractions of different age were 
analyzed, it became evident that the increase of the HbA1c percentage as well as 
the decrease of the HbA0 percentage are caused only by changes in older cell 
fractions; the difference in HbA1e2 percentage less so (Figure 4 and Figure 5).
Examination of the changes in the absolute amounts of HbA1c, HbA1e2, and HbA0 in 
the youngest and oldest fractions of control and asplenic individuals indicates that 
the relative increase of MCH of old cells of asplenic individuals is mainly the 
result of an additional increase in the absolute amounts of HbA1c and HbA1e2 
(Table 5).
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Table 5. The absolute amounts of HbA1c, HbA1e2, and HbA0 in young and old RBCs of control (n : 
5) and asplenic individuals (n = 5)
Hb com­
ponent
Absolute amount (amol/cell ± SD)
Young* Oldf
Control Asplenic Control Asplenic
HbA1c 67.5 ± 16.8 87.1 ± 16.0 98.0 ± 5.5 141.7 ± 10 .6 t
HbA1e2 47.1 ± 5.8 62.7 ± 13.1 63.7 ± 6.9 85.5 ± 7 ++
HbA0 1691 ± 130 1735 ± 42 1251 ± 138 1329 ± 46
*,t Fractions with lowest and highest HbA1c values, respectively.
t  Significantly different (P < .01) from control old RBCs (Mann-Whitney U test, two-tailed P value)
Fig.ure 4. The relationship between 
HbA1c percentage and absolute 
amount of glycated 
hemoglobins. For details see 
legend to Figure 3.
Figure 5. The relationship between 
HbA1c percentage and absolute 
amount of nonglycated 
hemoglobins. For details see 
legend to Figure 3.
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Using a fractionation method that combines counterflow centrifugation (elutriation) 
with a discontinuous Percoll gradient fractionation, 24 fractions of different cell 
age could be obtained.1 As a marker of cell age the HbA1c percentage, validated 
in iron-59 cohort studies,11-13 was used. By means of this marker it became evident 
that changes of MCV, MCH, and MCHC are age dependent.1,2 The MCV and 
MCH indeed decrease by 30% and 20%, respectively, whereas the MCHC 
increases by 15%.1,2 The decrease in MCH occurs mainly during the second half of 
the RBC life span. In accordance, 15N-glycine and 14C-glycine studies show a 
continuous presence of the label in the hemoglobin degradation products stercobilin 
and urobilin, respectively, accompanied by a decrease of the label concentration 
within the RBC.3,4 A similar decrease was seen in studies featuring 59Fe as cohort 
label.11,12 Both the MCH and glycine studies indicate that hemoglobin loss from 
circulating RBCs predominantly occurs during the second half of the RBC life 
span.
As hemoglobin-containing vesicles are known to circulate in plasma,5 we used 
various methods to analyze them. Irrespective of the way plasma was obtained, 
electron microscopy analysis showed that vesicles are heterogeneous in size. As to 
the origin of these vesicles, 2 different mechanisms seem to be involved: the 
large vesicles are predominantly pinched off, whereas the relatively small vesicles 
are pinched off as well as fragmented. Immunoblot data fail to demonstrate the 
presence of most cytoskeletal proteins such as spectrin but show the presence of 
integral membrane proteins such as band 3 (F.L.A.W., G.J.C.G.M.B., and J.M.W., 
manuscript in preparation). Examination by flowcytometry showed that 
approximately 65% of the vesicles are RBC derived and that most RBC-derived 
vesicles contain hemoglobin.
When the hemoglobin composition of vesicles was studied, we identified all 
hemoglobin components that are normally found within RBCs. The hemoglobin 
composition closely resembled that of old RBCs. The results from these vesicle 
studies suggest a continuous loss of hemoglobin in vesicles increasing during the 
second half of the RBC life span. This is in accordance with studies that show 
small-size vesicles (< 300 nm) within normal RBCs.6
Discussion
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In asplenia, not only a 4-fold increase in the number of these small vesicles can 
be found, but also abnormally big vacuoles (diameter > 300 nm) in about 30% of 
RBCs, some of which are known to contain hemoglobin.6 A previous study 
indicated a positive relationship between the number of RBCs with big 
vacuoles (“pitted” cells, as seen with phase-contrast microscopy) and the HbAl 
percentage in RBC populations fractionated according to density.7 Also, in this 
study the HbA1 percentage of whole blood was increased. In order to clarify a 
possible relationship, we determined the MCH and hemoglobin composition in RBC 
populations fractionated according to volume and density in splenectomized 
individuals. Our present data show that the extra decrease of MCH observed in 
older fractions of control RBCs is absent in RBCs of asplenic individuals This 
phenomenon must be attributed to a lesser decrease of HbA0 and an enhanced 
increase of HbA1c and HbA1e2 in these older fractions, which suggests retention of 
hemoglobin-containing vesicles.
In summary we conclude that circulating RBCs lose hemoglobin by 
vesiculation, especially from older cells, and that the spleen facilitates this 
latter process in analogy to the "pitting" of Heinz bodies.14
Preliminary observations suggest that rat RBCs lose hemoglobin in a comparable 
way by vesiculation. The resulting vesicles are rapidly cleared from the circulation 
chiefly by Kupfer cells in the liver and, to a lesser extent, by other parts of the 
mononuclear phagocyte system. As in rats, vesicles in humans probably also are 
rapidly eliminated from the circulation, presumably by an immunological process.15
Our findings do not only elucidate some aspects of the heterogeneous nature 
of RBC indices, but they also help to understand RBC survival studies in which 
hemoglobin is labeled either with a cohort label (glycine and iron) or a random 
label (sodium chromate). When considering the efficacy of RBC transfusions, it is 
obvious that considerable loss of hemoglobin from circulating donor cells is 
another reason why the effect of an RBC transfusion is less than one would 
expect. Furthermore, these findings should be taken into account while 
studying diabetic control, as already during normoglycemia, asplenia gives rise to 
an increase of the HbA1c percentage.
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Abstract
Previous studies have shown that during the lifespan of red blood cells 
(RBCs) 20% of hemoglobin is lost by shedding of hemoglobin-containing 
vesicles. However, the fate of these vesicles is unknown. To study this fate 
we used a rat model, after having established that rat RBCs lose hemoglobin 
in the same way as human RBCs, and that RBC-derived vesicles are 
preferentially labeled by Na251CrO4. Such labeled vesicles were injected into 
recipient rats. Within 5 minutes, 80% of the radioactivity was cleared from the 
circulation with a concomitant uptake by the liver of 55% of the injected dose. 
After 30 minutes, Kupffer cells contained considerable amounts of 
hemoglobin and were shown to be responsible for 92% of the liver uptake. 
Vesicle clearance from the blood as well as liver uptake were significantly 
inhibited by preinjection of the scavenger-receptor ligands polyinosinic acid 
and phosphatidylserine. We conclude that in rats Kupffer cells rapidly remove 
RBC-derived vesicles from the circulation, mainly by scavenger receptors. 
The same mechanism is likely to be responsible for the elimination of human 
RBC vesicles, thereby constituting an important pathway for the breakdown of 
RBCs in humans.
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In previous studies, we have shown that a fractionation method combining 
counterflow centrifugation and subsequent Percoll gradient centrifugation is 
superior to any of these methods alone with respect to analyzing differences 
in cell age-related parameters of the red blood cell (RBC) fractions.1 Using 
this fractionation method, we obtained data that strongly suggest that during 
the RBC lifespan the mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH) content, and mean surface area decrease by 30%, 20%, 
and 20% respectively, whereas the mean corpuscular hemoglobin 
concentration (MCHC) increases by 14%.1-3 This means that loss of 
hemoglobin and of membrane parts occurs from intact RBCs in vivo. In a later 
study it could be shown that these losses are caused by shedding of 
hemoglobin-containing vesicles.4 Moreover, the results of these studies 
indicated that vesicles are produced by RBCs of all ages with vesicles 
derived from older RBCs containing more hemoglobin. However, the fate of 
these vesicles is unknown. Due to practical reasons this issue is virtually 
impossible to study in humans. We, therefore, studied the kinetics of vesicle 
elimination in a rat model that is analogous to the murine model used by one 
of us (T.J.C.v.B.) in a study, in which the fate of damaged RBCs was 
investigated.5 In addition this rat model enabled us to study the putative 
involvement of the mononuclear phagocyte system and its receptors. First, 
however, we had to establish that circulating rat RBCs lose hemoglobin by 
vesiculation in a similar manner to human RBCs.
Materials and methods
Materials
Sodium 51Cr-chromate was obtained from Amersham (Buckinghamshire, 
United Kingdom). Collagenase (type IV), bovine serum albumin (BSA, 
fraction V), 3,3'-diaminobenzidine, and polyinosinic acid (poly-I) were 
obtained from Sigma (St Louis, MO). Bovine brain phosphatidylserine (PS) 
and egg yolk phosphatidylcholine (PC) were purchased from Fluka (Buchs, 
Switzerland).
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Rats
Ten- to 12-week-old male Wistar rats weighing between 250 and 300 g were 
used. Rats were kept in our local facility under low pathogen conditions with 
free access to food and water.
Preparation of vesicles
Approximately 9 mL blood was drawn from a male Wistar rat in a tube 
containing 18 mg K-EDTA (potassium-ethylenediaminetetraacetic acid). 
Plasma was obtained by centrifugation for 10 minutes at 1900g. Blood cell 
vesicles were obtained from plasma by 30 minutes of centrifugation at 
16 000g and vesicles were washed 3 times with phosphate-buffered saline 
(PBS) containing 10% sodium citrate (10 minutes at 11 200g). Labeling of 
the isolated vesicles was carried out with 50 ^Ci (1.85 MBq) sodium 51Cr- 
chromate in 500 ^L vesicle suspension for 60 minutes at 37°C. Vesicles 
were washed 3 times for 10 minutes at 11 200g to remove free chromate.
Flow cytometry
The presence of vesicles was determined by side-scatter-forward-scatter 
(SSC/FSC) dot plots. The expression of HIS49 and exposure of PS on, and the 
presence of hemoglobin in vesicles, were examined by flow cytometry (Becton 
Dickinson, FACScan Research Software version 2.1, San José, CA and 
Beckman Coulter, Fullerton, CA, respectively). The following reagents were 
used: anti-HIS496 mouse monoclonal antibodies specific for rat RBCs and 
their vesicles (IQProducts, Groningen, The Netherlands) in combination with 
goat polyclonal F(ab')2 anti-murine immunoglobins labeled with fluorescein 
isothiocyanate (FITC; Dako Cytomation, Glostrup, Denmark), annexin V 
labeled with FITC or R-phycoerythrin (PE; Southern Biotechnology 
Associates, Birmingham, AL), and anti-Hb antibody labeled with FITC (clone 
4B8, IgG2b; Wallac, Akron, OH). For each analysis 1 x104 events were 
collected using Beckman Coulter software EXPO32 on the flow cytometer. 
In the SSC/FSC dot plot a gate was set around the area with small particles. 
To identify the presence of hemoglobin, vesicles were blocked, fixed, 
permeabilized, and washed as described before.4 The sorting of human
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vesicles was performed in the presence of antibodies specific for RBC-derived 
and platelet-derived vesicles by a Coulter Epics Elite (Coulter Beckman, 
Hialeah, FL). The following reagents were used: anti-glycophorin A 
(GPA) labeled with R-PE (clone JC159, IgG1; Dako Cytomation, Glostrup, 
Denmark) and an antibody against platelet protein IIIa (CD-61) labeled with 
FITC (clone Y2/561, IgG1, Dako). After sorting, the isolated RBC-derived 
vesicles and platelet-derived vesicles were separately labeled with sodium 
51Cr-chromate. After washing the pellet per 105 sorted events the label was 
preferentially bound to the RBC-derived vesicles in comparison to the 
platelet-derived vesicles (ratio 16.7 : 1).
Hemoglobin fractionation
Hemoglobin fractionation was performed by means of ion exchange 
chromatography (Protein-Pak, SP8HR, Millipore, Billerica, MA). The 
elution buffers used were based on the buffer system described by Jeppson et 
al.7 The composition of buffer A was 20 mM malonic acid and 1 mM NaCN, 
pH 5.9, in high-performance liquid chromatography (HPLC)-grade water. 
Buffer B had the same composition as buffer A with the addition of 380 mM 
NaNO3. Sodium cyanide was used as a stabilizer of hemoglobin. Before use, 
the buffers were passed through a 0.22-^m filter and degassed. The column 
was kept at 30°C. The hemoglobin components were separated with the use of 
a buffer gradient and monitored at 417 nm with a photodiode array detector. 
The relative amount of each component was calculated from the peak area of 
that component at 417 nm divided by the total area of all components. With the 
use of this technique, 11 fractions were separated. After incubation of rat 
RBCs in a glucose medium (overnight incubation of 1 mL packed cells in 3 
mL 5% glucose at 37°C) peaks 5 and 7 proved to be the most pronounced 
glycated hemoglobin components (mean increase 6.2% and 2.1% of total 
hemoglobin, respectively). Therefore, these peaks were used as markers of 
RBC age.
RBC fractionation according to cell volume
RBC fractionation according to cell volume was performed using counter-flow
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centrifugation in a Dijkstra Curame 3000 elutriation system (Dijkstra 
Vereenigde, Lelystad, The Netherlands) as described before for human 
RBCs.4
The separation was performed at a flow rate of 10 mL/min at 20°C, using an 
isotonic buffer containing albumin and glucose (GASP): 9 mM Na2HPO4, 1.3 
mM NaH2PO4, 140 mM NaCl, 5.5 mM glucose, and 0.8 g/L BSA (fraction V, 
pH 7.4; Sigma). Blood was diluted 1 : 3 with GASP buffer, and 2 mL of this 
suspension was introduced into the buffer flow to the elutriation chamber. 
RBCs with increasing volume were eluted from the elutriation chamber at 8 
different speeds of rotation from 2200 to 1500 rpm, yielding 8 fractions.
RBC parameters
MCH content, MCV, and RBC count were determined on an ADVIA 
(Bayer-Technicon, Tarrytown, NY).
Liver uptake, blood decay, and tissue distribution of51Cr -labeled vesicles in 
rats
Rats were anesthetized with a subcutaneous injection of a mixture of 
Hypnorm (6.75 mg fluanisone/kg and 0.21 mg fentanyl citrate/kg) and 
midazolam (3.38 mg/kg). The abdomens were opened, and 480 ^L 51Cr 
labeled vesicles were injected via the inferior vena cava with or without 
preinjection of competitors. At the indicated times, liver lobules were tied 
off, excised, and weighed. The total amount of liver tissue tied off during the 
experiment did not exceed 10% of the total liver weight. Blood samples 
(300 ^L) were taken, and radioactivity was measured. At 30 minutes, the 
rats were killed and tissues were excised, weighed, and the radioactivity was 
determined. The radioactivity in liver and other tissue samples was corrected 
for blood present at the time of sampling, according to earlier determinations 
with 125I-BSA.
Isolation of liver cells and light microscopy
At 30 minutes after injection of 51Cr-labeled vesicles, the liver was 
preperfused at 8°C for 10 minutes with Hanks buffer, pH 7.4, with HEPES
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(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; 6.7 mM), at a flow 
rate of 14 mL/min and subsequently with 50 mL Hanks buffer with HEPES 
(6.7 mM) containing 20 mg collagenase type VI. Parenchymal, endothelial, 
and Kupffer cells were isolated by differential centrifugation and counter­
flow elutriation, as described earlier.5,8 The endothelial fraction contained 
more than 95% of endothelial cells, the percentage of Kupffer cells in the 
Kupffer cell fraction being 85% ± 5% (n = 3). The cell fractions were 
stained with 3,3'-diaminobenzidine to determine the peroxidase activity as 
an indication for the presence of endogenous peroxidase and hemoglobin by 
light microscopy. Microscope information is as follows: make, Leica; 
model, DMRE; lenses, Leica PL Fluotar 100 X 1.30; camera, Nikon FX 90; 
image processing was not performed.
Liposomes
Unilamellar liposomes were prepared with egg yolk PC, bovine brain PS, and 
cholesterol in a phospholipid-to-cholesterol molar ratio of 2 : 1.5 Lipids in 
chloroform were mixed and evaporated under nitrogen. The lipid film was 
resuspended in sterile PBS at a concentration of 3 mM total lipid and sonicated 
for 30 minutes with an MSE soniprep 150 (amplitude 16 ^m) at 52°C under a 
constant stream of argon.
Statistical analysis
Data are shown as mean ± SEM. Statistical significance was calculated using 
the student t test (2-tailed).
Results
Vesicles in rats and humans
Visual inspection of the pellets obtained after centrifugation indicated that 
vesicle-like material can be obtained from rat plasma. Flow cytometry 
studies confirmed this (Figure 1).
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Figure 1. Flow cytometry of rat vesicles. SSC/FSC dot plots of vesicles of rats (A) and humans (B). 
Both determinations were performed in the presence of annexin V-PE.
Studies with antibodies against RBC-specific antigen HIS49,6 anti-hemoglobin 
antibodies, and annexin V demonstrated that at least 21% of all vesicles were 
derived from RBCs, of which 66% contained hemoglobin and 67% exposed 
PS. In RBC fractions obtained by counterflow centrifugation, there was an 
inverse relationship between MCH content and the glycated hemoglobins 
peak 5 and peak 7 that were used as cell age markers (Figure 2).
Figure 2. The relationship between MCH content and the glycated hemoglobins 5 and 7.
Determinations in rat 1 (A) and rat 2 (■) show an inverse relationship between MCH and peak 5 (left) 
and peak 7 (right). The lines are the regression lines.
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This means that the hemoglobin content decreases as the RBCs become older. 
The decrease in the percentage of peak 5 and peak 7 in the fractions with the 
lowest MCH content, that is, in the fractions containing the oldest cells, is 
explained by presuming that the decrease of these glycated hemoglobin 
components from these cells cannot be compensated for by their generation 
within these cells. This decrease of glycated hemoglobins in RBC fractions 
with the lowest MCH content has been described by us in humans.4 Likewise, 
it has been described that in the first 80 days after infusion of 59Fe-labeled 
transferrin a linear rise of the hemoglobin Aic percentage and thereafter 
leveling off and even a decrease occur.9
When the relative decrease of the MCH content and the relative increase of the 
most pronounced glycated hemoglobin components were compared between 
rats and humans, a striking similarity was found despite the obvious differences 
between rat and human RBC parameters (Table 1). These differences are 
remarkable because rat MCH content and MCV are approximately half of 
those in humans, and the RBC count in rats is twice as high.
Table 1. Comparison of relative changes of MCH content and glycated hemoglobin 
components in humans and rats
Humans, n = 5 Rats, n = 2
MCH content decrease, % 20 23.6
Glycated hemoglobin increase, % 45* 42/49Î
*Percent hemoglobin A1c.
tPercent peak 5 and peak 7, respectively.
Vesicle clearance and liver uptake
Vesicles were isolated, labeled with sodium 51Cr-chromate, and injected into 
recipient rats. Within 5 minutes, 80% of the labeled vesicles were removed 
from the circulation with a concomitant uptake by the liver of 55% of the 
injected radioactive dose. At 30 minutes, 91% of the vesicles were cleared, the 
liver uptake being unchanged (Figure 3).
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Figure 3. Blood decay and liver 
uptake of 51Cr vesicles (6 
experiments). At time 0 a single bolus 
of donor blood cell-derived vesicles 
was injected into recipient rats and at 
various times after injection a liver 
lobule and a blood sample were taken. 
Blood decay is indicated by o and liver 
uptake by •.
To analyze which liver cell type is responsible for the avid liver uptake, we 
isolated parenchymal, endothelial, and Kupffer cells at 30 minutes after 
injection of the sodium 51Cr-chromate-labeled vesicles. Nearly all liver 
activity was found in the Kupffer cells (Table 2).
Light microscopy showed that most of the Kupffer cells contained a considerable 
amount of hemoglobin (dark brown staining in Figure 4). Kupffer cells of 
uninjected animals only contained very slight staining, as compared to the 
vesicle-injected animals. Liposome uptake by Kupffer cells did not influence 
the slight staining of the cells,10 indicating that the dark brown color within the 
Kupffer cells is indeed the consequence of hemoglobin uptake.
Table 2. Relative contribution of different cell types to the 
uptake of 51Cr vesicles by 3 rat liver specimens
Cell type Percent
Parenchymal cells 0.7 ±  0.1
Endothelial cells 7.7 ±  1.7
Kupffer cells 91.6 ±  1.6
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Figure 4. Histochemistry of Kupffer cells 
for the presence of peroxidase activity at 
30 minutes after injection of vesicles.
Cells were isolated as described in “Materials 
and methods.” Cytospins were fixed in acetone 
and stained with 3,3'- diaminobenzidine. The 
large quantities of stainable material in the 
Kupffer cells indicate the presence of 
hemoglobin. The endothelial cells (E) are 
slightly stained indicating the presence of 
endogenous peroxidase. Original objective 
magnification x 100. The procedure was 
repeated 2 times with very similar results.
Effect of preinjection of PC and PS liposomes andpoly-I 
Preinjection o f  PC liposomes d id not alter the b lood decay and live r uptake o f  
51Cr vesicles. In  contrast, PS liposomes inh ib ited the live r uptake o f  vesicles by 
40%  o f  the to ta l rad ioactive  dose w ith  a concom itant s low ing down o f  the 
b lood decay (Figure 5).
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Figure 5. Blood decay and liver uptake of Cr vesicles after preinjection of PC and PS 
liposomes (2 experiments). Left, blood decay after preinjection of PC liposomes (□) and PS 
liposomes (V). Right, liver uptake after preinjection of PC liposomes (■) and PS liposomes (▼). 
‘ Significantly different (.01 < P < .05) from controls. "Significantly different (P < .01) from controls.
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Also, preinjection of poly-I inhibited the liver uptake by 40% of the total 
radioactive dose and was accompanied by a slower removal of the vesicles 
from the blood circulation (Figure 6).
comparison to controls (2 experiments). Left, blood decay after preinjection of poly-I (△) in 
comparison with controls (o). Right, liver uptake after preinjection of poly-I (A ) compared to 
controls (•). *Significantly different (0.01 < P < .05) from controls. "Significantly different (P 
< .01) from controls.
Figure 6. Blood decay and liver uptake of Cr vesicles after preinjection of 2 mg poly-I in
Tissue distribution of vesicles
At 30 minutes after injection, tissue radioactivity was found in declining 
order in liver (44.9%), bone (22.5%), skin (9.7%), muscle (5.8%), spleen 
(3.4%), kidney (2.7%), and lung (1.8%). The blood still contained 9.1% of the 
radioactivity. The same pattern was seen after preinjection of PC liposomes. 
In contrast, preinjection of poly-I and PS liposomes affected mainly the 
uptake of radioactivity in the liver, whereas after preinjection of poly-I an 
increase in bone and lung activity was seen. After preinjection of both poly-I 
and PS liposomes more labeled vesicles were still present in the blood as 
compared to the control situation (Figure 7).
Discussion
Using counterflow centrifugation as fractionation procedure of rat RBC 
populations, and 2 glycated hemoglobin components as cell age markers, we 
showed that circulating RBCs in the rat lose relatively as much hemoglobin
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as human RBCs. As in human plasma, vesicles were also present in rat 
plasma. It was demonstrated that at least 21% of vesicles were derived from 
RBCs; 66% of these vesicles contained hemoglobin. Taking these data 
together we conclude that not only in humans but also in rats hemoglobin loss 
from circulating RBCs results from vesiculation.
To study the fate of the blood cell-derived vesicles in the rat we chose sodium 
51Cr -chromate because in RBCs this label is bound to hemoglobin. Possibly 
this label also binds to platelet-derived vesicles because 51Cr binds to 
cytoplasmic constituents such as mitochondria in intact platelets.11 However, 
this label binds preferentially to human RBC-derived vesicles in comparison to 
platelet-derived vesicles, as revealed by sorting experiments with anti-GPA 
antibodies and anti-CD61 antibodies. The difference in binding of the 51Cr 
label to RBC-derived vesicles and platelet-derived vesicle is, despite the 
difference in numbers, so large (ratio, 16.7 : 1) that more than 80% of the 
radioactive label is bound to RBC-derived vesicles, and as a consequence the 
hemoglobin-containing RBCderived vesicles contribute to more than 50% of 
total radioactivity (Table 3).
Table 3. Percentage of total radioactivity bound to 
vesicles with or without haemoglobin
51Cr-labeled RBC-derived
Percentage injected dose
All vesicles 100
RBC-derived vesicles 82*
RBC-derived vesicles + hemoglobin 54t
‘Calculated from percentage HIS49+ vesicles (21%) and 51Cr-binding ratio of RBC- 
derived and platelet-derived vesicles (16.7:1), assuming that non-RBCderived 
vesicles in the rat are platelet-derived (79%): 21/79 X 16.7/1 = 4.43/1 ^ 4.43/(4.43 + 1)
= 81.6%.
tCalculated from percentage of hemoglobin-containing RBC-derived vesicles (66%):
0.66 X 81.6 = 53.8%.
Therefore, it is not surprising that not only approximately 50% of the injected 
radioactive dose but also a considerable amount of hemoglobin is present in the 
Kupffer cells at 30 minutes after injection. Both phenomena are a strong 
indication for a large turnover of this RBC constituent. When 51Cr-labeled
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donor rat vesicles were injected into recipient rats, we found a biphasic blood 
decay. Most vesicles (approximately 85%) were removed from the plasma 
within minutes, the remaining much more slowly.
The reason for this dichotomy might be explained by the ratio of labeled RBC- 
derived versus platelet-derived vesicles or PS exposure or both. Also, 
differences in release from tissues, in which vesicles are trapped, could play a 
role. The liver uptake showed the inverse pattern with a steep rise within 
minutes followed by a plateau phase. After fractionation of liver tissue more 
than 90% of liver radioactivity was found in the Kupffer cells.
The uptake of vesicles by Kupffer cells was inhibited by preinjection of PS 
liposomes and poly-I, equivalent to 40% of the injected dose. In accordance, 
67% of RBC-derived vesicles exposed PS. When these data were 
compared to those of the study in which the kinetics of oxidized murine 
RBCs were investigated,5 a marked similarity was noted. This suggests that 
the same mechanism is responsible for the elimination from the circulation of 
both RBC-derived vesicles and oxidatively damaged RBCs.
Tissue distribution of radioactivity after preinjection with poly-I showed not 
only slower removal of circulating vesicles from the plasma, but also an 
increased uptake in bone and lung, possibly due to a compensatory activity of 
bone marrow and lung macrophages. No such increased uptake was seen 
after preinjection with PS liposomes, suggesting inhibition of PS-binding 
macrophages in bone marrow and lungs besides the inhibition of 
macrophages in the liver (Kupffer cells). Putative receptors that are 
operative in these processes consist of scavenger receptor A, CD68, CD 36, or 
LOX-1.12 Possibly the PS-specific receptor, which plays such a crucial role 
in the uptake of apoptotic cells, is also of importance in the uptake of PS- 
exposing vesicles by Kupffer cells.13
We conclude that in rats RBC-derived vesicles are rapidly removed from the 
circulation mainly by liver Kupffer cells and to a lesser extent by other 
macrophages of the mononuclear phagocyte system.
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liver bone skin muscle spleen kidney lung blood 
tissues
Figure 7. Tissue distribution of 51Cr vesicles at 30 minutes after injection. The bars 
represent control rats (■), rats with preinjection of PC liposomes (□), rats with preinjection of 
poly-I ( )^, and rats with preinjection of PS liposomes (»). The recovery of the injected dose in the 
various tissues and blood was for the various groups: controls, 100.0% ± 10.5%; PC liposomes,
107.9% ± 0.2%; poly-I, 98.8% ± 6.3%; and PS liposomes, 90.8% ±0.8%. *Significantly different 
(P = .038) from controls. "Significantly different (P < .01) from controls.
In  th is  process receptors tha t can be b locked  by  PS liposomes and po ly -I, 
but not by PC-liposomes, p lay an im portant role. Because hem oglob in  loss 
from  RBCs in  humans is s im ila r to that in  rats, the same mechanism is 
probably operative fo r  human R BC -derived vesicles.
A pproxim ate ly  20% o f  hem oglobin and 20% o f  surface area are lost from  
circulating human RBCs during their lifespan. Therefore, vesicu la tion  can be 
conceived as the f irs t step o f  an im portant pathway o f  R BC  breakdown. I t  
also means that by using f lo w  cytom etric sorting o f  RBC -derived vesicles the 
prem ortal substrate o f  20% o f any RBC is at our disposal. The results presented 
here, together w ith  p re lim inary  data ind icating that human RBC -derived and 
p la te le t-derived vesicles expose PS in  v iv o ,14 support the hypothesis that 
exposure o f  PS on bo th  c ircu la tin g  ce lls and vesicles leads to the ir rem oval 
by K u p ffe r cells and other macrophages o f  the m ononuclear-phagocyte 
system.
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Abstract
Previous studies demonstrated that 20% of haemoglobin is lost from 
circulating erythrocytes during their total lifespan by vesiculation. To study 
whether removal molecules other than membrane-bound haemoglobin were 
present in erythrocyte-derived vesicles, flowcytometry and immunoblot 
analysis were employed to examine the presence of phosphatidylserine (PS) 
and IgG, and senescent cell antigens, respectively. It was demonstrated that 
67% of glycophorin A-positive vesicles exposed PS, and that half of these 
vesicles also contained IgG.
Immunoblot analysis revealed the presence of a breakdown product of band 3 
that reacted with antibodies directed against senescent erythrocyte antigen- 
associated band 3 sequences. In contrast, only the oldest erythrocytes 
contained senescent cell antigens and IgG, and only 0.1% of the erythrocytes, 
of all ages, exposed PS.
It was concluded that vesiculation constitutes a mechanism for the removal of 
erythrocyte membrane patches containing removal molecules, thereby 
postponing the untimely elimination of otherwise healthy erythrocytes. 
Consequently, these same removal molecules mediate the rapid removal of 
erythrocyte-derived vesicles from the circulation.
96
erythrocyte vesiculation as a self-protective mechanism
Introduction
Erythrocytes lose a substantial amount of haemoglobin during their lifespan. 
We have previously described the fractionation of erythrocytes by a method 
in which the first separation, based on volume, is combined with a separation 
using a density gradient, deploying the percentage HbA1c as a marker of 
erythrocyte age (Bosch et al., 1992). Using this method it was demonstrated 
that in splenectomized subjects, erythrocytes lose 15% haemoglobin 
gradually during their lifespan in a linear fashion. In healthy subjects, an 
additional 5% of the haemoglobin is lost during the second half of the 
erythrocyte lifespan (Willekens et al, 2003). This is in accordance with the 
studies using 14C/15N-glycine labelling of erythrocytes, that demonstrated a 
gradual and substantial haemoglobin loss of circulating erythrocytes as well 
as the continuous appearance of the label in the haemoglobin degradation 
products stercobilin and urobilin (London et al, 1950; Berlin et al, 1954). The 
erythrocyte-derived vesicles isolated from the plasma of freshly drawn blood, 
contained all haemoglobin components in a pattern similar to that of old 
erythrocytes, in accordance with the increased haemoglobin loss in the 
second half of the erythrocyte lifespan (Willekens et al, 2003). Vesicles were 
also observed in erythrocytes of all ages and were shown to accumulate after 
splenectomy (Reinhart & Chien, 1988). In asplenia, vesicles or vacuoles that 
are larger than 300 nm, can be observed as “pits” in the smear. After 
splenectomy, these pits originate equally in young and old cells (De Haan et 
al, 1988), whereas the mean corpuscular haemoglobin of old erythrocytes 
remains relatively higher because of increased absolute amounts of HbA1c 
and HbA1e2 (Willekens et al, 2003). On the basis of these findings we 
concluded that the removal of haemoglobin by vesiculation, including 
irreversibly modified haemoglobin, occurred during the total erythrocyte 
lifespan.
It has been calculated that there is not enough membrane in the erythrocyte as 
a whole to package 20% of the haemoglobin in the form of vesicles 
(V.L.Lew, personal communication). It must therefore be assumed that either 
the haemoglobin loss was somehow overestimated, or that the extra loss of
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surface area in comparison to the haemoglobin loss is compensated for by 
incorporation of lipids, probably originating from plasma lipoproteins (Reed, 
1968; van Deenen & De Gier, 1974; Verkleij et al, 1976; Brossard et al, 
1997). As we are not aware of an alternative route for haemoglobin to leave 
the circulating erythrocyte, we think the second explanation the most 
plausible.
In a rat model, almost 50% of erythrocyte-derived vesicles were rapidly 
removed from the circulation by Kupffer cells through a phosphatidylserine 
(PS)-dependent mechanism (Willekens et al, 2005). The same PS-dependent 
mechanism was responsible for the elimination of oxidatively damaged 
erythrocytes by Kupffer cells in a murine model (Terpstra & van Berkel, 
2000). PS is considered to be an early sign of apoptosis in nucleated cells, 
proffering a binding site for macrophages. Indeed, PS exposure is enhanced 
in a substantial proportion of sickled red blood cells, and may contribute to 
the phagocytosis of these cells in vitro (Kuypers & de Jong, 2004). Also, 
erythrocytes of thalassaemia patients show an increased PS exposure 
(Kuypers & de Jong, 2004).
In addition, it is generally accepted that age-dependent removal of 
erythrocytes from the circulation is mediated by the binding of physiological 
autoantibodies (Kay, 1975, 1978), which form the trigger for the recognition 
and removal of senescent erythrocytes by macrophages. The senescent cell- 
specific autoantigens (SCA) originate on band 3, the anion exchanger and 
major membrane protein of the erythrocyte (Kay, 1984b, 2004). It is 
speculated that SCA generation is triggered by the binding of denatured 
haemoglobin to the cytoplasmic domain of band 3, thereby inducing 
clustering and/or degradation of band 3. Both aggregation and degradation 
may lead to neoantigen formation (Kay, 1984a; Low et al, 1985; Kay et al, 
1986; Schluter & Drenckhahn, 1986). It is uncertain whether, in normal 
erythrocyte ageing, activated complement or complement-regulating proteins 
play a role comparable with that in sickle cell anemia and paroxysmal 
nocturnal haemoglobinuria (Lutz, 2004).
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To be able to prevent premature loss of erythrocytes, either ex vivo during 
processing in the blood bank or in vivo in patients, it is important to elucidate 
the mechanisms that have an effect on the relationship between the 
generation of erythrocyte-derived vesicles and the process of erythrocyte 
ageing at the molecular level. In the course of our investigations in this area, 
we developed the hypothesis that generation of vesicles may not only serve to 
remove modified haemoglobin and its toxic derivatives, but may also help to 
eliminate premature removal molecules from otherwise functional 
erythrocytes. The effective disposal of such molecules would preserve the 
integrity of the erythrocyte and may expand its life span. To test this 
hypothesis, we explored the presence of putative removal molecules such as 
band 3-related senescent cell antigens and PS, and the presence of IgG and 
complement-regulating proteins on erythrocyte-derived vesicles and on the 
membranes of erythrocytes of various ages.
Materials and Methods
Vesicle preparation
Blood (10 ml) was drawn from six healthy donors using citrate as an 
anticoagulant and the samples were centrifuged at 1550 g for 15 minutes. 
The supernatant plasma was centrifuged again at 1550 g for 10 minutes in 
order to remove any remaining cells. Finally, the vesicles were pelleted by 
centrifugation of the supernatant at 12 000 g during 20 minutes in cone­
shaped tubes.
Quantification of vesicles in plasma
Erythrocytes from freshly drawn blood were sphered and fixed using a 
solution of 0.11% glutaraldehyde and 0.035 mmol/l sodium dodecyl-sulphate 
in phosphate-buffered saline (PBS) (Mohandas et al, 1986). These stabilized 
erythrocytes (Stab-RBCs), which remained positive for glycophorin A, were 
used as an internal standard. Stab-RBCs were counted in a haematology 
analyser (XE2100, Sysmex, Kobe, Japan), and 105 Stab-RBCs were added to
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the vesicles isolated from 500 ^l of plasma. CD253a-PE (a monoclonal anti- 
glycophorin A antibody, clone JC159, DakoCytomation, Glostrup, Denmark) 
was added to this suspension. After washing with PBS, flow cytometric 
analysis was performed using a FACscan (Becton Dickinson, San Jose, CA, 
USA). The signals generated by respectively glycophorin A-positive vesicles 
and Stab-RBCs could clearly be distinguished in the dot plots. The ratio of 
glycophorin A-positive vesicles and Stab-RBCs-related signals, multiplied by 
the number of Stab-RBCs that had been added, provided the number of 
erythrocyte-derived vesicles in 500 ^l of plasma.
Erythrocyte fractionation
Erythrocytes were fractionated according to cell volume followed by a 
fractionation according to cell density, as described earlier (Bosch et al, 
1992). As a result of the low yield per fraction the final 24 samples were 
combined to achieve five fractions (I -  V); fraction I comprised the four 
portions containing the youngest cells and fraction V the four portions with 
the oldest red cells (Bosch et al, 1994).
Flow cytometry analysis of vesicles and red cells
The expression of glycophorin A, CD55 and CD59, the presence of IgG, and 
the exposure of PS on vesicles and red blood cells were measured by means 
of flow cytometry (FACscan, Becton Dickinson, San José, CA, USA), 
employing the following reagents: anti-glycophorin A ( CD235a-PE, clone 
JC159, DakoCytomation), CD55-fluorescein isothiocyanate (FITC) and 
CD55-phycoerythrin (PE) (clone IA10, Pharming, Becton Dickinson), CD59- 
FITC (clone MEM-43, ITK, Hoorn, The Netherlands), FITC labelled F(ab)2- 
fragment of rabbit anti-human-IgG (specificity against the Fc-domain of the 
IgG molecule) and its non-immune rabbit F(ab’)2 negative control (Sanquin 
Diagnostica, Amsterdam, The Netherlands), Annexin A5-PE and Annexin 
A5-FITC (Southern Biotechnology Associates, Birmingham, AL, USA). 
CD235a was diluted (1:10 to 1:25) to prevent agglutination of the 
erythrocytes. All other antibodies were used as provided by the manufacturer.
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Immunoblot of membranes and vesicles
Vesicles and erythrocytes were lysed in lysis buffer [5 mmol/l phosphate, 1 
mmol/l EDTA, 1 mmol/l EGTA, pH 8.0, protease inhibitors (‘Complete’, 
Roche Diagnostics GmbH, Mannheim, Germany)], and the membrane 
fractions were examined by immunoblotting as described previously 
(Bosman et al, 1991), on the basis of chemiluminescent detection of the 
immunoreaction using the SuperSignal system (Pierce, Rockford, USA). Five 
.^g of protein was loaded in each lane. The specificities and characteristics of 
the antibodies against band 3 have been described previously (Bosman et al, 
1991; Renkawek & Bosman, 1995). Semiquantitative analysis of the signals 
was performed using densitometry (Molecular Analyst, Bio-Rad Laboratories 
B.V., Veenendaal, The Netherlands).
Results
Vesicles
Vesicle count in plasma.
Using stabilized red cells as an internal standard, we developed a 
reproducible flow cytometric technique to determine the number of 
erythrocyte-derived vesicles in plasma. This technique revealed that the 
blood of adult, healthy subjects contains, on average, 169 erythrocyte-derived 
vesicles per .^l plasma [N = 5; standard deviation (SD): 35; range: 61-308].
Presence of IgG and exposure of phosphatidylserine.
Two-colour flow cytometric analysis, employing a combination of anti- 
glycophorin A-PE and Annexin-A5-FITC, demonstrated that 55% of the 
vesicles were positive for glycophorin A and that 67% of these glycophorin 
A-positive vesicles exposed PS [Table I (a)]. In addition, almost 40% of the 
glycophorin A-positive vesicles were shown to contain IgG [Table I (a)].
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Table I. Characterization of (a) glycophorin A-positive* and (b) IgG-positivet 
vesicles
Positive for Percentage Mean ± SD N
a IgG 39 ± 11 6
PS 67 ± 17 4
b Glycophorin A 85 ± 14 6
PS 85 ± 6.1 6
* The results are shown as the percentage of glycophorin A positive vesicles that 
are positive as well for IgG and PS respectively.
t  The results are shown as the percentage of IgG positive vesicles that are 
positive as well for glycophorin A and PS respectively.
PS, phosphatidylserine; SD, standard deviation
Proteomics analysis also showed high amounts of immunoglobulins in 
glycophorin A-positive vesicles (G.J.C.G.M. Bosman, unpublished 
observations). Interestingly, the expression of glycophorin A appeared to 
vary considerably (Fig 1), but the presence of IgG on vesicles was almost 
exclusively restricted to vesicles with a high expression of glycophorin A 
(Figs 2A and B).
Fig 1. Glycophorin expression and 
phosphatidylserine exposure on circulating human 
vesicles. Flowcytometric fluorescence dot plots 
of human vesicles, incubated with anti- 
glycophorin A-PE and Annexin A5-FITC.
Conversely, hardly any IgG was found on the glycophorin A-negative 
vesicles [Table I(b) and, Figs 2A and B]. Moreover, 85% of the IgG- 
containing vesicles did expose PS [Table 1(b) and , Figs3A and B].
Presence of CD55 and CD59.
Glycophorin A-carrying vesicles were positive for complement-regulating 
CD55 and CD59 proteins in 84% and 97% of vesicles, respectively (data not 
shown).
Annexin-A5-FITC
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Fig 2. Presence of IgG on human erythrocyte-derived vesicles. Flowcytometric fluorescence dot plots of 
human vesicles incubated with anti-glycophorin A-PE in combination with anti-IgG-F(ab)2-FITC. A: negative 
control and B: anti-IgG-F(ab)2-FITC.
Fig 3. Phosphatidylserine-exposure and the presence of IgG on human vesicles. Flowcytometric 
fluorescence dotplots of human vesicles incubated with Annexin A5-PE in combination with anti-IgG-F(ab)2- 
FITC. A: negative control and B: anti-IgG-F(ab)2-FITC.
Characteristic senescent cell antigen-related band 3 on vesicles.
Immunoblot analysis with antibodies against band 3 peptides indicated the 
existence of an altered band 3 in vesicles (Fig 4). A strong immunoreactivity 
was revealed by two antibodies to two closely related epitopes (aa 562-565, 
and aa 565-569) in the N-terminal part of the membrane domain (Table II), 
that participate in senescent cell antigen activity (Kay, 2005).
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Fig. 4. Membrane immunoblot of red cell fractions and vesicles. Immunoblots of membrane fractions 
I -  V (see Methods) and of vesicles with antibodies reactive with aa 542-555, 812-827, and 566-569 
of band 3, that are illustrative of the data summerized in Table 2. At the right the apparent molecular 
weights of the immunoreactive bands are indicated.
Table II. Semi-quantitative analysis of the reactivity of anti-band 3 
antibodies in red blood cells of various ages and in vesicles.
Band 3 epitope 
(amino acid number)
Presence in 
fraction I ^  V
Presence in 
vesicles
25-35 ++ ^  ++ 0
812-827 ++ ^  + 0
390-550 + ^  ++ +
542-555 + ^  ++ +
840-911 ++ ^  +++ +
562-565 0 ^  ++ +++
566-569 0 ^  0 ++
0 , not present; the no +’s is based on an arbitrary densitometry scale. 
Fractions are numbered as described in the Materials and Methods section.
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These particular antibodies were mainly reactive with a protein of 
approximately 70 kDa in size. Antibodies against other epitopes in the N- 
terminal and C-terminal parts of the membrane domain displayed a weak 
immunoreactivity at the most.
Erythrocytes
Exposure of phosphatidylserine and presence of IgG on erythrocytes of 
various ages.
Only 0.11% of the erythrocytes exposed PS at the outer leaflet of their 
membrane.
Table III. Percentage of Annexin A5-positive erythrocytes in whole 
blood and in fractions of different cell age of healthy individuals (N=6 ).
RBC fraction
% HbA1c 
mean ± SD
% Annexin A5 positive cells 
mean ± SD
Whole blood 5.20 ± 0.35 0.11 ± 0.04
Fraction I 3.73 ± 0.54 0.26 ± 0.17*
Fraction II 4.47 ± 0.39 0.14 ± 0.04
Fraction III 5.28 ± 0.54 0.15 ± 0.08
Fraction IV 6.21 ± 0.64 0.12 ± 0.05
Fraction V 6.71 ± 0.59 0.12 ± 0.03
* Fraction I differed significantly (p < 0.05; Wilcoxon matched pair test) 
from whole blood. SD, standard deviation
Remarkably, in the fraction containing the largest proportion of old cells 
there was no increase in the number of cells exposing PS compared with 
other fractions, whereas a statistically significant increase was found in the 
fractions that contained the youngest erythrocytes (Table III). Proteomics 
analysis showed that only the oldest erythrocytes contained small amounts of 
immunoglobulins (G.J.C.G.M. Bosman, unpublished observations).
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Complement-regulating proteins CD59 and CD55 on ageing erythrocytes.
The mean intensity of the fluorescence signal (MFI) elicited by CD55 and by 
CD59 revealed a small, ageing-related decrease, which was statistically 
significant in the oldest fraction (fraction V, Table IV).
Table IV. The mean fluorescence intensity (MFI) of CD55 and CD59 in erythrocyte 
fractions of different cell age.
Erythrocyte
Fraction
MFI
CD55 CD59
I 100 100
II 96 ± 4 96 ± 2
III 95 ± 3 96 ± 3
IV 93 ± 4 96 ± 3
V 89 ± 2* 92 ± 3*
The MFI was measured in six different experiments, and is expressed as percentage of 
the MFI in fraction I ± SD.
* Fraction V differed significantly (p < 0.02, Wilcoxon matched pair test) from fraction I 
SD, standard deviation
Band 3-related senescent cell-specific epitopes on erythrocytes of various 
ages.
The relationship between the data from the semiquantitative analysis of the 
immunoreaction and the specificity of the various antibodies for specific 
domains, suggested that some areas within the membrane are preferentially 
affected during erythrocyte ageing (Table II, Fig 4). Particularly, antibodies 
directed against epitopes in the N-terminal part of the membrane domain (aa 
540-565) and, to a lesser extent, an antibody directed against the C-terminal 
part of the membrane domain (aa 840-911), that together constitute the 
senescent cell antigen (Kay, 2005), showed an age-related increase in 
reactivity (Table II). Interestingly, these very antibodies also showed a 
positive reaction with vesicle proteins (Table II). The antibodies that reacted 
strongly with vesicles, reacted mainly with membranes of old erythrocytes.
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Discussion
In this study, the erythrocyte-derived vesicle concentration was found to be 
approximately 170 vesicles per ^l, comparable to the number found by 
others (Berckmans et al, 2001; Shet et al, 2003; Hron et al, 2007). The mean 
diameter of these vesicles is 0.5 ^m (Willekens et al, 2003). These data 
enable us to calculate roughly the dynamics of vesiculation, when the loss of 
15-20% (15 ^m3) of the erythrocyte volume occurred through vesiculation. 
Assuming a spherical shape, the vesicle volume is approximately 0.065 ^m3. 
To lose 15 ^m3, the erythrocyte has to produce on average 231 (15 ^m3 /
0.065 ^m3) vesicles over 120 d, or 2/d. A total erythrocyte mass of 25.1012, as 
can be found in a healthy male, produces 580.106 vesicles per second, which 
have to be removed at the same time, assuming an equilibrium condition. The 
total amount of erythrocyte-derived vesicles in blood is 850.106 (170 x 
5.106), indicating that it takes only 0.7 seconds to clear half of all the 
vesicles from the circulation. This is at least one order of magnitude less than 
one circuit around the circulation, and in large contrast to the calculated half­
life of 25 s of 61%, and a half-life of 6.6 min of 30% of 51Cr-labeled 
erythrocyte-derived vesicles in a rat model (Willekens et al, 2005). The same 
experiments showed that 70% of the vesicles were cleared within two 
minutes, while at the same time 30% of the radioactivity was taken up by the 
liver, indicating that 40% was taken up elsewhere. Accordingly, after 30 min 
the distribution of radioactivity was 45% in the liver and 46% in other 
organs, namely , bone, skin, muscle, spleen, kidney and lung (23%, 10%, 6%, 
3%, 2.5%, and 1.5% respectively) (Willekens et al, 2005). This indicated that 
the liver and other organs were equally effective in removing erythrocyte- 
derived vesicles from the circulation. Taken together, these data suggest that 
most vesicles are taken up almost directly by the macrophages of the organ in 
which they originate before they can reach the venous circulation and be 
counted. Apparently, the body has developed an efficient mechanism to 
remove these vesicles that could be harmful because of the coagulation- 
promoting activity of the PS-exposing vesicle membrane. The rate of 
clearance was substantially inhibited by a prior intravenous injection with 
PS-exposing liposomes in the liver, but not in the other organs, indicating a
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saturation of scavenger receptors by PS in Kupffer cells (Willekens et al, 
2005). In the present study of human vesicles, a two-colour flow cytometric 
analysis employing anti-glycophorin A and annexin-A5 showed that the 
erythrocyte vesicles that expose PS all showed a high expression of 
glycophorin A (Fig 1). As a considerable proportion of these PS-exposing 
vesicles also contain IgG, it seems reasonable to assume a role for an 
immune-mediated mechanism that helps to maintain the overall quality of the 
erythrocyte population. As has been postulated before, clearance may be 
facilitated by PS-mediated phagocytosis (Wu et al, 2006), but also IgG is 
recognised by specific Fcy-receptors on macrophages (Nimmerjahn & 
Ravetch, 2006), leading to phagocytosis.
Almost all vesicles carry the complement-regulating proteins CD55 and 
CD59. This observation strongly suggests the presence of a complement 
protection mechanism, and indicates that under physiological circumstances 
complement activation does not play an important role in vesiculation, nor in 
vesicle clearance.
Vesicle formation appears to be accompanied by breakdown of band 3. The 
present study demonstrated the presence of band 3-related proteins in vesicles 
that are formed in vivo. These band 3-related proteins could be visualized 
with antibodies directed against membrane areas that are involved in 
senescent cell antigen activity (Table II, Fig 4). In addition, virtually no intact 
band 3 was found in the vesicles; proteins with a molecular weight of 
approximately 70 kDa or less dominated the immunoblot picture. In earlier 
studies we observed that antibodies with a similar specificity only bind to 
their epitopes after these had been made accessible by proteolysis of band 3 
(Renkawek & Bosman, 1995). Taken together, these data support the 
hypothesis that vesicle formation in vivo is associated with changes in the 
structure and/or breakdown of band 3, that probably result in an increased 
exposure of senescent cell antigen-related epitopes on vesicles.
Using a combined volume/density separation procedure that results in well- 
defined fractions (Bosch et al, 1992), we found that only a very small 
proportion of cells exposed PS. The numbers of these cells were slightly
108
erythrocyte vesiculation as a self-protective mechanism
increased only in the fraction containing the youngest red blood cells, 
presumably as a consequence of the presence of reticulocytes that shed RNA 
and other cell components through exocytosis. The other fractions 
demonstrate a remarkably equal percentage of erythrocytes exposing PS. This 
suggests the presence of a process independent of cell age. As vesiculation 
itself is independent of cell age and linked to the development of PS 
exposure, it is tempting to speculate that the PS-exposing erythrocytes are 
involved in the process of vesiculation. On average, 0.1% of erythrocytes are 
PS exposing. Assuming that the PS exposure is a sign of vesiculation, one in 
every thousand erythrocytes is releasing a vesicle. As 1000 erythrocytes 
release 1340 (2000 x 0.67) PS-exposing vesicles per day or 0.93/min, this 
leads to the conclusion that the formation of a PS-exposing vesicles takes 
approximately 1 min.
Although others reported an increase in the proportion of PS-exposing red 
blood cells in the most dense fractions (Shukla & Hanahan, 1982; Connor et 
al, 1994), it has to be emphasized that the density separation techniques used 
to obtain the fractions enriched with erythrocytes of old age yield only a 
heterogeneous fraction (Bosch et al, 1992). Our combination separation 
method proved superior in producing red blood cell fractions of well-defined 
cell age (Bosch et al, 1992), which enabled us to conclude that the increase of 
PS exposure in the most dense fraction obtained by density separation alone 
is not due to the old cells in that fraction and that there are no data to support 
the hypothesis that PS-exposure constitutes a causal factor in the 
physiological removal of old cells in vivo.
Theoretically, the ageing-related decrease in the amount of CD55 and CD59 
on the oldest red blood cells could foster an enhanced susceptibility to 
complement binding and activation. However, the net outcome of this ageing 
process does not result in an ageing-related decrease of the density of CD55 
and CD59, as the 14% and 11% decrease in the concentrations of CD55 and 
CD59 molecules per red cell, respectively, is accompanied by a simultaneous 
decrease in the mean surface area of about 16 % (Bosch et al, 1994).
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Starting from the same well-defined fractions as described before, we could 
confirm previous reports on the occurrence of structural and immunological 
changes in band 3 during erythrocyte ageing in vivo (Kay, 2005). These 
changes were especially apparent with antibodies reactive with epitopes in 
the N-terminal part of the membrane domain. These antibodies show an age- 
related increase in immunoreactivity, which leads us to conclude that age- 
related changes in band 3 occur principally in regions that participate in the 
generation of senescent cell antigens. Subtle changes occurring in intact band 
3 proteins may generate activity of senescent cell antigen; breakdown of band 
3 may not be necessary for this process (Kay, 2005). .
Taken together, the available data indicate that vesiculation is not only 
associated with the removal of membrane-bound haemoglobin, but also 
associated with generation of senescent cell antigen, a neoantigen that 
originates from band 3 after breakdown of band 3 in senescent red blood 
cells. The high percentage of erythrocyte vesicles that expose PS suggests 
that, similar to that found in rats, exposure of this molecule is an additional 
important factor for their rapid removal in humans. Binding of IgG, another 
removal molecule, is putatively associated with the presence of senescent cell 
antigens. The capability of removal of damaged cell components is crucial 
for the viability of the erythrocyte, as this cell contains a restricted 
mechanism for self-repair and lacks the capacity of repair by renewal. It is 
concluded that vesiculation constitutes a mechanism for the removal of 
erythrocyte membrane patches associated with removal molecules, thereby 
postponing the untimely elimination of otherwise healthy erythrocytes. 
Consequently, these same molecules play a causative role in the rapid 
removal of erythrocyte-derived vesicles from the circulation. However, the 
present study has not determined why the protective mechanism eventually 
fails to prevent the death of an erythrocyte.
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Abstract
In physiological circumstances, erythrocyte aging leads to binding of 
autologous IgG followed by recognition and removal through phagocytosis, 
mainly by Kupffer cells in the liver. This process is triggered by the 
appearance of a senescent erythrocyte-specific antigen. The functional and 
structural characteristics of senescent erythrocytes strongly suggest that this 
antigen originates on band 3, probably by calcium-induced proteolysis. 
Generation of vesicles enriched in denatured hemoglobin is an integral part of 
the erythrocyte aging process. These vesicles are also removed by Kupffer 
cells, with a major role for exposure of phosphatidylserine. Moreover, 
senescent erythrocyte-specific antigens are present on vesicles. Thus, vesicles 
and senescent erythrocytes may be recognized and removed through the same 
signals. These and other, recent data support the theory that erythrocyte aging 
is a form of apoptosis that is concentrated in the cell membrane, and provide 
the context for future studies on initation and regulation of the erythrocyte 
aging process. Insight into the normal aging mechanism is essential for 
understanding the fate of erythrocytes in pathological circumstances and the 
survival of donor erythrocytes after transfusion.
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Introduction
There is no dispute that erythrocytes have a definite lifespan in all animal 
species investigated so far, and there is little dispute on the length of the 
species-specific lifespans [1]. These simple statements imply that, as in other 
cells, life and death are well regulated for erythrocytes, in spite of their lack 
of capacity for protein synthesis. During the last decade, a general consensus 
has been established on the mechanisms by which senescent erythrocytes are 
removed from the circulation. However, the identity of the mechanisms by 
which erythrocytes become senescent, i.e. by which erythrocytes arrive at the 
verge of being removed, is still a subject of discussion. Here we will briefly 
review this discussion, and introduce a new aspect, namely vesicle formation, 
as an important and hitherto largely overlooked mechanism of erythrocyte 
aging and removal. We will incorporate this aspect in the established 
hypotheses on erythrocyte aging, and discuss the possibility that erythrocyte 
aging is a form of apoptosis.
Recognition of senescent erythrocytes
In physiological circumstances, senescent erythrocytes are bound by 
autologous IgG, which leads to recognition and phagocytosis. This represents 
one of the first demonstrations of a physiological role for an autoimmune 
process. In humans the responsible phagocytes are mainly Kupffer cells in 
the liver, but in other species, most notably rat and mouse, phagocytosis may 
also occur in other parts of the reticulo-endothelial system, such as the spleen 
[1, 2]. The IgG that is bound to senescent erythrocytes represents one of the 
few accessible clues to the identity of the antigen(s) it binds to, and thereby to 
the aging mechanism itself. Therefore, characterization of this IgG has been 
given a good deal of attention (for a recent, extensive review see [3]). 
However, this attention has not led to an unambiguous view, since it has been 
clouded by the use of research strategies that have depended too heavily on 
experiments in vitro, in combination with plasma as a source of naturally 
occurring antibodies. Plasma contains erythrocyte-specific antibodies with 
various affinities, specificities and activities: leading to complement 
activation or not, binding to intracellular erythrocyte proteins such as actin
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and spectrin, binding to extra- and intracellular domains of membrane 
proteins such as band 3, and of low and high affinity. The clearest view, 
based on analyses in which the materials were as clean and as close to the in 
vivo situation as possible, suggests that low numbers of bound IgG (e.g. 200 
molecules/erythrocyte) are sufficient for phagocytosis, and that significant 
IgG binding does not occur until during the last few weeks [4, 5]. Activation 
of complement is probably not involved. When erythrocytes of various ages 
were probed with antibodies against the anti-complement proteins CD55 and 
CD59, the mean fluorescence intensity decreased with erythrocyte age 
(CD55, 89 ± 1.8 %; CD59 92 ± 2.8 % in the oldest relative to the youngest 
erythrocytes). However, the mean surface decreased even more, resulting in a 
small increase with aging in the number of CD55 and CD59 per unit of 
surface area [6]. The low number of specifically erythrocyte-bound IgG 
found under physiological conditions in vivo indicates that removal of 
senescent erythrocytes is an efficient and well-orchestrated process. 
However, this also implies that it is difficult to obtain enough IgG for 
analysis. In those situations in which more bound antibodies can be obtained 
from ‘aged’ erythrocyte populations, it must be assumed that either the aging 
mechanism and/or the removal machinery are disturbed, and any data 
obtained in such circumstances must be doubted with regard to their validity 
for the physiological aging process. Various examples may illustrate this 
important caveat: 1, whereas senescent erythrocyte-specific immunoglobulins 
are all IgG, the immunoglobulins present on sickled erythrocytes consist of 
various classes, including IgA [7]; 2, antibodies that bind to experimentally 
aged erythrocytes have a low affinity, or may represent a blood group 
reaction [3, 8, 9]; 3, the amount of autologous immunoglobulin binding after 
oxidation in vitro mainly correlates with the degree of lysis, and probably 
results from lysis-induced appearance of intracellular autoantigens on the 
outside of intact erythrocytes (Bosman GJCGM and Kay MMB, unpublished 
observations).
CD47, also known as integrin-associated membrane protein, mediates 
adhesion-related processes [10]. Recent data have pointed towards CD47 as 
another molecule that may be involved in recognition of senescent
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erythrocytes by macrophages [11]. Erythrocytes from CD47 knock-out mice, 
in which they have a normal lifespan, rapidly disappeared from the 
circulation when brought into wild-type recipients. So, regulation of CD47 
expression might serve as a mechanism to control elimination of senescent 
RBC. However, erythrocytes from heterozygous animals survived normally 
in wild-type mice, which argues against a gradual disappearance of CD47 as 
the sole mechanism that regulates erythrocyte survival. It is more likely that 
the absence of CD47 triggers other processes leading to erythrocyte removal, 
that have not yet been identified in mice. In humans, CD47 is part of the 
Rhesus core complex, and Rhesusnull individuals with less than 25% CD47 
have hemolytic anemia and stomatocytosis, but there is no evidence that 
Rhnull erythrocytes are phagocytosed more readily than erythrocytes with 
normal amounts of CD47 [12].
Exposure of phosphatidylserine at the outside of erythrocytes is widely 
implicated as a trigger for the removal of senescent erythrocytes (for a recent 
review see [13]), notwithstanding the paucity of data showing that exposure 
of phosphatidylserine is actually increased during physiological aging. In 
fact, flow cytometry data show the virtual absence of erythrocytes exposing 
phosphatidylserine, as measured by the capacity to bind annexin V, in all age 
fractions (the youngest erythrocytes, 0.31 ± 0.16 %; the oldest erythrocytes,
0.11 ± 0.06 % positive cells [14]). The arguments for this theory are mainly 
based on pathological data, and on results from manipulation in vitro and in 
vivo. In erythrocyte pathologies such as sickle cell anemia, thalassemia and 
spherocytosis, a decrease in erythrocyte survival is associated with an 
increase in phosphatidylserine exposure [13]. Treatments leading to an 
increased calcium influx and oxidation, that induce more or less presumed 
aspects of erythrocyte aging and decreased erythrocyte survival, also lead to 
inhibition of flippase and/or activation of scramblase, both leading to loss of 
phospholipid asymmetry [15]. In general, all processes that lead to increased 
destruction are associated with an increased exposure of phosphatidylserine 
at the erythrocyte surface. In view of this evidence together with the general 
role that phosphatidylserine plays in recognition and removal of apoptotic 
cells [16], we are inclined to give phosphatidylserine the benefit of the doubt
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regarding it’s role in normal erythrocyte aging. It can not be excluded that 
exposure of phosphatidylserine leads to such a fast removal that it is 
underestimated [13, 14]. A decrease in phospholipid asymmetry may very 
well be one of the consequences of physiological aging at the level of the 
membrane, and may result in exposure of phosphatidylserine that, in 
conjunction with other signals, partakes in the recognition and removal of 
senescent erythocytes by phagocytes [16].
Thus, the accumulation of autologous, high-affinity, and specific IgG during 
the final part of the erythrocyte lifespan triggers, above a relatively low 
threshold, binding and phagocytosis of senescent erythrocytes. Removal may 
be promoted by the exposure of phosphatidylserine at the erythrocyte surface.
Identity of the senescent erythrocyte-specific antigen
Together with the consensus on the involvement of the immune system in the 
recognition and removal of senescent erythrocytes, a consensus also seems to 
have been reached on the involvement of band 3 in the generation of the 
senescent erythrocyte-specific antigen.
Band 3 is, at one million copies per cell, quantitatively the major protein of 
the erythrocyte membrane. The C-terminal half of the protein is an integral 
membrane domain that catalyzes the electroneutral exchange of chloride and 
bicarbonate. The N-terminal cytoplasmic domain provides, through the 
intermediate action of ankyrin, the interaction site by which the spectrin/actin 
cytoskeleton is anchored to the lipid bilayer [17]. In addition, the membrane 
domain carries the antigens of the Diego blood group system, and the 
cytoplasmic domain has high-affinity binding sites for key enzymes of the 
glycolysis such as glyceraldehyde-3-phosphate dehydrogenase, aldolase and 
phosphofructokinase [18]. In addition, carbonic anhydrase II and IV may be 
associated with band 3 at the intra- and extracellular side of the membrane, 
respectively, forming a ‘transport metabolon’ [19, 20]. Binding of 
glyceraldehyde-3-phosphate dehydrogenase to band 3 inhibits enzyme 
activity, suggesting that these associations, regulated by hitherto little
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explored signal transduction pathways, have a functional meaning in 
maintaining erythrocyte homeostasis. This is not restricted to metabolism and 
anion transport, since the linkage with ankyrin, the assocation with 
glycophorin A, and the association with the Rhesus complex through protein 
4.2 all place band 3 at the center of a complex that regulates cell shape and 
transport of other metabolites such as glucose and NH3 as well [5, 21, 22]. 
Also, deoxyhemoglobin and especially denatured hemoglobin (hemichromes) 
have a high affinity for the cytoplasmic domain of band 3 [5]. There may also 
be a role for band 3 in release of NO during the blood flow [23].
IgG that becomes specifically bound to erythrocytes during the final stages of 
their lifespan recognizes band 3, so it is obvious that changes in band 3 
occurring during the erythrocyte lifespan must precede this binding. 
However, the molecular identity of the senescent erythrocyte antigen that is 
recognized by this IgG, and thus the nature of these changes, has not been 
unambiguously identified. The discussion focuses on aggregation versus 
breakdown of band 3 as the ultimate steps in neoantigen formation. In the 
first hypothesis, binding of denatured hemoglobin to the cytoplasmic 
domains of band 3 causes oligomerization of band 3, resulting in the 
formation of a neoantigen that is recognized by senescent erythrocyte- 
specific IgG. This hypothesis is supported by many data showing an 
association between increased IgG binding and band 3 oligomerization in 
vitro and in vivo. The concomitant increase in membrane-bound globin 
chains supports the involvement of hemoglobin in this process [3, 4]. In the 
second hypothesis, breakdown of band 3 within the membrane domain is the 
central event that leads to conformational changes resulting in the generation 
of a senescent erythrocyte-specific neoantigen, senescent cell antigen (Figure
1, [5]). This hypothesis is supported by immunoblot data showing aging- 
related breakdown, and by functional data such as an aging-related decrease 
in anion transport capacity [5]. Both theories explain the loss of interaction 
between membrane and cytoskeleton, as indicated by the increased mobility 
of band 3, and the decreased numbers of high-affinity binding sites for 
ankyrin [4, 24]. In both scenarios there is a central role for oxidation as a 
causative event, be it through hemichrome generation in the oligomerization
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hypothesis or through inducing an increased sensitivy of band 3 to 
proteolysis in the breakdown hypothesis. Various data indicate that age- 
related breakdown of band 3 is caused by activation of calcium-sensitive 
proteases [25].
Fig. 1. Breakdown of band 3 within the 
membrane domain leads to a change in 
protein conformation, and generates 
senescent cell antigen [5].
At the moment both hypotheses remain unfalsified, probably for a number of 
reasons: 1, changes in the cytoplasmic domain of band 3 affect structure and 
function of the membrane domain and vice versa, which makes it difficult to 
pinpoint the original site of disturbance; 2, because of the central role of band 
3 in erythrocyte homeostasis, many processes induce changes in band 3, 
including erythrocyte-specific pathology but possibly also other conditions 
such as old age, pregnancy, cardiovascular pathology, and diabetes [26-28]. 
In addition, the presence of denatured hemoglobin per se, such as in unstable 
hemoglobinopathies, is not clearly associated with an accelerated erythrocyte 
aging phenotype [29]. This makes it difficult to establish a chain of cause and 
effect; 3, in view of the above, it is also difficult to establish the value of
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artificial and pathological model systems for all possibly relevant aspects of 
the physiological aging process; 4, structural changes in especially the 
membrane domain of band 3 that are present in situ may easily be lost upon 
membrane isolation and further analytical procedures; 5, obtaining 
erythrocyte populations of well-defined cellular age is a laborious procedure.
The role of vesiculation during erythrocyte aging
Using a combination of counterflow centrifugation and subsequent density 
centrifugation it was possible to determine unequivocally that during aging 
the erythrocyte volume decreases with time, with an increase in density 
especially during the first, and a decrease in hemoglobin content especially 
during the second part of the lifespan [30]. These changes are associated with 
a loss of cholesterol and phospholipid and a linear decrease in the mean 
surface area of 20 per cent, which all pointed towards a loss of membrane 
during aging. This loss could be readily explained through the formation of 
microvesicles by erythrocytes of all ages (Figure 2), with vesicles derived 
from older erythrocytes containing more hemoglobin. Immunological 
analysis of these vesicles by flow cytometry and immunoblotting revealed 
that a portion, but not all of these vesicles contain IgG at their surface, expose 
phosphatidylserine, and may contain breakdown products of band 3 that are 
also found on the oldest erythrocytes (Willekens et al, in preparation). HPLC
Fig. 2. Plasma contains 
small (< 200 nm) vesicles 
with rightside-out and
membranes, and larger 
(200 -  800 nm) vesicles 
with predominantly right- 
side-out membranes [33].
inside-out-oriented
123
Chapter 6
analysis showed that the hemoglobin composition of these vesicles resembles 
that of the oldest erythrocytes, including HbA1c and what are probably more 
advanced glycation and carbamylation products [31]. Vesicles disappear 
rapidly from the circulation: in a rat model, Kupffer cells in the liver remove 
naturally occurring, hemoglobin-containing, erythrocyte-derived vesicles 
from the circulation within minutes, mainly by scavenger receptors and with 
phosphatidylserine as the principal ligand (Figure 3, [32]). Taken together, 
these data represent the discovery of a new and hitherto obscure pathway of 
erythrocyte removal in which 20 per cent of the hemoglobin and the cell 
membrane are involved. They also place a considerable fraction of the 
premortal substrate at our disposal. It should be noted that the spleen plays an 
important, although poorly understood role in the expulsion and possibly also 
the removal of vesicles. After splenectomy, vacuoles - the presumed 
precursors of vesicles - start to accumulate in erythrocytes of all ages. In 
older erythrocytes absolute increases of HbA1c and HbA1e2 are measured. 
Also, an increase in total hemoglobin content and an increase in surface area 
relative to those of control old cells could be demonstrated [33, 34]. Taken 
together, these observations point towards the retention of vesicles especially 
in erythrocytes containing older hemoglobin. Therefore, it can be stated that 
the spleen facilitates the erythrocyte vesiculation process. It is plausible that 
Heinz bodies and other inclusion bodies leave the erythrocyte the same way. 
It can also be speculated that the beneficial effect of splenectomy in some 
patients with hemolytic anemia, caused by inborn errors in erythrocyte 
membrane proteins [35], may be caused by the prevention of inappropriate 
vesiculation which, in these patients, would result in more robust 
erythrocytes.
A full proteomic and immunologic comparative analysis of the vesicles 
produced in physiological circumstances in vivo and erythrocyte fractions of 
various ages is on the way (Bosman et al, in preparation). However, the 
available data already allow the combination of aging-associated vesiculation 
with the current hypotheses described above, into a new hypothesis on the 
erythrocyte aging mechanism.
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Fig. 3. A, within 5 minutes, 51Cr-chromate-labeled vesicles are removed from the circulation with a concomitant 
uptake by the liver; B, nearly all liver activity is found in Kupffer cells, with a concomitant uptake of hemoglobin; 
C, this uptake is inhibited by preinjection of phosphatidylserine liposomes (▼), but not phosphatidylcholine 
liposomes (■) [32].
We propose that protein modification by oxidation, glycation, carbamylation, 
nitrosylation, or ubiquitinylation occurs already early in the life of the 
erythrocyte. The occurrence of all these processes in the erythrocyte has been 
documented, in some cases also modifying band 3 [36]. If hemoglobin is the 
main victim, this may result in the binding of denatured hemoglobin to the 
cytoplasmic domain of band 3 and subsequent breakdown within the band 3 
membrane domain. When band 3 is the main victim, this may result in the 
binding of hemoglobin to band 3 breakdown products that are already 
present. Activation of proteases by calcium is likely to be involved in band 3 
breakdown, with calcium entering the erythrocyte possibly through activation 
of cell volume-sensitive cation channels [37, 38]. Either theory explains the 
presence of band 3 breakdown products in all but the youngest fraction at 
much higher concentrations than seem to be necessary for binding of the few 
hundred IgG molecules that are sufficient for phagocytosis of the senescent 
fraction [5]. The presence of band 3 breakdown products may also explain 
the loss of water during the first part of the lifespan as an osmotic 
consequence of a decrease in band 3-catalyzed anion transport capacity [5, 
30]. Lateral diffusion of the band 3 fragments, driven either by aggregation of 
the associated hemichromes, or by exclusion from the functional units 
consisting of band 3 dimers and tetramers, may lead to their aggregation
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which would increase membrane curvature and thereby induce vesiculation 
[39]. Alternatively, breakdown of band 3 within its membrane domain is 
likely to disturb the lipid organization by loss of lipid anchorage, and to 
affect the mobility of lipids in succesive layers. It remains to be established if 
this is reflected by or related to raft formation [40, 41]. This could lead to 
vesicle formation where the cytoskeleton remains intact, such as occurs in the 
erythrocytes of band 3 knock-out animals [42]. Thus, vesicles containing 
denatured hemoglobin also display the signal for their removal in the form of 
senescent erythrocyte-antigen on band 3 fragments. Through this process, 
non-functional and/or toxic products are continuously removed from the 
erythrocyte for the better part of its lifespan. At the end, however, the cellular 
defenses wear down and the vesicle formation system becomes 
overburdened, resulting in removal of the whole erythrocyte. Although there 
are similarities between the mechanisms and receptors involved in 
recognition and phagocytosis of vesicles and senescent erythrocytes, it is not 
clear whether they are completely identical.
Erythrocyte aging represents the execution phase of the apoptosis process
Cell death is considered as apoptosis when it processes through an ordered 
chain of events, that are triggered by an extracellular or intracellular stress 
signal (the activation phase), and when: 1, the protein components of the cell 
death process are constitutively expressed; 2, the execution phase involves a 
calcium-dependent proteolytic cascade (the execution phase); 3, activation is 
controlled by dedicated regulatory proteins; 4, the remains are removed by 
phagocytosis, without inflammation (burial phase). In addition, 
destabilization of the connection between the cytoskeleton and the cell 
membrane, resulting in blebbing and fragmentation, may be a regulated 
event, and phagocytosis of cell fragments is triggered by ‘distinguishing 
features’ such as the presence of phosphatidylserine at their surface [16, 43]. 
A compilation of the keywords of the processes that lead to the removal of 
senescent erythrocytes from the circulation described above -  aging, 
autoimmunity, calcium-dependent proteolysis, vesiculation, oxidation,
126
erythrocyte aging, the membrane, and apoptosis
phagocytosis, phosphatidylserine exposure -  shows an almost complete 
overlap with the terms that characterize the apoptotic process of nucleated 
cells. This has already been put forward by others [37, 38, 44], and is 
supported by data suggesting the involvement of calcium, showing oxidation 
and aging-related activation of caspases [45, 46], possibly mediated by 
membrane-associated Bcl-X(L) [47], and leading to phosphatidylserine 
exposure, breakdown of band 3 and phagocytosis [45, 48]. In this context it 
should be emphasized that the data obtained during the last decade show that 
the erythrocyte contains a complex, functional set of regulatory systems. ATP 
content, concentrations of anions and cations, cell volume and cell shape are 
not the immutable consequences of the erythrocyte’s surroundings but, as in 
all cells, are regulated as a response to and meeting the demands of 
neighbouring cells and organs [49-51]. Thus, various signal transduction 
pathways are present and active, putting life and death of the erythrocyte 
once more at a central position in the study of organismal homeostasis.
The current knowledge of the erythrocyte aging process reviewed here, 
together with the view of the erythrocyte as a specialized cell with its own 
homeostasis and signal transduction machinery, lead inevitably to the thesis 
that the processes leading to removal of erythrocytes from the circulation are 
those of the execution phase of a apoptosis program. This conclusion may 
accelerate the slowly progressing research on erythrocyte aging by inspiring 
the search for the pieces that are still missing from a complete apoptosis 
picture. Perhaps more accessible problems than the long-time elusive 
molecular identity of the senescent erythrocyte-specific antigen can now be 
addressed, such as the identity of the activation signal, the mechanism of 
calcium increase, the identity of any regulatory proteins, etc. In a reciprocal 
view, the erythrocyte may once more constitute a valuable model system, e.g. 
for the study of the final stages of apoptosis such as membrane blebbing, 
vesicle formation, and immune recognition and phagocytosis. Finally, an 
unequivocal description of the physiological erythrocyte aging pathway will 
be invaluable in understanding the fate of erythrocytes in pathological 
circumstances and the survival of donor erythrocytes after blood transfusion, 
and thereby open the road towards rational intervention procedures.
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Abstract
An erythrocyte-fractionating method combining volum e and subsequent 
density separation is described. Iron isotope (59Fe) validation proved this 
combination o f  methods to be complementary. B y deploying H bA ic as cell 
age marker, the obtained fractions demonstrated that circulating erythrocytes 
lose 20% o f  hem oglobin and membrane by shedding vesicles. Vesiculation  
from older cells proved to be facilitated by the spleen. Anim al studies 
revealed that such vesicles are rapidly removed from the circulation by 
scavenger receptors on Kupffer cells with phosphatidylserine acting as the 
principal ligand. These studies reveal the existence o f  an alternative pathway 
o f  erythrocyte breakdown. This means that the premortal substrate o f  20% o f  
any erythrocyte is at our disposal. A s this kind o f  vesiculation takes place 
during the entire erythrocyte lifespan, loss and som etim es reutilisation o f  
marker substances limits the usefulness o f  isotope studies to the first h a lf o f  
the erythrocyte lifespan, thereby putting the dogmatic lifespan o f  120 days 
into question. Furthermore, these studies add to the understanding o f  
hem oglobin A ic (H bA ic) m etabolism and the origin o f  the w ide variation o f  
erythrocyte parameters in peripheral blood. Removal o f  old erythrocytes from  
the circulation and from donor blood may open new  w ays into the treatment 
o f  both bilirubin and secondary iron overload.
Abbreviations: AChE: acetylcholinesterase; DFP: diisopropylfluorophosphate; 
HbA0: hemoglobin A; HbAi: hemoglobin A1 (e.g. HbA1c, HbA1e2) ; HbA2: 
hemoglobin A2; IgG: immunoglobulin G; MSA: mean surface area; MCH: mean 
corpuscular hemoglobin content; MCHC: mean corpuscular hemoglobin 
concentration; MCV: mean corpuscular volume; PS: phosphatidylserine; RBC: red 
blood cell; SCA: senescent cell antigen; 51Cr, 59Fe, 15N, 32P: isotopes of chromium, 
iron, nitrogen, phosphor
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The knowledge o f  cell age-dependent changes o f  red blood cells (RBCs) has 
always been considered essential to transfusion m edicine as the quality o f  
RBCs is inversely related to their age. In this context many have studied the 
changes in RBCs that precede cell death. Concerns about the burden o f  
rapidly dying donor RBCs led to attempts to enrich RBC concentrates with  
young cells. H owever, clinically speaking the effect o f  using these 
concentrates in chronically transfused patients w as o f  limited importance 
(8,10). The main reason for the limited success o f  the determination o f  cell 
age-dependent changes for storage reasons, and the limited efficacy o f  the 
enrichment o f  RBC concentrates with young cells for transfusion w as the 
extensive use o f  procedures that fractionate RBCs according to density. 
These poor results were to be expected since this technique selects fractions 
only moderately enriched with young cells (<23 days) but not with older cells  
(Fig. 1A) (24). Follow ing Sanderson and Bird (20), w e introduced a 
fractionation procedure w hich makes use o f  differences in volum e 
(counterflow centrifugation). Soon it became clear that this procedure 
resulted in fractions not only enriched in young cells (8 to 23 days), but also 
in older cells (23 to 80 days). However, very young RBCs (0 to 8 days) (Fig. 
1B) and in particular reticulocytes were not separated (24).
A s both procedures seem ed complementary in the separation o f  RBCs o f  
different ages, counterflow centrifugation and subsequent Percoll gradient 
centrifugation were combined. This combined procedure resulted in fractions 
highly enriched in young and very young cells and devoid o f  old cells (Fig. 
2) (3,23).
W hen the three separation techniques were compared in terms o f  volum e and 
density, it appeared that in these respects Percoll gradient and counterflow  
centrifugation were truly complementary (Table) (2).
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Fig. 1 A) The Fe-activity is shown in red cells from the top fraction (▲ - ▲) and from 
the bottom fraction (• - •) obtained by Percoll density centrifugation. B) The 59Feactivity in 
fractions of red cells with a MCV of 105 to 110 fl (A - A) and with a MCV of 85 to 90 fl (o - o) 
obtained by counterflow centrifugation is shown for the same subject (23).
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59F e - A C T I V I T Y  IN RED C EL L S
A comparison of red cells in fractions obtained with counter- 
flowcentrifugation with red cells of fractions obtained with the
Days after ^e-adm inistration
a-----a Red cells w ith  M C V ,ra n g in g  from 105-110 fl
o— o Red cells w ith  M C V ,ra n g in g  from 85- 90 fl
 *  a Red cells w ith  M C V ,ra n g in g  from 105-110 fl and o f lowest den s ity
-- •  •  Red cells w ith  M C V ,ra n g in g  from  85- 90 fl and o f h ighest den s ity
Fig. 2 59Fe-activity in red cells with a MCV of 105 to 110 fl and of lowest density and in 
red cells with a MCV of 85 to 90 fl and of highest density compared with data of Fig. 1B (same 
subject as in Fig. 1A and 1B). Fractions were obtained by separating counterflow fractions on 
a discontinuous Percoll density gradient (23)
Table Comparison of MCV and MCHC values in young and old fractions obtained by three 
separation methods from normal individuals (n=5)
Percoll Gradient 
Centrifugation
Counterflow
Centrifugation
Combination
Centrifugation
MCV Young + 92.6 98.2 101.4
Old ++ 82.4 82.7 71.5
MCHC Young + 19.6 21.5 20.4
Old ++ 24.0 20.5 24.0
+ Fractions with highest MCV; ++ fractions with lowest MCV
Taking all data together w e concluded that cells with the highest mean 
corpuscular volum e (M CV) and low est mean corpuscular hem oglobin  
concentration (M CHC) are young and cells with the low est M CV and highest 
MCHC are old (2,23).
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Obviously a radioactive cohort label like 59Fe is not suitable as cell age 
marker in studies which necessitate the use o f  multiple RBC fractions. 
Therefore, a product o f  a post-translational process was used for this purpose. 
W e chose the glycated hem oglobin com ponent hem oglobin A 1c (H bA1c), as 
Bunn et al. already had shown that there is a nearly linear rise in labeled  
H bA 1c in the first 80 days after infusion o f  59Fe-labeled transferrin (6). Using  
H bA 1c as cell age marker, the age dependence o f  RBC-indices could be 
studied in more detail (Fig. 3) (27).
From Fig. 3A  it can be deduced that RBC volum e decreases with time in a 
linear fashion from more than 100 fl to 70 fl (a loss o f  30%). From Fig. 3B  
and 3C it can be deduced that RBC density increases and RBC hem oglobin  
content decreases, m ainly during the first and second part o f  the RBC  
lifespan, respectively. This indicates that the decrease o f  RBC volum e is 
initially the consequence o f  water loss and later on mainly the result o f  
hem oglobin loss. W hen the various hem oglobin components were studied, it 
could be shown that during the first ha lf o f  the red cell lifespan the amount o f  
H bA0 and HbA 2  mainly decrease by glycation and that during the second  
h alf the amount o f  HbA0 and HbA 2  but also that o f  the glycated hem oglobin  
components decrease by loss from the RBC.
In addition, the cell age dependence o f  other RBC parameters was studied. 
The mean surface area (M SA ) showed a linear decrease o f  20% resulting in 
an increase o f  the M SA/M CV ratio, and accordingly a decrease in osm otic 
fragility w as demonstrated (4). A lso, a concomitant linear decrease in 
cholesterol and phospholipid contents during the RBC lifespan indicated an 
age-related loss o f  membrane (25).
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Fig. 3 The relation between 
MCV (A), MCHC (B) and MCH 
(C) on the one hand and 
HbA1c-percentage on the other. 
The straight line represents the 
regression line. The curved lines 
respresent a second order curve 
fit. Each symbol represents the 
mean of five observations per 
fraction (27).
In summary, during its life in the circulation the RBC loses 30% o f  its 
volum e and 20% o f  its hem oglobin content and o f  its surface area, whereas 
the hem oglobin concentration increases by 14%, indicating that relatively  
more water than hem oglobin is lost.
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Etiology of haemoglobin and water loss from RBC’s in vivo
In 1950 a RBC cohort study em ploying isotope-labeled glycine was 
published. This study demonstrated that between days 80 and 120 after the 
start o f  the consumption o f  15N -glycine not only a substantial hem oglobin  
marker loss occurs, but also that there is a continuous presence o f  the label in 
the hem oglobin degradation product stercobilin, with an increased excretion  
o f  labeled stercobilin during the second half o f  the RBC lifespan (Fig. 4)
(15).
Fig. 4
15N-concentration in 
hemin and stercobilin 
of a normal man after 
the start of feeding 
15N-labeled glycine for 
2 days (15).
The same pattern has been demonstrated after the consumption o f  14C -glycine 
with urobilin as the hem oglobin degradation product (1). In contrast, 59Fe as 
cohort label is not found in hem oglobin degradation products as the 
consequence o f  nearly com plete reutilisation. A s 59Fe has been the only used  
cohort label after the fifties o f  the last century, the intriguing glycine pattern 
had to wait for its unravelment for half a century.
This glycine pattern suggests a simultaneous loss o f  hem oglobin and its label 
from the RBC. M uch later it was shown that hem oglobin-containing vesicles  
circulate in plasma (10,11). A lso  small vesicles (<300 nm) could be shown  
within RBCs o f  all ages. In the absence o f  a functioning spleen these small 
vesicles increased in number whereas also larger vesicles (300-800 nm) 
appeared in circulating RBCs (18).
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These observations stimulated the exploration o f  a possible role o f  plasma 
vesicles in the process o f  hem oglobin loss (28). Freeze fracture electron 
m icroscopy revealed the presence o f  tw o types o f  plasma vesicles. R elatively  
small vesicles (<200 nm) with right-side-out but also inside-out oriented 
membranes were present. This means that som e o f  the small vesicles  
probably have phosphatidylserine exposed on the outer membrane. This was 
confirmed in a later study (30). A lso, larger vesicles (200-800 nm) with  
predominantly right-side-out membranes were found in plasma. 
Flowcytom etry demonstrated that at least 65% o f  the vesic les is RBC- 
derived and that m ost o f  these vesicles contain hem oglobin. A ll the 
hem oglobin components were found to be present in a ratio that closely  
resem bles that o f  old RBCs.
Furthermore, the role o f  the spleen was studied. It was shown that in RBCs 
from asplenic individuals not only the number o f  the aforementioned small 
vesicles is increased, but that also large vesicles materialize intracellularly 
(18). Such large vesicles can also be seen by phase contrast m icroscopy as 
"pits". W e found that the percentage o f  "pitted" cells in a given fraction is 
correlated with an increase o f  its density and its HbAi-percentage (13). After 
splenectom y the percentage o f  those pitted cells in young and old fractions 
sim ultaneously increased to a level o f  approximately 30%. The increased 
HbAi-percentage o f  w hole blood is caused by an increase o f  the amount o f  
H bA ic and H bA 1e2 in older cells (28). Accordingly the extra decrease o f  the 
M CH in normal old cells is absent in asplenic old cells. Apparently the spleen  
facilitates the loss o f  hem oglobin from circulating RBCs by vesiculation  
especially from older cells. This process bears resemblance to the function o f  
"pitting" o f  H einz bodies, H ow ell-Jolly bodies and siderotic granules, as this 
function refers to the capacity o f  the spleen to remove particles from the 
cytoplasm  o f  RBCs without affecting their viability. This suggests that the 
underlying mechanism o f  pitting is vesiculation. However, in which w ay the 
spleen induces the vesiculation o f  hem oglobin containing vesicles and 
perhaps also the vesicles that contain the aforementioned inclusion bodies, is 
not clear. Eventually formed, these vesicles w ill probably be removed by the 
mononuclear phagocyte system, in particular the scavenger receptors o f  the
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Kupffer cells.
A s yet the etiology o f  the age-dependent water loss from RBCs has not been 
studied. Probably the spleen also plays a role in this respect as in the asplenic 
state RBCs o f  all cell ages show an increased M CV o f  approximately 10 fl in 
combination with a decreased MCHC o f  approximately 1.5 m m ol/l, 
indicating that a functionally active spleen induces som e water loss (12). The 
M CH decrease o f  asplenic RBCs seem s to influence the MCHC increase in 
such a manner that the M CV w ill decrease in a strictly linear way, identical to 
what is seen in normal RBCs.
The fate of RBC-derived vesicles
Until recently nothing w as known about the fate o f  the red blood cell-derived  
vesicles but gradually the picture o f  the mechanism o f  vesicle formation and 
the role o f  vesiculation in the aging o f  erythrocytes begins to materialize. 
Since the fate o f  blood cell-derived vesicles in human subjects is virtually 
im possible to study, w e studied the kinetics o f  vesic le  elimination in a rat 
m odel that is analogous to the murine m odel developed by Terpstra et al. 
(22). First w e established that rat RBCs lose hem oglobin in the same w ay as 
human RBCs, and that hem oglobin-containing vesicles are present in rat 
plasma (26). Subsequently rat blood cell vesicles were labeled with 51Cr and 
injected into recipient rats (manuscript in preparation). W ithin minutes m ost 
o f  the radioactivity was cleared from the circulation by Kupffer cells in the 
liver. This conclusion is based on the fast accumulation o f  the majority o f  the 
label in the liver, and on the concom itant appearance o f  hem oglobin in 
Kupffer cells. These phenomena were inhibited by preinjection o f  liposom es 
containing scavenger receptor ligands such as phosphatidylserine. These data 
suggest that RBC-derived vesicles have a high turnover rate, and that the 
m echanism by which they are formed also provides the means by w hich they  
are removed, i.e. the presence o f  phosphatidylserine at the outside o f  the 
vesicle membrane. This process bears a striking resemblance with that by 
which oxidatively damaged erythrocytes are removed from the circulation in 
m ice (22). In accordance, one third o f  the human RBCderived vesicles also
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have PS exposed on their outside membrane (30). In addition, preliminary 
data suggest that the same band 3-derived antigens (senescent cell antigens, 
SCA), that trigger the removal o f  old RBCs, may also be present on RBC- 
derived vesicles (5). Complement activation does not seem  to be part o f  the 
elimination process, as vesicles expose a full set o f  anti-complement proteins 
(manuscript in preparation). In summary, removal o f  vesicles is a fast process 
that takes place in Kupffer cells in the liver, and is mediated by the exposure 
o f  PS and possibly the same SCA-mediated binding o f  IgG that leads to 
removal o f  old RBCs (14). It is important to note that old RBCs obtained by 
the com bined centrifugation method do not expose PS more often than 
younger RBCs, i.e. on approximately 0.2%  o f  cells (29).
Discussion
The aforementioned findings carry several diagnostic and therapeutic 
consequences.
Isotopes to study RBC lifespan
W e have shown that 20% o f  the amount o f  hem oglobin leaves the RBC  
during its life in the circulation and that the iron that is released during this 
process, is being reutilized. Re-use o f  iron is quantitatively very important as 
59Fe studies show that between days 60 and 120 after infusion o f  59Fe labeled 
transferrin as much label activity is found in old RBC as in young RBC (24). 
Unfortunately, such an effective reutilization makes the em ploym ent o f  59Fe - 
or to a lesser degree any other incorporated label - unreliable for the 
measurement o f  erythrocyte survival in cohort studies. Due to its uneven  
elution rate, which makes the estimation o f  the red blood cell lifespan  
hazardous, 51Cr is no longer regarded the random label o f  choice (7). 
Differential agglutination has limited usefulness because o f  the inability to 
measure RBC survival o f  the subjects’ cells in their own circulation. Using  
DF32P which binds especially to acetylcholinesterase (AChE), a linear curve 
is obtained with a mean lifespan o f  124 days. N o elution o f  the label was 
demonstrated after 10 days. In this respect DF32P is considered a highly
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satisfactory label (9). H owever, it should be noted that w e showed that 20%  
o f  the RBC surface area is lost in a linear w ay during its entire lifespan by 
shedding vesicles. I f  these in  vivo  vesicles contain as much AChE as was 
demonstrated in vesicles produced in  v itro  (19), the RBC lifespan should be 
extended by 20% to approximately 150 days.
H b A ic metabolism
A s stated, Bunn et al. (6) have shown that there is a nearly linear rise in 
labeled H bA 1c in the first 80 days after infusion o f  59Fe-labeled transferrin. 
After 80 days the rise levels o f f  and even a decrease in radioactivity o f  H bA 1c 
was demonstrated (6). This decrease has been explained by enzymatic 
degradation induced by RBC proteolytic enzym es(17). It should be noted that 
these data can also be explained by loss o f  H bA 1c. Indeed, w e showed that 
vesicles circulate in plasma containing hem oglobins with a com position  
similar to that o f  old RBC (28). Moreover, it is interesting to note that in 
patients with asplenia this process is inhibited resulting in an increase o f  the 
total amount o f  H bA 1c and H bA 1e2 in old RBC. This increase even leads to a 
significant increase in the H bA 1c percentage o f  whole blood. Therefore, these 
findings should be taken into account w hile treating diabetes m ellitus in 
patients with impaired splenic function, as already during norm oglycaem ia  
asplenia g ives rise to a significant increase o f  the H bA 1c percentage. 
O bviously the combination o f  diabetes m ellitus type I and asplenia in a 
patient is rare. However, this is not the case in elderly patients with diabetes 
m ellitus as it has been demonstrated that there is evidence o f  impaired splenic 
function (4-10%  "pitted" RBCs) in 25% o f  elderly people (16).
RBC  param eters
Large differences in M CV, MCH, MCHC and M SA  appear to be dependent 
on cell age. The M CV and M SA  decrease in a linear fashion during the 
lifespan o f  a RBC by 30% and 20%, respectively. The M CH and MCHC  
decrease and increase by 20% and 14% mainly during the second and first 
h alf o f  the RBC lifespan, respectively. The M CH and M SA  decrease can be 
explained by shedding o f  hem oglobin-containing vesicles; the M CV decrease
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by loss o f  hem oglobin and water; the MCHC increase by loss o f  relatively 
more water than hem oglobin. It should be kept in mind that the youngest 
population obtained by volum e/density fractionation already shows 
considerable differences in cell volum e and cell hem oglobin concentration, 
which probably originate during erythropoiesis. The m onotonous appearance 
o f  RBCs in the blood picture is caused by the fact that the differences in cell 
volum e and cell hem oglobin concentration disappear by the smearing and 
drying o f  the slides. Only h a lf o f  the cell surface area is visible and therefore 
only M SA  differences o f  10% can be seen in the smear. A s M SA  and M CH  
decrease relatively in the same way, the cells look isochromic.
Transfusion o f  red  b lood  cells
Improvement o f  the oxygen transport function in the patient is one o f  the 
forem ost reasons to give a blood transfusion. A s the binding o f  oxygen is 
pivotal o f  hem oglobin it may be clear that a reduction o f  20% in the 
hem oglobin mass w ill have clinical consequences. This thrashing o f  
hem oglobin material m ay help to explain the rather unsatisfactory efficacy o f  
a red cell transfusion, particularly under critical conditions such as mandatory 
intrafetal transfusions. Under these circumstances it seem s feasible to reduce 
the transfusion frequency by tailoring donor red cell suspensions that are 
depleted o f  old cells by means o f  either volum e fractionation (for smaller 
volum es o f  blood) or im m unological removal deploying antibodies to 
senescent antigens (for larger volum es o f  blood). Assem bling erythrocytes 
suspensions that are depleted o f  old cells are presumably also beneficial when  
the accumulation o f  hem oglobin waste products m ay becom e a serious health 
threat such as secondary hemochromatosis due to iron overload in 
polytransfused patients. Under these conditions one could even com e to 
consider removing ex v ivo  old cells from the blood o f  a patient with clinically  
symptomatic iron overload as a result o f  many blood transfusions and an 
enhanced intestinal absorption. To accom plish a clinically significant 
reduction in body iron, a regular blood refreshing procedure would be 
mandatory, analogous to hem odialysis for renal insufficiency. More efficient 
handling such as tim ely elimination o f  old erythrocytes and hem oglobin
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degradation products could prove o f  importance in the treatment o f  patients 
with bilirubin overload, e.g. Najjar's disease.
Conclusion
Our findings concerning the considerable loss o f  hem oglobin from  
circulating RBCs by spleen facilitated vesiculation and those concerning the 
fate o f  the resulting vesicles made it worthwhile to revisit old problems o f  
RBC physiology especially in matters o f  life and death.
The m ost striking findings were the discovery o f  an alternative pathway o f  
RBC breakdown in which 20% o f  hem oglobin and 20% o f  membrane o f  any 
RBC are involved. This means that by using flowcytom etric sorting o f  RBC- 
derived plasma vesicles w e now  have the premortal substrate o f  20% o f  any 
RBC at our disposal. In fact w e showed in a rat m odel that vesicles, just like 
damaged RBCs in a murine m odel, are rapidly removed from the circulation 
by scavenger receptors on Kupffer cells, with phosphatidylserine acting as 
the principal ligand.
Another finding was that, assuming D F32P is the best label to determine the 
RBC lifespan, this span has to be considered as approximately 150 days, i.e. 
20% longer than generally assumed.
Future developm ents w ill consist o f  finding w ays to making RBC  
concentrates deficient in old cells, as w ell as removing old cells from the 
blood o f  patients with secondary iron overload and o f  patients with bilirubin 
overload, e.g. Najjar's disease.
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general discussion and summary
In this thesis the loss o f  haem oglobin from the erythrocyte through 
vesiculation and the physiological role o f  erythrocyte-derived vesic les have 
been studied. The loss o f  haem oglobin accelerates during the second h a lf o f  
the lifespan o f  the erythrocyte, and the various haem oglobin components 
contribute differently to this loss. The haem oglobin-containing vesicles  
m ainly are shed from older erythrocytes and the spleen facilitates this 
vesiculation. The erythrocyte-derived vesicles are rapidly cleared from the 
circulation and are taken up by macrophages through the action o f  the 
rem oval-signalling m olecules phosphatidylserine (PS) and IgG. V esicles are 
highly enriched in band 3 breakdown products, which particularly react with  
antibodies that are directed to band 3 amino acid sequences that are 
associated with senescent cell antigens.
These new  data are integrated into a new  m odel o f  erythrocyte aging that 
may have consequences for the physiology, pathophysiology and transfusion 
o f  erythrocytes.
Loss o f  haem oglobin: con tribu tion  o f  ind iv id ua l haemoglobin components 
(Chapter 2)
During aging, erythrocytes lose volum e, surface area, haem oglobin, and 
water. The loss o f  water exceeds the loss o f  haem oglobin, which causes an 
increase in density. This conclusion emerged from studies using a 
fractionation method that com bines counterflow centrifugation (elutriation) 
with a subsequent discontinuous density gradient fractionation (B osch et a l , 
1992). The mean age o f  each fraction w as established by determination o f  the 
percentage o f  H bA ic, a marker o f  cell age. Both the fractionation method and 
the use o f  HbA 1c have been validated by 59Fe-cohort studies (Bunn et a l, 
1976; Van der V egt et a l, 1985;).
The decrease in volum e correlates w ell with age, since the M CV decreases 
linearly with the percentage o f  HbA 1c with a high degree o f  significance 
(Bosch et a l, 1992). The loss in haem oglobin (MCH) and the increase in 
density (MCHC) correlate with erythrocyte age to a lesser extent. In both
General discussion and summary
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cases a second order correlation fits better than a linear one. The increase in 
MCHC m ainly takes place during the first h a lf o f  the erythrocyte lifespan  
and appears to be related to reticulocyte maturation. The loss o f  haem oglobin  
occurs more prominently during the second h a lf o f  the erythrocyte lifespan.
Haem oglobin consists o f  various components. One group (HbA0, HbA2 and 
HbF) is coded by one gene for the a-chain and three different genes for the ß- 
chain; another group (the HbA 1 -components) are the result o f  
posttranslational m odification o f  HbA0. During the first h a lf o f  the 
erythrocyte lifespan, the decrease o f  HbA0 is mainly caused by 
posttranslational m odification. Subsequently, the cellular loss o f  
haem oglobin is accelerated whereas the gain in HbAi-com ponents declines. 
During this phase the cell not only loses som e o f  its HbA0 and H bA2, but 
also som e o f  its m odified haem oglobin components. The combination o f  
posttranslational m odification and loss o f  cellular material results in a net 
loss o f  HbA0 o f  approximately 450 am ol/cell and a net gain o f  H bA i- 
components o f  approximately 85 am ol/cell. The erythrocyte loses 365 
haem oglobin am ol/cell, which is 20% o f  the total haemoglobin. This loss 
explains the tapering increase in 59Fe-labelled H bA 1c after 60 days as 
observed (Bunn et a l, 1976), as w ell as the loss o f  15N-label from  
erythrocytes and the appearance o f  15N-label in stercobilin during the period 
between the early destruction o f  erythroblasts and the destruction o f  
erythrocytes at 120 days after labelling (London et a l, 1950).
W e were the first to demonstrate that the haem oglobin com position o f  
erythrocyte-derived vesicles from plasm a closely  resembles that o f  old  
erythrocytes. This confirms the conclusion that continuous loss o f  
haem oglobin in vesicles accelerates during the second h a lf o f  the erythrocyte 
lifespan.
H aem oglob in -conta in ing  vesicles and the spleen (Chapter 3)
In individuals with asplenia, erythrocytes are larger and show an increased 
HbAi content. In these individuals, the young erythrocytes contain the same 
amount o f  haem oglobin per cell as those o f  healthy controls. On the other
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hand, the decrease o f  M CH shows a linear pattern without the accelerated  
loss o f  haem oglobin during the second part o f  the erythrocyte lifespan, as is 
seen in normal individuals. Older erythrocytes display a lesser decrease o f  
HbA0 and an enhanced increase o f  H bA 1. Peculiar features o f  erythrocytes 
from splenectom ised persons are a four-fold increase in the number o f  small 
cytoplasm ic vacuoles as compared to controls, and the occurrence o f  
abnormally large vacuoles in approximately 30% o f  the erythrocytes 
(Reinhart & Chien, 1988). Some o f  the large vacuoles contain haemoglobin. 
A  previous study showed a positive relationship between the number o f  
erythrocytes with large vacuoles (“pitted ce lls”) and the H bA 1 percentage in 
erythrocyte fractions obtained by density separation (De Haan et a l, 1988). 
This suggests a retention o f  haem oglobin-containing vesicles in asplenia. W e 
conclude that circulating erythrocytes lose haem oglobin by means o f  
vesiculation, and that the spleen facilitates this process, in analogy to the 
spleen-facilitated “pitting” o f  H einz bodies, H ow ell-Jolly bodies, and 
siderotic granules.
The ultrastucture o f  the vesicles was studied by freeze fracture electron 
m icroscopy. The size o f  the vesicles shows a large heterogeneity. Small 
vesicles (< 200 nm) are observed with right-side-out-oriented and inside-out- 
oriented membranes, as w ell as vesicles with a w ide range in size (200-800  
nm) with predominantly right-side-out membranes. These observations hint 
at two m echanism s o f  vesiculation: the larger vesicles may be pinched o ff  
whereas the relatively small vesicles m ay originate by pinching o f f  as w ell as 
by fragmentation.
Interestingly, immunoblot as w ell as proteomics data fail to demonstrate the 
presence o f  the cytoskeletal proteins spectrin and ankyrin in vesicles, but do 
show the presence o f  acetylcholinesterase and the integral membrane protein 
band 3. A  similar pattern is observed in vesicles that are produced from  
erythrocytes under various experimental conditions.
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The kinetics o f  vesicle elimination were studied in a rat m odel. In rats the 
loss o f  haem oglobin by vesiculation is comparable to the process in human 
erythrocytes. W hen rat plasma vesicles are labelled with 51Cr- 
sodiumchromate, predominantly haem oglobin is labelled. Such labelled rat 
vesicles disappear rapidly from the rat’s circulation. The disappearance curve 
can be described in two components: one very rapid component with a half­
life o f  25 s and a slower com ponent with a ha lf life o f  6.6 min. This 
dichotom y might be explained by the heterogeneity in size and sidedness o f  
erythrocyte vesicles as observed by electron m icroscopy. Flowcytometry 
shows both phosphatidylserine(PS)-exposing erythrocyte vesicles o f  which  
60 % contain IgG, and erythrocyte vesicles that neither expose PS nor 
contain IgG.
The liver uptake o f  the radioactive label shows a steep rise within minutes, 
that is follow ed by a plateau phase. After 30 minutes approximately 50% o f  
the injected radioactivity is present in the liver. More than 90% o f  the liver 
radioactivity was found in the Kupffer cells, which also have been shown to 
contain haem oglobin. The mononuclear phagocyte system  o f  other organs, 
especially that o f  the bone marrow, probably also participates in the removal 
o f  vesicles from the circulation.
PS and polyinosinic acid (PI) both are ligands o f  scavenger receptors 
(Terpstra et a l, 2000). Preinjection o f  PS-liposom es and PI-liposom es results 
in a considerable inhibition o f  the liver uptake o f  vesicles from plasma and 
in a slower removal o f  circulating vesicles. Neither o f  these effects is seen  
after the pre-injection o f  phosphatidylcholine(PC)-liposom es. In accordance 
with this observation, flow  cytometry showed that the rat erythrocyte-derived 
vesicles expose PS. Tissue distribution o f  radioactivity after preinjection with  
PI shows a diminished uptake in the liver o f  circulating vesicles, that is 
accompanied by an increased uptake in bone marrow and lungs. This is 
possibly due to a compensatory enhanced activity o f  bone marrow and lung 
macrophages. N o such increase in uptake was seen after preinjection with  
PS-liposom es, which suggests an inhibition o f  PS-binding macrophage
Vesicle clearance in a rat model (Chapter 4)
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activity in the bone marrow and lungs in addition to the inhibition o f  
macrophages in the liver. Possibly, the PS-specific receptor (Fadok et a l, 
2001), which plays a crucial role in the uptake o f  apoptotic cells, is also 
important in the uptake o f  PS-exposing vesicles by Kupffer cells. Since the 
pattern o f  haem oglobin loss from erythrocytes in humans is similar to that in 
rats, the same mechanism is probably operative for the removal o f  
erythrocyte-derived vesicles in humans.
Eryth rocyte -derived  vesicles in  humans: a self-protective mechanism  
(Chapter 5)
Approxim ately 70% o f  the plasma vesicles derived from human erythrocytes 
expose PS. A  considerable portion o f  the PS-exposing vesicles also contains 
IgG. Clearance o f  vesicles m ay not only be facilitated by PS-mediated  
phagocytosis, but also by the immune-mediated m echanism that is 
responsible for the removal o f  old erythrocytes through the binding o f  natural 
autoantibodies to senescent cell antigens (Kay, 2005).
The number o f  erythrocyte-derived vesicles is approximately 170 vesic les per 
microliter o f  plasma, which is comparable with the numbers reported by 
others (Simak & Gelderman, 2006). It can be calculated that every 
erythrocyte produces approximately tw o vesicles per day, which im plies that 
in every second 580-106 vesicles are produced, and that it takes 0.7 sec to 
remove h a lf o f  all the vesicles from the circulation. This is at least one order 
o f  magnitude shorter than one cycle through the circulation, and much shorter 
than the half-life found for vesicles in the rat model. A s the liver and other 
organs are equally effective in removing erythrocyte-derived vesicles, it was 
concluded that m ost vesic les are directly trapped by the macrophages o f  the 
organ in which they originate, i.e. before they can reach the venous 
circulation. This mechanism restricts the potential harmful trombotic effect o f  
vesicles, that arises from the coagulation-promoting activity o f  the PS- 
exposing vesicle membrane (Simak & Gelderman, 2006). It also has been 
shown that secretory phospholipase A 2 uses the PS-exposing membrane to 
generate lysophosphatidic acid (LPA) (Fourcade et a l, 1995). LPA has been 
shown to open Ca2+-channels in erythrocytes, possibly leading to further
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vesiculation (Yang et a l, 2000; Chung et a l, 2007), although a Ca2+- 
independent mechanism m ay also explain the effects o f  LPA (Chung et a l, 
2007)
A lm ost all vesicles carry the complement-regulating proteins CD55 and 
CD59. The presence o f  these com plem ent protection proteins indicates that, 
under physiological circumstances, com plem ent activation does not play an 
important role in vesicle formation or vesicle clearance.
Furthermore, vesicle formation is accompanied by the breakdown o f  band 3. 
Band 3 is present in vesicles, but proteins with a m olecular w eight o f  70 kDa  
or less dominated the im munoblot picture. A  strong reaction is observed with  
antibodies directed against membrane areas o f  band 3 that are involved in 
senescent cell antigen activity. These data suggest that vesicle formation in  
vivo  is associated with changes in the structure and/or breakdown o f  band 3, a 
process that probably results in an increased exposure o f  senescent cell 
antigen-related epitopes on vesicles.
W e conclude that vesiculation serves to remove erythrocyte membrane 
patches associated with or containing damaged cell components containing 
phagocytosis-related removal m olecules. These removal m olecules facilitate 
a rapid clearance o f  the vesicles. In this w ay, vesiculation protects the 
erythrocyte against untim ely removal. The same strategy is demonstrated in 
the protection against the com plem ent membrane attack com plex (M AC). 
The resulting local influx o f  Ca2+ causes the shedding o f  vesicles containing 
the M AC (Sim s & W iedmer, 1986; Iida et a l, 1991).
The surface area o f  the shed vesicles considerably exceeds the loss o f  surface 
area o f  the erythrocyte during its lifespan. This exceeding loss m ay be 
compensated by the incorporation o f  lipids from plasm a lipoproteins and into 
the erythrocyte membrane. The exchange o f  lipids between lipoproteins and 
plasma membrane is w ell documented (Reed, 1968; van Deenen & D e Gier, 
1974; Verkleij et a l, 1976; Brossard et a l, 1997). Cholesterol and PC are 
exchanged readily, whereas phosphatidylethanolamine (PE) and PS are 
exchanged to a lesser extent. W hen the erythrocyte replenishes its deficit o f
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lipids, the lipid com position o f  the membrane changes due to these 
differences. This phenomenon could lim it the capacity to vesiculate.
A g ing  erythrocytes: exposure o f  phosphatidylserine and  changes in  band 3 
(Chapter 5)
Studying the PS exposure o f  intact erythrocytes, w e found that less than one 
per cent o f  cells o f  all ages expose PS. The number o f  PS-exposing cells is 
slightly increased in the fraction that contains the youngest erythrocytes, 
presumably as a consequence o f  the presence o f  reticulocytes. The other 
fractions showed a remarkably equal percentage o f  PS-exposing cells, which  
indicates that PS-exposure is a cell age independent process. A s vesiculation  
itse lf  is independent o f  cell age and linked to the developm ent o f  PS- 
exposure, it is tempting to speculate that the fraction o f  PS-exposing  
erythrocytes is involved in the process o f  vesiculation. Previously, an 
increase in the proportion o f  phosphatidylserine-exposing erythrocytes in the 
m ost dense fractions has been reported (Shukla & Hanahan, 1982;Connor et 
a l, 1994). H owever, density separation by itse lf yields highly heterogeneous 
fractions (Bosch et a l, 1992). Our combination separation method proved 
superior in the production o f  erythrocyte fractions o f  w ell defined cell age 
(Bosch et a l, 1992). This superior purity allow s us to draw tw o conclusions. 
Firstly, the increase o f  PS exposure in the m ost dense fraction obtained by 
density separation alone is not due to the old cells in that fraction, and, 
secondly, that there are no data to support the hypothesis that 
phosphatidylserine exposure constitutes a causal factor in the physiological 
removal o f  old cells in  vivo. Notwithstanding, exposure o f  PS is w idely  
implicated as a trigger for the removal o f  old erythrocytes. The arguments for 
this theory are mainly based on data from pathological erythrocytes, and on 
results from manipulation o f  erythrocytes in  v itro . In general, all processes 
that lead to increased erythrocyte destruction are associated with increased 
exposure o f  PS. In view  o f  this evidence, together with the general role that 
PS plays in recognition and removal o f  apoptotic cells, w e can not exclude 
that PS m ight have a role in normal erythrocyte aging. Exposure o f  PS may
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lead to such a rapid removal that it is underestimated in erythrocytes from  
healthy individuals, the so-called Piom elli paradox (Piom elli, 1988).
Starting from the same w ell-defined fractions as described above, w e were 
able to confirm previous reports on the occurrence o f  structural and 
im m unological changes in band 3 during erythrocyte aging in vivo (Kay, 
2005). These changes were especially apparent with antibodies reactive with  
epitopes in the N-terminal part o f  the membrane domain. These antibodies 
show an age-related increase in immunoreactivity, which leads us to conclude 
that age-related changes in band 3 occur principally in regions that participate 
in the generation o f  senescent cell antigens. Subtle changes occurring in 
intact band 3 proteins may generate activity o f  senescent cell antigen; 
breakdown o f  band 3 may not be necessary for this process (Kay, 2005).
A new model: vesiculation as an essential process in erythrocyte aging 
(Chapter 6)
These data taken together, erythrocyte vesiculation should be regarded as a 
hitherto undiscovered aspect o f  erythrocyte aging. W e integrated vesiculation  
in a new  hypothesis o f  erythrocyte aging. The first step in this hypothesis is 
protein m odification, especially oxidation and proteolysis o f  haem oglobin  
and/or band 3. This results in band 3 breakdown and binding o f  denatured 
haem oglobin to band 3 and membrane-bound band 3 breakdown products. 
This process disturbs the anchorage o f  the lipid bilayer to the cytoskeleton. 
The membrane exerts a stretching force on the cytoskeleton network, and a 
disturbance o f  the cytoskeleton-membrane interaction diminishes this 
stretching force. This causes, at the site o f  membrane damage, relaxation o f  
the cytoskeleton, which drives the plasm a membrane to buckling. The buckle 
pinches o ff  easily, forming a vesicle with a surface area o f  one cytoskeleton  
unit. The m odel o f  the stretched cytoskeleton predicts the transition o f  excess  
surface area from neighbouring cytoskeleton network units to the membrane 
buckle (Sens & G ov, 2007). This causes the shedding o f  larger vesicles. In 
this vesiculation mechanism, the loss o f  lipid asymmetry o f  the membrane 
nor the binding o f  autologous IgG are necessary. Alternatively, aggregation 
o f  band 3 breakdown products, possibly driven by binding o f  hemichromes,
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can contribute to vesiculation by inducing an increase in membrane 
curvature. In experimental erythrocyte vesiculation, the shape transition o f  
the erythrocyte from discoid cell to an echinocyte appears to be an essential 
step in vesiculation. The vesicles seem  to pinch o f f  at the top o f  echinocytic 
protrusions, where the membrane curvature is extrem ely large.
The presence o f  PS-exposing, erythrocyte-derived vesicles implicates the 
existence o f  additional m echanisms leading to the loss o f  lipid asymmetry o f  
the plasma membrane. An increased intracellular Ca2+-concentration plays a 
central role in the loss o f  lipid asymmetry in platelet activation and in various 
experimental erythrocyte vesiculation m odels. An increased Ca2+- 
concentration inhibits the enzym e flippase, which is responsible for the 
maintenance o f  the lipid asymmetry, and activates scramblase, responsible 
for the rapid and aspecific exchange o f  membrane lipids between the inner­
and outer-leaflet o f  the membrane. A t the site o f  band 3 associated  
hem oglobin-induced damage, volum e-sensitive cation channels could be 
activated or the activity o f  Ca2 -ATPase may becom e impaired. A s a result o f  
the locally increased Ca2+-concentration, not only PS appears at the outer 
leaflet o f  the membrane, but also Ca2+-dependent proteolysis and breakdown 
o f  phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5- 
biphosphate is induced. A ll these effects contribute to a further weakening o f  
the interaction between cytoskeleton and the lipid bilayer, inducing vesicle  
shedding. W hether the release o f  potassium with a concomitant loss o f  water 
through the activation o f  the Gardos channel in  v ivo  is as important as it 
seem s to be in experimental erythrocyte vesiculation, is unknown.
The PS-exposing vesicles partially contain IgG, which presumably 
recognizes senescent cell antigens. Binding o f  imm unoglobulines influences 
the shape o f  the plasma membrane, especially when dimerisation or 
oligom erisation o f  membrane components occurs. In experimental 
conditions, binding o f  antibodies to various membrane proteins as 
glycophorin A , acetylcholinesterase or glycophorin C causes vesiculation. 
Thus, binding o f  natural, autologous IgG to senescent cell antigens may 
contribute to aging-associated vesiculation.
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Detachm ent o f  the p lasm a membrane fro m  the cytoskeleton: a key event in  
vesicu lation
After the initial damage, several m echanisms m ay occur that all contribute to 
a weakening o f  the interaction between cytoskeleton and plasma membrane, 
which leads to the shedding o f  vesicles. This m ay explain the marked 
heterogeneity o f  the erythrocyte-derived vesicles. B y this process the initial 
damage can be removed.
A  disturbance o f  the interaction between cytoskeleton and plasma membrane 
in the aging erythrocyte, leading to relaxation o f  the local cytoskeleton unit 
and buckling o f  the plasma membrane, resulting in vesicle formation, could  
serve as a m odel for vesiculation o f  other cells.
Consequences f o r  physiology, patho fys io logy and  transfusion o f  erythrocytes 
(Chapter 7)
Our findings have various consequences for the physiology o f  vesiculation  
and for the interpretation o f  the presently available data on erythrocytes and 
haemoglobin:
(1) Vesiculation as a process that is induced by membrane damage and that 
subsequently removes the damaged membrane patch as a part o f  the shed 
vesicles, including the associated removal signalling m olecules, may also be 
present in other cells.
(2) The detailed characterization o f  the changes in band 3 in vesicles may 
extend our knowledge about the m olecular nature o f  the senescent cell 
antigen activity.
(3) The close relation o f  the volum e o f  the erythrocyte and erythrocyte age 
indicates the existence o f  a hom eostatic regulation mechanism. In a recent 
proteomic analysis, several proteins associated with signal transduction were 
found to be differentially enriched in the membrane o f  the senescent 
erythrocyte, and/or in the vesicle proteome as compared to the erythrocyte 
membrane (Bosm an et a l , 2009).
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(4) The observed loss o f  surface area causes doubts about the interpretation 
o f  the disappearance curves o f  erythrocytes that were obtained by labelling  
with D F32P, which binds to the membrane-bound acetylcholinesterase. W ith 
20 % loss o f  surface area by vesiculation, this approach o f  measuring 
erythrocyte lifespan implicates a life span longer then 120 days. These data 
are supported by the observation that even after 35 days o f  storage, a portion 
o f  the erythrocytes survives for 120 days after transfusion. Furthermore, in a 
recent study the lifespan o f  the erythrocyte was shown to range from 100 to 
140 days in healthy subjects, influencing the H bA 1c percentage in healthy 
individuals (Cohen et a l, 2008).
(5) Our data on the m etabolism  o f  H bA 1c strongly suggest that loss o f  splenic 
function, which occurs in 25% o f  elderly persons, causes an increase 
independently o f  an increased mean glucose concentration. This effect 
warrants caution about the interpretation o f  H bA 1c-percentage in elderly 
individuals.
(6) In patients with hereditary spherocytosis (HS) the loss o f  surface area by 
vesiculation is due to the underlying genetic defect in cytoskeleton or 
membrane. Furthermore, the spleen contributes to the dehydration, but also to 
the loss o f  surface area by its vesiculation-promoting activity. Thus, 
splenectom y not only prevents dehydrated microspherocytes to be trapped in 
the splenic vasculature, but also alleviates the loss o f  surface area by 
vesiculation. Although the spherocytosis and the abnormal osm otic fragility 
do not disappear, the survival time o f  the H S erythrocytes normalizes and the 
formation o f  dehydrated microspherocytes decreases after splenectomy.
(7) V esiculation also occurs in erythrocyte units stored under blood bank 
conditions. This constitutes a storage lesion that does not contribute to 
oxygen transport and possibly overloads the mononuclear phagocytic system. 
Studies on the in  vivo  survival o f  stored erythrocytes demonstrate that a 
considerable portion o f  donor erythrocytes do not survive the first day in the 
recipient (Bosm an et a l, 2008). It can not be excluded that stored erythrocytes 
that survive the first day after transfusion more readily lose haem oglobin by 
vesiculation than autologous erythrocytes. Thus, identification o f  the
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mechanism responsible for the generation o f  in  v itro  aged erythrocytes are o f
utmost importance for the improvement o f  erythrocyte units for transfusion,
especially in im mune-compromised and transfusion-dependent patients.
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Vesiculatie en rode bloedcellen: een overlevingsstrategie
Rode bloedcellen worden gevormd in het beenmerg. N a 120 dagen 
verdwijnen ze uit de bloedbaan. In de laatste weken van hun leven treden 
veranderingen in de celmembraan op, die direct o f  indirect worden 
opgemerkt door opruimcellen -  macrofagen. D eze macrofagen pakken de 
oude rode bloedcellen op en breken deze af.
In de loop van hun leven verliezen rode bloedcellen hem oglobine, het eiw it 
dat de rode bloedcel zijn kleur geeft en verantwoordelijk is voor het transport 
van zuurstof. D e rode bloedcellen worden kleiner en verliezen water. Omdat 
ze relatief m eer water verliezen dan hem oglobine neem t hun dichtheid toe.
In dit proefschrift is gezocht naar de oorzaak van het hem oglobineverlies. Dit 
verlies bleek plaats te vinden via hem oglobine bevattende blaasjes die door 
de rode bloedcel worden afgestoten: vesiculatie. Vesiculatie is een belangrijk 
algem een biologisch proces dat bij veel functies betrokken is. H et bleek  
m ogelijk enige details van de functie van vesiculatie in rode bloedcellen te 
ontrafelen.
In  hoofdstuk 1 wordt een schets gegeven van de ontwikkeling van het 
onderzoek naar leeftijdsafhankelijke veranderingen van de rode bloedcel. Een 
methode die rode bloedcellen eerst scheidt op grootte en daarna op dichtheid 
levert celfracties op, die aanmerkelijk in leeftijd verschillen.
Eerder onderzoek heeft aangegeven dat de milt een bijzondere functie voor 
de rode bloedcel heeft, met name voor de verwijdering van insluitsels.
H et onderzoek dat is gedaan naar de betekenis van herkenningsmoleculen  
voor de verwijdering van oude rode bloedcellen laat zien dat hierbij 
veranderingen van een eiw it, band 3, dat een belangrijk deel uitmaakt van de 
membraan van rode bloedcellen, van belang zijn. Band 3 is verantwoordelijk 
voor het transport van bicarbonaat en levert zo een bijdrage aan de transport 
van kooldioxide (CO2) van de w eefsels naar de longen. Op band 3 ontstaan 
verouderingsantigenen die natuurlijk voorkomende autoantistoffen 
aantrekken. D eze autoantistoffen op de oude rode bloedcel leiden tot
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herkenning door macrofagen, die vervolgens deze oude rode bloedcellen  
verwijderen. Autoimmuniteit heeft hier dus een fysiologische functie.
Een tweede belangrijk algem een herkenningsmolecuul voor verwijdering is 
een bestanddeel uit de membraan van cellen, het fosfolipide fosfatidylserine, 
dat normaal alleen in de binnenkant van de membraan voorkomt. A ls het aan 
de buitenkant verschijnt, wordt het herkend door macrofagen en bevordert 
het de stolling. D it laatste effect kan bijdragen aan trombose.
In  hoofdstuk 2 is beschreven hoe verschillende hem oglobinecom ponenten  
bijdragen aan het hem oglobineverlies. In de eerste helft van het leven van de 
rode bloedcel blijkt de afname van de genetisch bepaalde hem oglobinen  
(HbA0, HbF en H bA2) vooral veroorzaakt te worden door chem ische 
veranderingen. Vooral de omzetting naar HbA1c, een reactie product van 
H bA0 en glucose, valt op. D it H bA ic, wordt gebruikt bij de controle van 
diabetes mellitus. Bij ontregelde suikerziekte is het percentage H bA ic te 
hoog. In de tweede helft van hun leven verliezen rode bloedcellen ook de 
veranderde hem oglobinen zoals H bA ic. In de tw eede helft van het leven van 
de rode bloedcel is het verlies van totaal hem oglobine duidelijk groter dan in 
de eerste helft.
In hoofdstuk 3 komt de rol van vesiculatie bij het hem oglobineverlies ter 
sprake. De vesikels zijn bekeken met behulp van de elektronenmicroscoop. 
Ze variëren sterk in grootte m et een diameter van 200 -  800 nm.
In de vesikels blijken dezelfde hem oglobinecom ponenten aanwezig te zijn als 
in rode bloedcellen ze lf en hun onderlinge verhouding is dezelfde als die van 
oude rode bloedcellen.
Eerder is gevonden dat binnen in de rode bloedcellen van personen, die hun 
milt m issen, blaasjes voorkomen, in dit geval vacuolen genaamd. Daarom is 
bij dergelijke personen gekeken naar het verlies van hem oglobine. Bij deze 
personen treedt het extra verlies van hem oglobine in de tw eede helft van het 
leven van de rode bloedcel niet op. Er treedt een retentie van hem oglobine in 
de rode bloedcel op samen met een hoger percentage HbA1c terwijl er geen
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sprake is van suikerziekte. De milt blijkt dus nodig voor normale vesiculatie  
van rode bloedcellen.
In hoofdstuk 4 is onderzocht hoe vesikels overleven in de bloedbaan. Voor dit 
onderzoek is gekozen voor een diermodel, de rat. In de rat blijken de rode 
bloedcellen hem oglobine te verliezen zoals in de mens. Uit het bloed konden 
vesikels worden geïsoleerd. De vesikels die van rode bloedcellen afkomstig 
waren, konden gemerkt worden m et radioactief chroom. H et bleek dat de 
vesikels snel uit de bloedbaan verdwijnen en dat de helft van de 
radioactiviteit in de lever teruggevonden werd en w el vooral in de 
macrofagen van de lever, de Kupffercellen. De overige activiteit was 
verdeeld over verschillende andere organen.
In dit model is onderzocht hoe de macrofagen de vesikels herkennen als te 
verwijderen partikels. In deze experimenten zijn de herkenningsplaatsen, 
receptoren, die op de macrofagen voorkom en specifiek geblokkeerd vlak  
voor de toediening van de vesikels.
H et bleek dat fosfatidylserine leidt tot de snelle verwijdering van de vesikels. 
Fosfatidylserine blijkt dan ook op de buitenkant van deze vesikels voor te 
komen.
In hoofdstuk 5 zijn de vesikels die uit bloed van m ensen werden geïsoleerd  
onderzocht op het voorkomen van verwijderingsignalen. Ook is onderzocht 
o f band 3 voorkomt in vesikels en o f  veranderingen daarvan aangetoond 
kunnen worden. Bovendien is een methode ontwikkeld om vesikels te tellen  
in de bloedbaan.
Er zijn maar heel w einig vesikels in de bloedbaan, 170 per ^l, ongeveer 
1000x minder dan bloedplaatjes. Een rode bloedcel maakt gem iddeld  
ongeveer 2 vesikels per dag, dat zijn in totaal 850 miljoen vesikels per 
seconde. D it betekent dat vesikels heel snel opgepakt worden door 
macrofagen. Omdat bijna 70% van de vesikels fosfatidylserine aan de 
buitenkant van de membraan heeft, is de snelle verwijdering van belang om  
trombose te voorkomen.
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Een aanzienlijk deel van de vesikels, die fosfatidylserine aan de buitenkant 
vertonen, draagt ook IgG-antistoffen die leiden tot herkenning en 
verwijdering door macrofagen. Tenslotte zijn in de vesikels afbraakproducten 
van band 3 gevonden, die geassocieerd zijn met de verouderingsantigen die 
eerder op oude rode bloedcellen zijn gevonden. D eze verouderingsantigenen  
zijn in hogere concentratie aanwezig op vesikels dan op oudere rode 
bloedcellen.
M eting van fosfatidylserine aan de buitenkant van rode bloedcellen laat zien  
dat maar 0,1 % van de rode bloedcellen fosfatidylserine aan de buitenkant 
vertonen. De jongste fractie nog het meest, waarschijnlijk w egens het 
rijpingsproces van reticulocyten, de directe voorloper van de rijpe rode 
bloedcel. Het voorkom en van fostatidylserine op de buitenkant van de rode 
cel is dus niet leeftijdsafhankelijk en speelt dan ook waarschijnlijk geen rol in 
de verwijdering van de oudste rode bloedcellen. Het is echter niet uitgesloten  
dat als fosfatidylserine aan de buitenkant van de rode bloedcel verschijnt, 
deze rode bloedcel zo snel uit de bloedbaan verwijderd wordt, dat z o ’n rode 
bloedcel niet is aan te tonen. W el konden in de oudste rode bloedcelfracties 
veranderingen in band 3 gevonden worden, die overeenkom en met wat eerder 
is gevonden, maar die minder ingrijpend zijn dan de veranderingen van band 
3 in vesikels.
D eze gegevens wijzen erop dat vesiculatie een belangrijke functie heeft in het 
schoonhouden van de rode bloedcelmembraan. De rode bloedcel verwijdert 
via  vesiculatie beschadigde stukken membraan met daarop 
herkenningsm oleculen voor verwijdering door macrofagen. Daardoor zal de 
rode bloedcel z e lf  niet door een macrofaag herkend worden. Waarom dat 
uiteindelijk w el gebeurt, blijft echter (nog) een raadsel.
In hoofdstuk 6 wordt een nieuw m odel beschreven voor de veroudering van 
de rode bloedcel. Beschadigingen aan band 3, die aanleiding geven tot 
afbraak o f  aggregatie van band 3, hebben als gevolg  dat de celmembraan 
loslaat van het onderliggende spectrinenetwerk, dat verantwoordelijk is voor 
de unieke elastische eigenschappen van de rode bloedcel. D it netwerk, dat 
onder strekspanning staat, zal iets inkrimpen waardoor de celmembraan een
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uitstulping vormt. Bovendien kan op de buitenkant van de membraan ter 
plaatse fosfatidylserine verschijnen en aan het beschadigde band 3 kunnen 
autoantistoffen binden. De uitstulping kan worden afgesnoerd en zo verlaat 
een beschadigd stukje membraan als vesikel de rode bloedcel. D eze vesikels 
dragen de bijbehorende herkenningsmoleculen voor verwijdering. De 
vesikels worden snel uit de bloedbaan verwijderd en de rode cel kan 
opgeruimd verder.
In de hoofdstukken 7 en 8 worden de recente en oudere gegevens samengevat 
en wordt aangegeven dat verschillende aspecten van fysio logie en 
pathofysiologie van rode bloedcellen min o f  meer in een ander daglicht 
kom en te staan:
(1) Vesiculatie als een proces dat op gang wordt gebracht door 
membraanbeschadiging en vervolgens de membraanbeschadiging verwijdert 
als onderdeel van het afgesnoerde vesikel van de cel zou ook bij andere 
cellen dan rode bloedcellen van toepassing kunnen zijn.
(2) Onderzoek naar veranderingen in band 3 in vesikels geeft m ogelijk meer 
informatie over verouderingsantigenen.
(3) De rol van moleculaire signaaloverdracht bij de opvallende 
leeftijdsafhankelijke volum eregulatie van de rode bloedcel verdient aandacht, 
nu recent de aanwezigheid en activiteit van verschillende signaaleiwitten in 
rode bloedcellen is aangetoond.
(4) De rode bloedcel zou w el eens langer kunnen bestaan dan 120 dagen. 
Recent is gebleken dat de leeftijd van rode bloedcellen niet voor iedereen  
even lang en som s w el 140 dagen is.
(5) Omdat bij 25% van de oudere m ensen de m ilt niet m eer volledig  
functioneert, moet daarmee bij de interpretatie van het percentage HbA 1c bij 
ouderen rekening worden gehouden.
(6) Bij erfelijke sferocytose, een ziekte m et ronde in plaats van schijfvormige 
rode bloedcellen treedt onder invloed van de milt een watertekort in de rode 
bloedcel op. H et effect van het verwijderen van de m ilt bij erfelijke
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sferocytose is echter niet alleen te danken aan het voorkom en van dit 
watertekort, maar ook aan het minder vesiculeren van de rode bloedcel, een  
proces dat immers door de m ilt wordt bevorderd.
(7) V esikels kom en ook voor in rode bloedcellen die bewaard worden voor 
transfusie. H et m oet uitgezocht worden o f  vesiculatie samenhangt m et het 
verschijnsel dat na transfusie tot w el 25% van de gegeven rode bloedcellen  
binnen 24 uur verdwijnt. A ls onderzoek het m ogelijk maakt deze rode 
bloedcellen die snel zullen verdwijnen van te voren te herkennen en te 
verwijderen, zal dat een enorme verbetering van de kwaliteit van het 
bloedproduct ‘rode b loedcellen’ betekenen en waarschijnlijk veel van de 
ongewenste bijeffecten van rode bloedceltransfusie doen afnemen, met name 
bij immuun gecompromitteerde patiënten en patiënten die regelmatig een 
transfusie m oeten ontvangen.
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Woord van dank
Dit proefschrift is het resultaat van samenwerking m et als kem  het Klinisch  
Chemisch en H em atologisch Laboratorium (KCHL) van Ziekenhuis Rijnstate 
en Streekziekenhuis Zevenaar, onderdeel van A lysis Zorggroep, de afdeling 
Interne Geneeskunde, Ziekenhuis Rijnstate, de afdeling Biochem ie en het 
Laboratorium voor M edische Im munologie (voorheen ABTI), St Radboud 
Universiteit N ijm egen M edisch Centrum en de Bloedbank Arnhem, thans 
onderdeel van de Stichting Bloedvoorziening Sanquin. Daarnaast hebben de 
afdeling Biopharmacie van de Universiteit Leiden en de afdeling M oleculaire 
Cel B iologie van de Universiteit Utrecht, bijgedragen aan dit onderzoek. Het 
stemt mij zeer dankbaar dat ons onderzoek in dit samenwerkingsverband 
m ogelijk was.
Beste Jan, voor mij ben je  de grote inspirator en drijvende kracht achter het 
onderzoek van de veroudering van de rode bloedcel. Jouw enthousiasme en 
aanhoudende energie heeft dit proefschrift m ogelijk gemaakt. Ik ervaar het 
als zeer bijzonder dat ik m et dit proefschrift een kwartet van proefschriften 
com pleet mag maken, dat zal getuigen van jouw  inspanningen op dit gebied  
en waaraan ik m et zoveel plezier heb m ogen bijdragen. Daarom w il ik je  
bijzonder hartelijk danken voor m eer dan 25 jaar intellectuele en 
wetenschappelijke samenwerking en vriendschap. Ik heb ervan genoten.
Beste Giel, ook jij bent z o ’n drijvende kracht. Jouw kom st heeft een  
w ezenlijke bijdrage en aanvulling betekend voor ons onderzoek. De  
gezam enlijke inspanningen en discussies om ideeën, resultaten en inzichten  
goed tot zijn recht te laten komen, heb ik altijd zeer gewaardeerd, al zag het 
som s rood en blauw voor mijn ogen. Bijzondere dank, ook voor jou.
Beste Irma, ik w il je  graag bedanken voor de warme belangstelling die je  
voor ons onderzoek hebt getoond en het wijdere perspectief waarin je  ons 
onderzoek plaatste. Dat grotere perspectief zie je  ook voor de 
laboratoriumgeneeskunde. Daarom is het een voorrecht onder jou w  hoede te 
promoveren.
183
Beste Ben, van jou  heb ik geleerd hoeveel nuances de Engelse taal kent en 
hoeveel valstrikken. Graag w il ik je  bedanken voor de gastvrijheid voor ons 
onderzoek op je  afdeling, voor de ondersteuning bij het schrijven, voor je  
geduld met mijn overenthousiaste planning. Ik w eet nu ook m eer over 
schim m els en fado. H et is goed samen Zeeuw te zijn, ieder aan zijn eigen  
zijde van de mond van de W esterschelde.
Beste Y vonne, de zeer gedegen uitvoering van experimenten heeft wezenlijk  
bijgedragen aan de resultaten van ons onderzoek, hoe bescheiden je  daar ze lf  
ook over bent. De voortreffelijke inrichting van het labjournaal is ons een 
aantal keren zeer van pas gekom en. Je administratieve vaardigheid is voor  
mij als een lichtend en onhaalbaar baken. Ik w il je  danken voor de vele jaren 
van inzet en samenwerking.
Beste Bregt, ook jouw  handen hebben veel degelijk experimenteel werk 
gedaan. Daarbij b lee fje  p ositief kritisch nadenken over nut en uitvoering. Dat 
vormde een zinvol onderdeel van onze discussie. Dank en waardering voor je 
werk.
Beste Theo en Kar, ik w il ju llie danken voor de plezierige samenwerking op 
het gebied van de klaring van vesikels in jullie rattenmodel.
Dank past ook aan de recent overleden Arie Verkleij voor het 
elektronenmicroscopisch werk aan vesikels.
Beste Vera en Annegeet, graag w il ik jullie bedanken voor je  belangstelling  
en je  bijdragen aan onze discussies en voor de m ogelijkheden die ju llie ons 
hebt geboden om ons onderzoek meer bekendheid te geven.
Bij een KCHL van een groot opleidingsziekenhuis hoort, zij het op 
bescheiden schaal, wetenschap. Ik dank de huidige en voorm alige leden van 
de vakgroep, Janneke, Pim, Darryl, W im  en Reinder voor de gelegenheid die 
zij mij hebben gegeven om dit vele jaren achtereen in te vullen. De open en 
collegiale sfeer waarin w e ons vak beoefenen en verder ontwikkelen, ook in 
bestuurlijke zin, waardeer ik zeer.
M edewerkers en leidinggevenden van het KCHL w il ik danken voor het 
begrip voor de extra bepalingen aan erythrocytenfracties, het medegebruik
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van de HPLC en de centrifuges en zoveel andere zaken, die het drukke 
routinepatroon hebben doorbroken. D it werk en dus dit proefschrift hoort bij 
onze afdeling, het KCHL. Jullie delen in de uitstraling ervan.
H et management van het KCHL, W im, Henk, Frank, Ron, Pim en Jos w il ik 
danken dat zij in tijden van steeds krimpende budgetten zo lang faciliteiten  
voor toegepast wetenschappelijk onderzoek hebben w illen  handhaven. Ik 
hoop dat het jullie lukt daar in een andere vorm w eer gestalte aan te geven.
De Raad van Bestuur van A lysis Zorggroep w il ik in de personen Gert de 
B ey en Jankees Cappon danken omdat zij zich blijvend inzet voor het klimaat 
van opleiding en wetenschap in onze ziekenhuizen, ingebed in onze primaire 
taak van patiëntenzorg. Ik heb m et veel genoegen in deze om geving gewerkt.
Beste Gerrit, als directeur destijds van de Bloedbank Arnhem, heb je  ons met 
menskracht en investeringen ondersteund. Dat is heel belangrijk gew eest 
voor de continuïteit van ons onderzoek. Hartelijk dank daarvoor.
Lieve Marian, thuis bij elkaar is onze basis. Jouw ondersteuning vanuit deze 
basis is onontbeerlijk gew eest voor het lezen van de vele lettertjes en het 
neerschrijven van zoveel woorden. Plots schieten nu woorden tekort om je  
dank te zeggen, dat je  er bent.
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Curriculum Vitae
D e schrijver van dit proefschrift is geboren op 9 februari 1947 te Middelburg. 
N a het behalen van het diploma Gymnasium B op het St. Oelbertgymnasium  
te Oosterhout (NBr), studeerde hij scheikunde aan de Katholieke Universiteit 
te Nijm egen. Hij rondde zijn studie in de biofysche chemie in 1972 a f  op een  
onderzoek over hem oglobine.
Hij heeft een aantal jaren gewerkt op het Instituut voor Pathologie van de St 
Radboud Universiteit aan onderzoek over kraakbeenveroudering en over 
ijzerstapeling. V anaf 1977 genoot hij de opleiding K linisch Chemie aan het 
laboratorium van het voorm alige Gemeente Ziekenhuis te Arnhem (opleiders 
Dr. E. Sindram en B.R. van Neerbos). Aan hetzelfde ziekenhuis, dat m et de 
andere Arnhemse ziekenhuizen opgegaan is in het Rijnstate Ziekenhuis, is hij 
vanaf 1981 tot heden verbonden gebleven als klinisch chem icus, eerst met 
aandachtsgebied endocrinologie en daarna m et aandachtsgebied hem atologie 
en transfusie.
Naast zijn werk als klinisch chem icus participeerde hij o.a. in samenwerking 
m et de afdeling Inwendige Geneeskunde van het Gemeente Ziekenhuis in 
onderzoek op diverse gebieden en verzorgde hij statistische ondersteuning 
voor verschillende andere afdelingen. Op het gebied van de veroudering van 
de rode bloedcel is hij nauw betrokken gew eest bij eerdere proefschriften die 
over dit onderwerp zijn geschreven.
Hij is lid gew eest van het stafbestuur en voorzitter van de 
transfusiecom m issie.
A ls lid van de sectie hem atologie van de SKZL en later als penningmeester 
heeft hij zich ingezet voor de kwaliteitsverbetering van de klinisch-chem ische 
en hem atologische bloedonderzoeken in Nederland. Hij w as een aantal jaren 
lid gew eest van de wetenschapscom m issie van de NVK C. Hij is betrokken 
gew eest bij de ontwikkeling van enkele landelijke richtlijnen.
Hij is vader van Femke, Steven en Maartje en grootvader van Simon en 
Celine. Hij is getrouwd met Marian van Bentum.
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Naschrift
An erythrocyte has one delight 
To circulate both day and night.
I stopped one as he passed m y w ay  
And asked him what he had to say. 
‘Our life ’ he said ‘is one o f  crises 
Lived in the fear o f  instant lysis  
This m ay help to explain’ he said 
‘our motto: better red than dead’
Bij overlevering van Ben de Pauw
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